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ABSTRACT
STRUCTURAL AND FUNCTIONAL STUDIES OF
UREA AMIDOLYASE

Yi Lin, B.E.
Marquette University, 2014
Urea amidolyase (UAL) is a key virulence factor that regulates the yeast to
hyphae switch in the opportunistic pathogen, Candida albicans. UAL is a multi-domain
enzyme with two enzyme activities: urea carboxylase (UC) and allophanate hydrolase
(AH). UC is a biotin-dependent carboxylase that adds a carboxyl group to urea to make
allophanate by the coordinated action of three domains. Allophanate is subsequently
hydrolyzed into NH3 and CO2 in the AH domain. Studies on the structure and function of
UAL may lead to treatments for systemic candidiasis and can serve to clarify the
molecular basis for multi-functional swinging arm enzymes.
In the present study, the first structure of AH was solved by X-ray
crystallography. Site-directed mutagenesis and steady-state kinetic analysis of
Granulibacter bethesdensis AH reveal a role for two residues, Tyr299 and Arg307, in
maintaining substrate stringency and providing transition state stabilization. In addition,
as UAL activity is essential for urea-dependent growth of yeast, a yeast genetic screen
was developed to identify key functional residues in UAL. Random mutations were
introduced in the targeted region of UAL, and the roles of an active site loop and distant
residues in catalysis were highlighted in AH. The mechanisms of intermediate transfer
between UC and AH were also studied. To investigate whether allophanate is channeled
between the active sites, co-purification studies and substrate channeling assays were
performed in vitro to detect stable or transient interactions between UC and AH. No
strong coupling was detected between UC and AH. In addition, the coupling efficiency
between the individual catalytic domains in UC is low, indicating that an as yet
undiscovered activator may serve to facilitate the coordination among the three catalytic
domains of UC. Taken together, these studies describe UAL as a complex, multifunctional enzyme that exhibits a high degree of substrate specificity in each domain, but
does not require efficient substrate channeling to accomplish catalysis. These descriptions
serve to advance the understanding of the mechanism of multi-functional enzymes as a
whole.
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CHAPTER 1: BACKGROUND
1.1 Multi-functional Enzymes Are Good Models for Understanding Enzyme
Mechanisms and Their Roles in Cell Metabolism
Life-sustaining metabolic processes in the cell are carried out through numerous
chemical reactions and require the coordination among many chemical reactions from
various biochemical pathways. Enzymes play a fundamental role in driving these
biochemical pathways. It is, therefore, critical to understand the catalytic mechanism and
regulation of metabolic enzymes. A great many metabolic enzymes exist as large, multiprotein assemblies (Kuriyan, Eisenberg 2007). However, studies of these multi-enzyme
complexes often prove to be difficult both kinetically and structurally, owing to their
large size and inherent flexibility. Besides these, their interactions can be transient,
making the problem more complex (Pereira-Leal et al. 2006). Therefore, multi-functional
enzymes serve as a good model system and a reasonable mimic for the mechanisms of
multi-enzyme complexes, because they are more kinetically and structurally amenable
(Arjunan et al. 2002). This dissertation describes kinetic and structural studies on the
multi-functional enzyme urea amidolyase (UAL). Through studies of how individual
domains of UAL catalyze specific chemical reactions and from the description of how
these domains coordinate their catalytic activities, it is anticipated that a more complete
description of coordinated catalysis in multi-component enzymes will begin to emerge.
1.2 Discovery and Early Characterization of UAL
Urea (or carbamide) is a simple organic molecule, with two –NH2 groups joined
by a carbonyl group. It was first discovered in urine by Herman Boerhaave in 1727, and
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was the first organic compound ever synthesized from inorganic materials in 1828 by
Friedrich Wöhler. Therefore, urea is considered the chemical that gave birth to the field
of organic chemistry. In 1926, James B. Sumner was able to isolate the urea-degrading
enzyme, urease. It became the first enzyme to be isolated and crystallized. This finding
not only represented the first crystalline enzyme, but also proved that the nature of the
enzyme is protein, which is another milestone in the development of modern
enzymology. In 1969, a new urea-degrading enzyme was described as an inducible, ATPdependent enzyme that exists in urease-negative yeast and uni-cellular green algae
(Rognes et al. 1969). This marked the initial discovery of UAL. Early studies
demonstrated that UAL was inhibited by purified egg white avidin, strongly suggesting
that it is a biotin-dependent enzyme (Rognes et al. 1969, Roon et al. 1972). Subsequent
studies of UAL in Candida utilis and Saccharomyces cerevisiae showed that UAL is
induced by urea and also by various compounds that can be degraded to urea (Roon,
Levenberg 1972). Ultimately, the enzyme was shown to be a ~ 202 kDa monomeric
multi-functional enzyme harboring two distinct activities: the avidin sensitive urea
carboxylase activity and the avidin insensitive allophanate hydrolase activity (Whitney et
al. 1973). It catalyzes the decomposition of urea through three consecutive reactions:
biotin carboxylation, urea carboxylation and allophanate hydrolysis. UAL was first
discovered in prokaryotes in 2004, and the prokaryotic enzyme has the urea carboxylase
and allophanate hydrolase activities on two separate proteins (Kanamori et al. 2004).
Despite these early studies on UAL, the enzyme was a largely ignored member of the
biotin-dependent enzyme family, perhaps because it is not present in humans and is not
involved in any major mammalian metabolic pathways.

3
1.3 UAL Is a Virulence Factor in Microbial Pathogenesis
A breakthrough in UAL studies occurred in 2009, when UAL was determined to
be a key virulence factor for the fungal pathogen Candida albicans. This is the first time
that UAL was discovered to be involved in human pathogenesis and thus brought UAL
back to people’s attention. UAL is the terminal enzyme of urea degradation and arginine
catabolism (Roon et al. 1972, Ghosh et al. 2009). Humans and higher eukaryotes do not
have the enzymes for urea metabolism, and urea is excreted and can be further degraded
by microorganisms. Urea-dependent signaling pathways play important roles in microbial
pathogenesis. Urea is hydrolyzed by urease in a wide range of species including plant,
fungi and bacteria. Extensive research has determined the critical role of urease in the
pathogenesis of Helicobacter pylori. H. pylori is a gram-negative bacteria that selectively
colonizes the human stomach. It may cause chronic gastritis, peptic ulcer, gastric
carcinoma and lymphoma, leading to its classification as a class I carcinogen (Cox et al.
2000, Follmer 2010).
A small group of fungi and a select group of bacteria, abandoned the use of Ni2+containing urease and, instead, use the Ni2+- and Co2+-independent UAL to catalyze urea
degradation (Navarathna et al. 2010). In bacteria, UAL has been found in representative
members of the α-, β-, and γ-proteobacteria, the chlamydiae-verrucomicrobia group and
the acidobacteria (Strope et al. 2011). In fungi, UAL is found in the two Ascomycota
classes (Sordariomycetes and Saccharomycetes), which do not have any Ni2+- or Co2+dependent enzymes, thus avoiding the acquisition of the necessary trace amount of Ni2+
and Co2+ (Navarathna et al. 2010).
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UAL is a key virulence factor in the opportunistic fungal pathogen Candida
albicans, which can cause lethal systemic infections in immunocompromised patients
(Ghosh et al. 2009, Navarathna et al. 2012). In the mammalian innate immune system,
phagocytic cells such as neutrophils and macrophages provide non-specific defense
against C. albicans infection. However, C. albicans undergoes a yeast-to-hyphae switch
inside macrophage cells, allowing the fungus to pierce through and escape from the
macrophage. The yeast-to-hyphae switch is a critical step in the ability of C. albicans to
evade the immune system (Berman, Sudbery 2002, Navarathna et al. 2012). C. albicans
cells that were rendered defective in the formation of hyphae were both less virulent in
animal models and more sensitive to macrophage engulfment and growth inhibition
(Morris 2006, Morris 2005). The urea-dependent signaling pathway plays an important
role in regulating the morphological switch. Urea was found to be the nitrogen source for
C. albicans that promotes mycelium growth (Morris 2002). Following internalization by
macrophages, C. albicans rapidly upregulates a set of arginine biosynthetic genes,
including the genes encoding arginase and UAL. The degradation of urea by UAL results
in the formation of NH3 and CO2; both are critical factors to trigger the switch (Figure
1.1). It has been reported that the formation of germ-tubes was enhanced in C. albicans
by incubation in atmospheres containing elevated CO2 (5-10%) (Cottier et al. 2013). Also,
the production of NH3 by UAL helps C. albicans to raise the extracellular pH, and thus
autoinduce hyphal morphogenesis (Vylkova et al. 2011). Nickerson and coworkers
constructed a UAL knockout strain of Candida albicans KWN6 (dur1,2Δ/dur1,2Δ), and
demonstrated that this strain could not make germ tubes in the presence of arginine or
urea, but did in the presence of 5% CO2. The complemented strain KWN8
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(dur1,2Δ::DUR1,2/dur1,2::DUR1,2) was able to escape from a murine macrophage cell
line (Ghosh et al. 2009). Follow up studies of these UAL mutants in a mouse model of
disseminated candidiasis revealed that UAL contributes to defects in the kidney
Interleukin-1 inflammatory pathway and that UAL is important for kidney and brain
colonization during disseminated candidiasis (Navarathna et al. 2012). In addition to
Candida albicans, the pathogenic bacteria Granulibacter bethesdensis is also postulated
to survive in the low-pH intracellular environment of macrophages and neutrophils
through the degradation of urea by UAL (Greenberg et al. 2010, Greenberg et al. 2006).
This may allow Granulibacter infections to persist in patients with chronic
granulomatous disease. These studies implicate UAL as an important virulence factor in
microbial infections and suggest that it is a new potential target for treatment of these
infectious diseases.

Figure 1.1 Metabolic pathways for urea amidolyase.
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1.4 Reactions and Mechanisms of UAL
UAL hydrolyzes urea into NH3 and CO2 in a two-step process catalyzed by two
distinct enzyme activities: urea carboxylase (UC, EC 6.3.4.6) and allophanate hydrolase
(AH, EC 3.5.1.54) (Figure 1.2). In many fungi, including Saccharomyces cerevisiae and
C. albicans, UC and AH reside on a single polypeptide chain (Whitney, Cooper 1972). In
bacteria, UC and AH always exist as two physically separate enzymes (Kanamori et al.
2004, Strope et al. 2011). UC belongs to the biotin-dependent enzyme family and
contains three domains that are found in all biotin dependent carboxylases. It utilizes a
“swinging arm” mechanism to transfer a carboxyl group from bicarbonate to urea,
forming allophanate (carbamoylcarbamate). Allophanate is subsequently hydrolyzed by
AH, a member of the amidase signature family which is known to hydrolyze a wide
variety of amide substrates (Waheed, Castric 1977, Lin, St. Maurice 2013).

A.

B.
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Figure 1.2 Domain structures and reactions catalyzed by UAL
In 2012, the structure of UC from Kluyveromyces lactis was solved, which helped
to correlate its structure with the catalytic mechanism (Fan et al. 2012). It utilizes biotin,
a prosthetic metabolite consisting of a valerate side chain attached to a bicyclic ring
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composed of fused ureido and tetrahydrothiophene rings (Figure 1.3), as a cofactor to
transfer carboxyl group among domains (Lombard, Moreira 2011). Also, as a member of
biotin-dependent enzyme family, it contains a common three-domain organization
harboring the biotin carboxylase domain (BC domain), the carboxyltransferase domain
(CT domain) and the biotin-carboxyl carrier protein domain (BCCP domain).

O
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Figure 1.3 Structure of carboxybiotin tethered to a lysine residue.
The BC domain catalyzes the ATP-dependent carboxylation of biotin. It is a
member of the ATP grasp enzyme superfamily. Structurally, it can be divided into three
subdomains. The N-terminal A subdomain consists of a five parallel β-sheet flanked by αhelices. The C-terminal C subdomain is the largest and consists of an 11-stranded
antiparallel β-sheet and 7 α-helices. The A and C subdomains together form the binding
pockets for biotin, (Mg2+)2ATP and HCO3-. The B subdomain contains a four stranded
antiparallel β-sheet flanked by two α-helices on one side. The B subdomain directly
interacts with the ATP substrate and undergoes a 45° rotation relative to the A- and Csubdomain upon nucleotide binding, which is thought to facilitate catalysis (Waldrop et
al. 1994). A conserved glycine rich loop (T-loop) connects the second and third β-strands
of the B subdomain, and its structure undergoes disordered-ordered transition upon
nucleotide binding, forming hydrogen bonds with β- and γ- phosphate oxygen atoms of
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ATP (Waldrop et al. 2012). Two Mg2+ ions are bound in the BC domain to help position
the ATP correctly in the active site. The “ATP-grasp” was named after this rotational
property of the B subdomain and the interaction of the T-loop with the phosphate oxygen
upon ATP binding (Novak et al. 2009). The reaction mechanism of the BC domain is
conserved in all biotin-dependent carboxylase. The E. coli acetyl-coA carboxylase (ACC)
BC domain has been extensively studied and is a well-characterized example of the
conserved BC domain mechanism. Sequence and structural alignment of K. lactis UC
with the ACC BC domain reveal that the positions of conserved catalytic residues are the
same. Therefore, the mechanism of the BC domain from UC is expected to be the same
as that in the ACC BC domain. The overall reaction has been proposed to occur in four
steps. Three substrates, BCCP tethered biotin, HCO3- and ATP bind at the interface
between the B subdomain and the C subdomain and triggers a conformational change in
the B subdomain, from an open state to a closed state (Waldrop et al. 1994). The reaction
is initiated by nucleophilic attack of the O1 atom of bicarbonate on the γ-phosphate of
ATP, leading to the formation of carboxyphosphate. Subsequently, a conserved general
base, Glu918 attacks the unstable carboxyphosphate intermediate, and it decomposes to
produces CO2 and PO43-. Third, the phosphate group acts as a general base that extracts
the proton from the N1 atom of biotin, leading to enolized biotin, which is stabilized by
the positive charge of Arg960. Finally, the biotin enolate attacks the CO2 and leads to the
formation of carboxylated biotin (Chou et al. 2009) (Figure 1.4).
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Figure 1.4 Reaction mechanism of the BC domain of UAL.
The BCCP domain is a signature characteristic for all biotin dependent family
enzymes. It has a consensus MK*E motif near the C-terminus, where biotin is covalently
tethered to the conserved lysine residue by the enzyme biotin protein ligase (Bower et al.
1995). This domain is composed of 7-8 antiparallel β-strands. BCCP forms a “swinging
arm” that extends 30-40 Å from the core of the protein, which has enough inherent
flexibility to swing between the distantly located BC and CT active sites (Fan et al.
2012).
The CT domain is the least conserved among the biotin-dependent carboxylases,
as it carboxylates different substrate in different enzymes. This domain provides the
specificity toward different substrates. One unique feature of UAL is that it is the only
enzyme in the family to add a carboxyl group onto a carbamide, compared to keto acid
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(e.g. pyruvate carboxylase), or thioester (e.g. acetyl-coA carboxylase) (Waldrop et al.
2012). To generate an enolate intermediate, the enzyme must abstract a proton from urea,
which has a relatively high pKa compared to the carbon acid substrates acted on by other
members of the family (Lundblad, Macdonald 2010). However, based on the structure of
Kluyveromyces lactis UC, it was suggested that, although the catalytic residues may vary
from other biotin-dependent carboxylases, the basic mechanism should be conserved in
this family (Waldrop et al. 2012). According to the structure of KlUC, the CT domain of
UC is composed of four subdomains (Fan et al. 2012). Subdomain A is a β-sandwich
flanked by an α-helix. Subdomain C forms mainly a five-strand antiparallel β-sheet with
two α-helices. Subdomains B and D share a very similar structure. They have an eightstranded antiparallel barrel structure, with two α-helices enclosing the barrel from either
side. There are two binding sites in the CT domain: one is the biotin binding site and the
other is for binding of urea and divalent cations. The reaction is carried out through two
critical steps. First, the BCCP tethered carboxybiotin translocates to the biotin binding
site in CT domain, where it decarboxylases spontaneously, to yield CO2 and the biotin
enolate. Then, a general base is required to enolize the substrate. Although urea exhibits a
relatively high pKa compared to carbon acid substrates in other biotin-dependent
carboxylases, it has been proposed that, similar to other biotin-dependent carboxylases,
UC utilize a general base, specifically Lys1605 in KlUC, to extract the proton from the
substrate, urea, to generate an enolate intermediate. During this reaction, the stabilization
of the two enolate anions, biotin enolate and substrate enolate, is critical (Jitrapakdee,
Wallace 2003, Waldrop et al. 2012). The CT domains largely differ in the strategies used
for enolate stabilization. In pyruvate carboxylase (PC), a conserved threonine (Thr908 in

11
the human PC, Thr876 in Staphylococcus aureus PC and Thr882 in Rhizobium etli PC)
plays such a role (St Maurice et al. 2007, Xiang, Tong 2008). In KlUC, the Asp1584,
Tyr1628 and Gly1635 are within hydrogen bond distance and together stabilize the substrate
enolate. The enolate intermediate subsequently attacks the CO2 released from
carboxybiotin, to form the final carboxylated product (Fan et al. 2012) (Figure 1.5).

Figure 1.5 Reaction mechanism of the CT domain of UAL.
1.5 UAL is A Good Model for Studies of Intermediate Transfer in Multi-functional
Enzymes
To facilitate sequential reactions in cell metabolic pathways, enzymes often
associate to form higher levels of organization, in the form of multi-enzyme complexes.
One well-characterized example is the enzymes for glycolysis, which physically associate
into a large enzyme complex to catalyze the serial reactions of glycolysis (Graham et al.
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2007). Other examples include the supercomplexes in oxidative phosphorylation (Wittig
et al. 2006) and enzyme complexes in fatty acid synthesis (Hammes 1981). There are
many advantages associated with the formation of multi-enzyme complexes. The
complexes organize enzymes in specific conformations so as to deliver metabolic
intermediates to precise locations for catalysis and to prevent the loss of intermediates to
enzymes in competing pathways (Spivey, Ovadi 1999). Moreover, multi-enzyme
complexes are more kinetically efficient and protect unstable intermediates against
chemical breakdown (Zhang 2011).
Evolution has favored a related strategy in certain enzymes that are multifunctional, where several distinct enzymatic activities are fused in a single polypeptide
chain or are arranged as subunits within an overall quaternary structure. Therefore, multifunctional enzymes serve as an ideal model system for studying the complexities of
intermediate transfer among distinct active sites and coordination between individual
catalytic domains. Intermediates are typically directly transferred in multifunctional
enzymes by one of three routes: swinging arms, channels and tunnels, and electrostatic
highways (Spivey, Ovadi 1999). Two representative examples for the first group,
swinging arm enzymes, are pyruvate dehydrogenase and biotin-dependent carboxylases.
They use a “swinging arm” which covalently attaches a prosthetic chemical group to
transfer a modified group from one active site to another, directly and precisely
(Jitrapakdee et al. 2008, Arjunan et al. 2002). The second class of intermediate transfer is
through “channels or tunnels” which physically connect the two enzymes to allow direct,
non-covalent transfer of a reaction intermediate from one catalytic center to another,
without dissociation and diffusion through the bulk solvent. Examples include trytophan
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synthase (Hettwer, Sterner 2002) and carbamoyl phosphate synthase (Raushel et al.
1998). The crystal structure of carbamoyl phosphate synthase revealed the presence of a
~3.3 Å wide, 96 Å long intra-molecular tunnel, which is thought to facilitate the transfer
of the metabolic intermediates, carboxyphosphate and carbamate, between three remote
active sites (Thoden et al. 1997). The third category of intermediate transfer is through an
external “electrostatic highway”, where a charged intermediate is guided from one active
site to another through the electrostatic surface connecting two distant active sites. This
type of intermediate transfer is specific for charged intermediates. A classic example of
this type of intermediate transfer is the bi-functional thymidylate synthase-dihydrofolate
reductase. The negatively charged dihydrofolate intermediate was proposed to move
along a positively charged surface between two active sites (Atreya et al. 2003).
Specifically, for UAL, the urea carboxylase enzymatic activity shares a similar
mechanism with other biotin-dependent carboxylases, utilizing a tethered biotin cofactor
to transfer carboxylated biotin between active sites through a “swinging arm” mechanism
(Lombard, Moreira 2011). What’s more, the intermediate transfer between the
carboxyltransferase and AH domains could conceivably take place through direct transfer
in a channel or tunnel. Therefore, UAL is an ideal model for studies on intermediate
transfer in multi-functional enzymes.
1.6 Questions and Aims for This Study
UAL is of significant interest not only because of its importance in microbial
pathogenesis, but also because, compared to other biotin-dependent carboxylases, UAL
incorporates a fourth domain, AH. Therefore, UAL serves as an ideal and accessible
paradigm for studying multifunctional enzyme catalysis, suitable for description of
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coordination of catalytic events in a single multi-domain enzyme complex. This study is
focused on the structure and catalytic mechanism in the individual domains of UAL and
the coordination of catalytic activity among the individual domains of this multifunctional enzyme. This investigation is subdivided into four detailed studies, which are
the focus of each individual chapter. Chapter 3 is focused on studying enzyme specificity
in the AH domain, specifically by determining its X-ray crystal structure and
investigating the substrate specificity of wild-type and mutant forms of the enzyme using
steady-state enzyme kinetics. Chapter 4 centers on development of an unbiased yeast
genetic screen that can be used to investigate the key functional residues of UAL in vivo.
Chapter 5 is an investigation of domain coordination in UAL, specifically looking at
whether allophanate is channeled from AH to UC and the coupling efficiency among the
three domains of the UC portion of the enzyme. Chapter 6 details some studies on the
potential function of the C-terminal domain of AH. In addition, attempts to crystallize UC
and full-length UAL are documented in detail in Appendix 1.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Materials
IPTG, ampicillin, kanamycin, arabinose, NADH, galactose and all inorganic salts
were purchased from Research Products International Corp. (Mount Prospect, IL).
Dextrose was purchased from EMD Millipore (Billerica, MA). Pfu turbo polymerase was
purchased from Agilent Technologies, Inc. (Santa Clara, CA). T4 DNA ligase, restriction
enzymes and dNTPs were purchased from New England Biolabs (Ipswich, MA).
Profinity IMAC Ni2+-charged resin and all reagents for SDS-PAGE were obtained from
Bio-Rad (Hercules, CA). Q-sepharose fast flow resin was obtained from GE Healthcare
(Pittsburgh, PA). Potassium allophanate was prepared by hydrolyzing ethyl allophanate
(Acros Organics, Fisher Scientific, Pittsburgh, PA) as described previously (Whitney,
Cooper 1972). Mouse monoclonal antibody [9E10] to c-Myc (HRP) was purchased from
Abcam (Cambridge, UK). All other chemicals were purchased from Sigma-Aldrich (St.
Louis, MO). All primers were synthesized by Integrated DNA Technologies (Coralville,
IA).
The yeast expression vectors pESC-URA and YCplac33 were provided by Dr.
James Anderson, Marquette University. The pFA-6a-kanMX4 vector, the Saccharomyces
cerevisiae strain W303 (MATa/MATα {leu2-3, 112 trp1-1 can1-100 ura3-1 ade2-1 his311, 15} [phi+]) and D273-10B (MATα mal) was provided Dr. Rosemary Stuart,
Marquette University. The URA3-52 mutation strain MLY40 (ura3-52 MATα) was
obtained from the Heitman lab at Duke University (Lorenz, Heitman 1997).
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Genomic DNA from Pseudomonas syringae pv. tomato str. DC3000 (strain ATCC
No. BAA-871D-5) and Granulibacter bethesdensis (strain ATCC BAA-1260/CGDN1H1)

was obtained from the American Type Culture Collection (Manassas, VA). Genomic
DNA of Saccharomyces cerevisiae strain W303 (MATa/MATα {leu2-3, 112 trp1-1 can1100 ura3-1 ade2-1 his3-11, 15} [phi+]) and Candida albicans strain SC5314/ATCC
MYA-2876 was isolated following the genomic DNA extraction procedure described in
Chapter 2.2.2. Genomic DNA of Pantoea ananatis LMG20103 was obtained from Dr.
Teresa A. Coutinho, University of Pretoria, South Africa.

2.2 Molecular Biology Methods
2.2.1 Polymerase Chain Reaction (PCR) and Site-Directed Mutagenesis
For molecular cloning purposes, Pfu Turbo polymerase was used to ensure high
fidelity during the PCR amplification reactions. The PCR reaction was carried out by
adding DNA template (50-100 ng plasmid DNA or 250-500 ng genomic DNA), forward
and reverse primers (0.5-1 µl of 10 µM stock), dNTPs (1 µl of 10 mM stock), reaction
buffer (5 µl of 10 × stock) and nuclease free water to a total volume of 50 µl. Hot start
was performed at 95 °C for 5 min before addition of the Pfu Turbo DNA polymerase (2.5
U). This was followed by 35 cycles of denaturation (95 °C for 30 sec), annealing (Primer
Tm - 5 °C, for 30 sec) and elongation (72 °C for 1 min per kb of target). A final elongation
at 72 °C for 10 min was used to ensure full extension of the products. The final PCR
product was analyzed by gel electrophoresis on a 1% agarose gel with 0.1 µl/ml ethidium
bromide using 1 × TAE buffer (40 mM Tris-acetate pH 8.0; 1 mM EDTA pH 8.0) at 100
V for 1h. QuikChange site-directed mutagenesis was used for point mutation(s) and
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deletion mutation(s) in the gene of interest. The reactions were performed according to
the QuikChange® II XL site-directed mutagenesis kit instruction manual (Agilent, Santa
Clara, CA).
2.2.2 Restriction Digestion and Ligation
Restriction digestions of plasmid DNA and PCR products were performed in the
appropriate buffer, according to the NEB restriction digestion protocol. The digested
DNA fragments were separated on a 1% agarose gel followed by staining in 20 × Fast
Blast DNA Stain (Bio-Rad, Hercules, CA) for 20 min. The DNA of interest was excised
from the gel and purified using the Wizard SV Gel and PCR Clean-Up System (Promega,
Madison, WI).
2.2.3 Ligation
Ligation reactions were performed using ~ 50-100 ng of linearized vector DNA.
Several molar ratios of vector: insert were combined in a gradient of 1:0; 1:2; 1:5; 1:10.
The reaction with 1:0 ratio was used as a control to assess the degree of vector digestion.
The ligation reaction was carried out at 16 °C overnight and 1 µl was transformed into E.
coli Top10 electrocompetent cells (see section 2.2.5).
2.2.4 Colony PCR
To screen for positive clones, colony PCR was performed using external primers.
Single colonies were picked from transformed plates and were suspended in 25 µl of TAE
buffer. The suspended solution was heated at 100°C for 5 min, followed by centrifugation
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at 15,871 × g for 5 min. 5 µl of supernatant was used as template for standard PCR as
described in 2.2.1.
2.2.5 Bacterial Transformation and Extraction of Plasmid from E. coli Cells
For bacterial transformations, ~ 50-100 ng of DNA was added to 50 µl of
electrocompetent cells of an E. coli cloning strain such as TOP10 or E. coli (DE3) protein
expression strains. The cell and DNA mix was transferred to 1 mm gap electroporation
cuvettes (Bio-rad). The DNA was introduced into the competent cells by electroporation
at 1.6 kV/resistance using 1 mm gap electroporator (Bio-rad). Cells were immediately
resuspended in 1 mL SOC medium (Table 2.1).
Table 2.1 Composition of media used for culturing E. coli and yeast
Media*
LB media

Composition
2.5% MILLER LB broth from Research Products International Corp.
(Mt. Prospect, IL); or 1% tryptone, 0.5% yeast extract and 1% NaCl.
Autoclave to sterilize.
M9 media
M9 salts (5×): 34 g Na2HPO4; 15 g KH2PO4; 2.5 g NaCl; 5.0 g NH4Cl;
adjust to 1000 ml with ddH2O, autoclave to sterilize.
M9 media (1×): 200 ml M9 salts (5×); 2 ml MgSO4 (1M); 20 ml 20%
glucose; 100 µl CaCl2 (1 M); 800 ml sterile ddH2O.
SOC media
0.5% yeast extract; 2% tryptone; 10 mM NaCl; 2.5 mM KCl; 10 mM
MgCl2; 10 mM MgSO4; 20 mM Glucose, autoclave to sterilize.
YPD media
2% peptone, 1% yeast extract, autoclave to sterilize. Add sterile glucose
to 2% before use.
Sc-URA
0.67% Yeast nitrogen base without amino acids, 0.14% yeast synthetic
media
drop out amino acid mix (-His, -Leu, -Trp, -Ura). Autoclave to sterilize.
Add sterile glucose to a final concentration of 2% before use. Add sterile
Trp, Leu and His to a final concentration of 0.4 mM, 2 mM and 0.3 mM.
Glucose/
3.18 g Na2HPO4; 4 g KH2PO4; 0.244 g KH2PO4; 0.5 mg CuSO4; 0.563
galactosemg ZnSO4; 1 mg MnCl2; 1 mg FeSO4; 1 mg biotin; 200 µg ThiaminePhosphate
HCl, dissolved in 950 ml ddH2O, autoclave to sterilize. Before use, add
urea/ammonia carbon source (glucose or galactose) to a final concentration of 2%, add
(GPU/GPA)
nitrogen source (urea or NH3) to a final concentration of 10 mM. For
media
medium containing uracil, 55 mg of uracil was added to 1 L of media.
* For making agar plates, 2% agar was added to the designated media before autoclave.
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The transformed cells were spread on LB agar plate (Table 2.1) containing the
appropriate antibiotic selection and incubated at 37 °C overnight. The E. coli cells were
grown in LB medium (Table 2.1) supplemented with appropriate antibiotics. Plasmid
DNA was isolated using the Promega wizard miniprep kit (Promega, Madison, WI)
according to manufacturer’s protocol.
2.2.6 Storage of Bacterial and Yeast Strains
Bacterial stocks were prepared by mixing 1 ml of overnight culture with 500 µl of
50% (v/v) sterile glycerol and stored at -80 °C. Yeast strain stocks were prepared by
scraping a freshly grown culture from plate with appropriate media for the specific strain.
The cells were resuspended in 1 ml of 15% (v/v) sterile glycerol. After mixing, the
glycerol stocks were stored at -80 °C.

2.3 Yeast Genetics Methods
2.3.1 Yeast Strains, Growth and Transformation
Yeast cells without plasmids were grown in YPD rich media (Table 2.1). Yeast
cells with pESC-URA or YCplac33 vectors were grown at 30 °C in synthetic complete
medium without uracil (Sc-URA, Table 2.1) to maintain selection for the vectors. To
screen for UAL gene expression, growth assays were carried out on glucose/galactosephosphate ammonia/urea media (Table 2.1).
The yeast cells were transformed with either the intact plasmid DNA or with PCR
product in conjunction with the gapped vector. To perform yeast transformations, first, ~
5-10 ml YPD was inoculated with the desired yeast strain. The culture was grown
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overnight with shaking at 30°C. The culture was diluted in 30 ml fresh YPD media to an
OD600 of 0.2-0.4 and was grown with shaking for an additional ~ 3.5 hours at 30 °C.
Cells were harvested when the OD600 reached 1.0 by centrifuging at 4,355 × g for 5 min.
Subsequently, cells were washed in 15 ml sterile ddH2O and pelleted by centrifugation as
before. After discarding the supernatant, cells were resuspended in 0.3 ml of sterile
ddH2O and transferred to a sterile 1.5 ml microcentrifuge tube. Cells were pelleted again
and resuspended in 0.3 ml of sterile ddH2O. Subsequently, the transformation mix was
established as follows: DNA (500 ng for intact vector or up to 3.5 µg for gapped vector +
PCR products), 3 µl of 10 mg/ml sheared salmon sperm DNA, 35 µl of 1 M lithium
acetate, 240 µl of 50% PEG 3350 and, added last, 50 µl of the cell suspension. Sterile
ddH2O was finally added to raise the total mix volume to 400 µl. The mixture was mixed
gently and incubated at 30°C for 1 h with intermittent vortex. Then, the cells were heat
shocked in a water bath at 42°C for exactly 15 min. The suspension was cooled to room
temperature and 1 ml of sterile ddH2O was added. Cells were pelleted at 6,000 × g for 30
s in a microcentrifuge (Eppendorf, Hauppauge, NY). The wash procedure was repeated.
The final cell pellet was resuspended in 0.3 ml sterile ddH2O. Appropriate volumes of the
cell suspensions were spread using glass beads on selective plates and incubated at 30°C
for 2-3 days.
2.3.2 Extraction of Genomic DNA and Plasmid from Yeast
To isolate genomic DNA from yeast, 5 ml of cells were grown to saturation under
appropriate growth conditions and 1.5 ml of culture was harvested by centrifugation at
15,871 × g. Cells were washed twice with ddH2O. Extraction buffer (0.2 ml of 10 mM
Tris-HCl, pH 8.0, 1.5 mM EDTA, 100 mM NaCl, 2% Triton X-100 and 1% SDS) and 0.2
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ml of phenol/chloroform/isoamyl alcohol (25:24:1; near neutral pH) were added to
resuspend the cell pellet. To this resuspension, 0.3 g of 0.5 mm acid washed glass beads
(Biospec, Bartlesville, OK) were added. The suspension was vortexed vigorously for 3-4
min. Subsequently, 0.2 ml of TE (10 mM Tris, pH 8.0, 1 mM EDTA) was added and the
solution was centrifuged at 15,871 × g for 5 min to separate the phases. The aqueous
layer was transferred to a new 1.5 ml microcentrifuge tube and the DNA was precipitated
by adding 1 ml of 100% ethanol. After inverting several times, the precipitated DNA was
pelleted by centrifugation at 15,871 × g for 2 min at room temperature. After aspirating
the supernatant, the pellet was resuspended in 0.4 ml of TE buffer. To get rid of RNA
contaminants, 3 µl of 10 mg/ml RNaseA was added and incubated at 37 °C for 5 min.
The DNA was precipitated by adding 10 µl of 4 M ammonium acetate and 1 ml of 100%
ethanol, followed by centrifugation at 15,871 × g for 2 min at room temperature. The
supernatant was aspirated and the pellet was washed with 1 ml of ice-cold 70% ethanol.
Finally, the DNA was pelleted again by centrifugation and, after aspirating the
supernatant, the DNA was air-dried and resuspended in 50 µl of ddH2O.
To isolate plasmid DNA from yeast cells, the cells with selected plasmids were
grown at 30°C overnight. The plasmid isolation from yeast is similar to the procedure for
E. coli, using the Promega Wizard® Plus Miniprep kit (Promega, Madison, WI), except
that 250 µl of 0.5 mm glass beads were added along with 250 µl cell resuspension buffer,
and vortexed at high speed for 5 minutes. Subsequent steps were the same as those
described in the Promega plasmid miniprep system protocol.
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2.3.3 Construction of the Yeast DUR1,2 Knockout Strain
The haploid Saccharomyces cerevisiae strain MLY40α (MATα ura3-52) (Lorenz,
Heitman 1997) was used as a host for further knockout of the DUR1,2 gene, encoding

UAL. The MLY40α strain carries a mutation in the URA3 gene with retransposon Ty1
insertion in the coding region, resulting in a strain that can select for the re-introduction
of the URA3+ gene marker. The DUR1,2 knockout strain (MATα ura3-52 dur1,2Δ) was
subsequently complemented by vectors harboring DUR1,2, and was used for the
expression of all UAL constructs. Deletion of the chromosomal DUR1,2 gene permits a
functional assessment of mutations in vectors encoding DUR1,2. The DUR1,2 gene was
cloned into a pESC-URA vector under control of the GAL promoter, making the
expression of the DUR1,2 gene dependent on galactose induction. This permits a direct
comparison between induced and un-induced protein expression levels. As a control,
D273-10B strain was also used for DUR1,2 gene knockout.
Homologous recombination was used to knockout the yeast chromosomal
DUR1,2 gene. The nucleotide sequence of the kanamycin resistance gene flanked by ~ 50
nucleotides upstream and downstream of the DUR1,2 sequence was PCR amplified. A
100 µl PCR reaction mix was set up using the pFA-6a-kanMX4 vector (Bahler et al.
1998) as template, along with primers #511 and #512 (Appendix 3). The reaction was
performed according to the protocol described in 2.2.1. The PCR product was purified by
gel extraction using the Wizard® Genomic DNA purification kit (Promega, Madison,
WI). The MLY40α strain or D273-10B strain was transformed with 5 µg of PCR product.
To screen for knockout mutants, the transformants were cultured on YPD plates
supplemented with kanamycin to a final concentration of 20 µg/ml. The transformants
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were plated on YPD with kanamycin media and individual colonies were picked as
successful mutants. The mutants were subsequently cultured in liquid YPD with
kanamycin media and the chromosomal DNA was extracted. A PCR reaction using
primers #515 and #516 (Appendix 3) was used to verify that the kanamycin resistence
gene was inserted in place of the DUR1,2 gene.

2.4 Protein Methods
2.4.1 Protein Over-expression in E. coli
For protein overexpression in E. coli, three types of expression cells were used.
BL21 (DE3) cells carry the λ DE3 lysogen and are ideal for use with bacteriophage T7
promoter-based expression systems for high level of expression of recombinant proteins.
HMS174 (DE3) strains may stabilize certain target genes whose products may cause the
loss of the DE3 prophage. Rosetta (DE3) host strains are BL21 (DE3) derivatives that
enhance the expression of proteins that are encoded by rare codons in E. coli.
The expression and solubility of designated proteins in all three strains, along
with two types of growth media, LB and M9 (Table 2.1), were evaluated. Those
conditions that produced the highest level of soluble proteins were chosen for large-scale
expression.
For large-scale protein over-expression, the selected competent cells were
transformed with the vectors encoding the designated gene and were grown in media
containing appropriate antibiotics. The selected growth media (50 mL) was inoculated
with a single colony transformant and incubated overnight at 37°C. The overnight culture
was used to inoculate 12 L (12 x 1 L in 2 L baffle flasks) of media which was grown at
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37°C to an OD600 = ~ 0.8-1.0. The cultures were chilled in an ice water bath prior to
induction with IPTG to a final concentration of 1 mM. The cultures were transferred to a
16°C shaking incubator for 24 h prior to cell harvesting.
In order to ensure complete biotinylation of UC, the UC was co-overexpressed
with BirA, a biotin ligase that catalyzes attachment of biotin to the lysine residue on the
BCCP domain (Bower et al. 1995). The expression cells were co-transformed with both
the vector for over expressing the designated protein and pCY216 (Chapman-Smith et al.
1994). Co-transformed cells were cultured in the selected medium containing appropriate
antibiotics with addition of 1 mg/L biotin. When the OD600 reached ~ 0.8-1.0, arabinose
(final concentration of 20.8 mM) and IPTG (final concentration of 1 mM) were added to
induce overexpression of both BirA and the designated biotin-containing enzyme. The
cultures were incubated in a 16 °C shaking incubator for 24 h post-induction. The cells
were harvested by centrifugation at 8,983 × g for 10 min at 4 °C.
2.4.2 Ni2+-affinity Chromatography
The cells harvested from 12 L of growth were resuspended in 200 ml buffer
containing 50 mM HEPES pH 8.0, 300 mM NaCl, 0.1 mM EGTA and protease inhibitors
(1 mM PMSF, 5 µM E-64, 1 µM pepstatin). EGTA, PMSF (phenyl methylsulfonyl
fluoride) and other protease inhibitors were added to help decrease protease activity. β–
mercaptoethanol was included to reduce inter-chain disulfide bonds. The cells were
disrupted by sonication at 70% maximum amplitude using a Branson Model 450 Digital
Sonifier with a model 102-c converter and a ½” diameter Tapped Bio Horn. The
temperature of the cell lysates was monitored during sonication using a thermoprobe and
the temperature was held below 10 ° C, to avoid overheating cells. After a total sonication
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time of 8 minutes, the cell debris were pelleted at 20,442 × g for 30 min at 4°C prior to
loading onto a column containing 10 mL Profinity IMAC Ni2+-charged resin.
The proteins bound on the Profinity IMAC Ni2+-charged resin were washed using
buffer containing 50 mM HEPES pH 8.0, 300 mM NaCl, 0.1 mM EGTA and 20 mM
imidazole and eluted from the column using a buffer with 50 mM HEPES pH 8.0, 300
mM NaCl, 0.1 mM EGTA at a gradient from 20 mM to 300 mM imidazole, with protein
typically eluting between 100-250 mM. The purified protein was subsequently pooled
and dialyzed overnight at 4°C against either storage buffer containing 10 mM HEPES pH
8.0, 50 mM NaCl, 1 mM DTT or loading buffer for the downstream ion-exchange
chromatography or size-exclusion chromatography step.
2.4.3 Ion Exchange Chromatography Using Q-sepharose Fast Flow Resin
The loading buffer for Q-sepharose ion-exchange column contained 20 mM
HEPES pH 8.0, 50 mM NaCl, 1 mM EGTA and 2 mM DTT. The column was washed in
the same buffer containing 50 mM NaCl and eluted in the same HEPES buffer in a
gradient from 100 mM to 750 mM NaCl. The enzymes typically elute between 250-500
mM NaCl.
2.4.4 Over-expression and Purification of Protein from S. cerevisiae
The MLY40α dur1,2Δ mutant strain was transformed with a high-copy vector,
pESC-URA, harboring the DUR1,2 gene, to generate the complement strain (MATα ura352 dur1,2Δ::pESC-URA- DUR1,2). The DUR1,2 gene is under control of the GAL1
promoter. Galactose-phosphate-urea media (Table 2.1) was used for large-scale growth of
yeast cells. Single colonies were picked and inoculated into 10 ml Sc-URA media for
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overnight growth, and subsequently inoculated into 1 L media for growth at 30 °C
overnight. Then, the overnight starter culture was used to inoculate 12 L of Galactosephosphate-urea media to an OD600 of 0.2. The cells were cultured with shaking at 225
rpm, 30 °C for ~ 12-16 hours until the OD600 reached ~ 1.5. The yeast cells were
harvested by centrifugation at 8,983 × g for 10 min. Harvested cells were resuspended in
lysis buffer containing 100 mM HEPES pH 8.0, 300 mM NaCl, PMSF (1 mM), E-64 (5
µM) and pepstatin (1 µM), and lysed by a bead beater (Hamilton Beach Model No.
HBB909) for a total disruption time of 10 min. The cell debris were pelleted first by
centrifugation at 48,384 × g for 30 min (Beckman Coulter Avanti J-26 XP centrifuge).
The supernatant was then ultracentrifuged at 100,000 × g for 1h (Beckman TL-100
ultracentrifuge) to further remove the lipid components. The supernatant was loaded onto
a Ni2+-NTA affinity column and purified according to the protocol in 2.4.2, except that all
buffers contained 100 mM HEPES pH 8.0 instead of 50 mM HEPES pH 8.0, for a
stronger buffer capacity. The purity of the eluted protein was typically judged to be at
least ~ 95% by SDS-PAGE.
2.4.5 Concentration and Storage of Protein
Purified protein fractions were pooled, concentrated to ~ 10 mg/ml by
centrifugation at 4,000 × g using centrifugal filter units from Millipore Corporation
(Billerica, MA). Two types of molecular cutoff filters were typically used: a 30 kDa
cutoff was used for AH and a 100 kDa cutoff was used for UC and UAL. The
concentrated protein was then dialyzed overnight at 4°C against storage buffer containing
10 mM HEPES pH 8.0, 50 mM NaCl, and 1 mM DTT. The proteins were flash frozen in
40 µl aliquots in liquid nitrogen for storage at -80°C.
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2.4.6 Proteolytic Cleavage of the N-terminal His-tag
The tobacco etch virus (TEV) protease was used in this study to remove Nterminal His-tags from proteins expressed from the pET28a-(His)8-TEV vector. The TEV
protease is a ~ 27 kDa enzyme that recognizes a linear epitope of ENLYFQS, with
cleavage occurring between Q and S. The target protein was dialyzed overnight at 4 °C
against a buffer containing 50 mM HEPES pH 8.0, 300 mM NaCl and 1 mM DTT. The
TEV protease and target enzyme were mixed at a molar ratio of 50:1 and incubated at
4 °C overnight. To separate the TEV protease and cleaved tag from the designated
enzymes, the proteins were loaded onto a Ni2+-NTA column. The flow through was
collected, which consisted of the His-tag cleaved enzymes. The cleavage was confirmed
using a Western blot against the His-tag (see Section 4.2.7).
2.4.7 Analysis of Purified Protein
The purity and subunit molecular weight of the purified proteins were estimated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Different
percent of resolving gels, ranging from 6%-12%, were prepared depending on the size of
the target protein. The SDS-PAGE was performed in gel electrophoresis buffer (2.9%
glycine, 0.1% SDS, 50 mM Tris-HCl pH 8.9). Protein samples were prepared by mixing
1:1 with 2 × Laemmli buffer (Bio-rad) and heating at 100 °C for 5 min. For 8-12% gel,
150 V was used, for 6% gel, 100-120V was used for electrophoresis. The SDS-PAGE
gels were either stained using coomassie stain (50% methanol, 10% acetic acid, 0.01% G250 coomassie brilliant blue), or transferred for Western blot analysis (see Section 4.2.7).

28
2.4.8 Calculation of the Protein Concentration
The protein concentration was determined spectrophotometrically at 280 nm. The
molar extinction coefficient of each enzyme was calculated using EXPASY (Gasteiger et
al. 2003). The extinction coefficient for the enzymes used in this study are: GbAH
(61,680 M−1 cm−1); PsAH (68,800 M−1 cm−1); PsUC (143,795 M−1 cm−1); WsUC
(141,485 M−1 cm−1); ScUAL (219,725 M−1 cm−1); CaUAL (239,290 M−1 cm−1); GbAHUC (192,615 M−1 cm−1). The number varies slightly for enzymes from different species.
2.4.9 Size Exclusion Chromatography Using FPLC
Both analytical and preparative size exclusion chromatography was used in this
study, in conjunction with an ÄktaTM FPLCTM system (Amersham Phamacia Biotech Inc.,
Piscataway, NJ). Analytical gel filtration chromatography was performed on a Superose 6
HR 10/30 (GE Healthcare) column in buffer containing 20 mM HEPES pH 7.5, 150 mM
NaCl, 1 mM DTT. The Superose 6 HR 10/30 column was equilibrated with degased and
filtered buffer at 0.3 ml/min flow rate for a total of two column volumes (60 ml). To
prepare the protein sample for loading, the protein sample at 1 mg/ml was centrifuged at
15,871 × g for 10 min at 4 ºC to clarify the sample and eliminate insoluble precipitates.
The supernatant was also filtered through a 0.2 µm syringe filter (NALGEN, Thermo
Scientific, Waltham, MA). The resulting sample was directly injected using a 200 µl
sample loop. A flow rate of 0.30 ml/min was used for running the sample. Protein
samples were collected automatically in a fraction collector (GE-Amersham) at 4 ºC.
After sample collection, the pump was washed with ddH2O and the column was washed
again with two column volumes of filtered ddH2O.
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The procedure for preparative gel filtration chromatography was similar to the
analytical gel filtration. A Superdex Peptide HR10/300 column was used, with a column
volume of 300 ml. Up to 10 ml of protein sample was loaded through a superloop onto
the column. A flow rate of 1.5 ml/min was used throughout the procedure.
2.4.10 Assessment of Biotinylation Levels
Avidin is a protein with a molecular weight of ~ 16 kDa, which has a very tight
association with biotin, with a KD of ~ 10−15 M. A gel shift assay was used to test the
level of biotinylation of the sample protein. The biotinylated enzyme was mixed at room
temperature with avidin to a final molar ratio of 1:2 (protein: avidin). The same amount
of untreated enzyme was used as a control. Both samples were heated to 95 °C for 5 min.
Approximately 10 µg (10 µl × 1 mg/ml) of enzyme was loaded for SDS-PAGE analysis.
If the sample is biotinylated, the corresponding band on SDS-PAGE is expected to shift
to the top of the gel. The amount of protein running at the original size represents the unbiotinylated sample.

2.5 Enzyme Assay Methods
2.5.1 ATPase Assay
The initial rate of ATP breakdown in the biotin carboxylase domain was measured
spectrophotometrically at varying concentrations of urea (0-50 mM). Breakdown of ATP
to ADP and inorganic phosphate was coupled to the conversion of phosphoenolpyruvate
and ADP to pyruvate and ATP by pyruvate kinase (PK). The pyruvate produced is
subsequently reduced to lactate by lactate dehydrogenase (LDH), which is coupled to the
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oxidation of NADH to NAD+ (Figure 2.1). The oxidation reaction corresponds to a
decrease in absorbance at 340 nm, which is continuously monitored using a UV-visible
spectrophotometer. The assay was performed in a buffer containing 50 mM HEPES pH
7.3 and 50 mM NaCl, in the presence of 8 mM MgSO4, 8 mM NaHCO3, 0-50 mM urea,
1.5 mM phosphoenolpyruvate, 0.15 mM NADH, 100 µM ATP, 5 units of PK and 12.5
units of LDH.

Figure 2.1 Coupling reactions for the ATPase activity assay.

2.5.2 Allophanate Hydrolysis Assay
Two methods were used to assay the production of NH3 by the hydrolysis of
allophanate.
Primarily, the hydrolysis of allophanate was assayed using a glutamatedehydrogenase coupled assay (Kimura et al. 2003) (Figure 2.2 A) in buffer containing 50
mM HEPES pH 7.4, 50 mM NaCl and 1 mM EGTA in the presence of 10 mM
allophanate, 40 U glutamate-dehydrogenase (GDH), 20 mM α-ketoglutarate, and 0.5 mM
NADH. The reaction progress was monitored spectrophotometrically at 340 nm. A
background rate was observed in all GDH-coupled reactions and it was subtracted from
the AH-catalyzed rate.
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Figure 2.2 Two assay methods for allophanate hydrolase activity.
(A) Coupling ammonia production to NADPH oxidation in the glutamate dehydrogenasecoupling assay. (B) Fixed-time detection of ammonia levels using the phenolhypochlorite assay.
The hydrolysis of the substrate analogs, malonamide and biuret, and the activity
of the GbAH Arg307 mutants with allophanate was assayed using a fixed-time phenolhypochlorite assay in 50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM DTT (M. W.
Weatherburn 1967) (Figure 2.2 B). Briefly, for the phenol-hypochlorite reaction, two
reagents were made. Reagent A contains 5 g of phenol and 25 mg of sodium nitroprusside
per 500 ml of solution. Reagent B contains 2.5 g of sodium hydroxide and 4.2 ml of
sodium hypochlorite per 500 ml of solution. Both reagents were stored in Amber bottles
at 4 °C. The standard curve of ammonia concentration versus absorption was made by
mixing 100 µl of various concentration of ammonia with 1 ml of reagent A and 1 ml of
reagent B. The colorimetric reaction was carried out at 37 °C for 30 min before the
absorption was monitored at a wavelength of 625 nm. The enzymatic reaction was started
by mixing substrates and enzyme to a total volume of 100 µl at room temperature and
was quenched by adding 1 ml of Reagent A and 1 ml of reagent B. The corresponding
amount of ammonia produced from enzymatic reaction can be obtained from the standard
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curve. The reaction with substrate analogs was slow and, in some cases, was monitored
for up to 10 hours in order to estimate rate constants. Despite the slow reaction rates,
enzyme-catalyzed reactions (typically 1,000 min-1) could easily be measured over the
very slow background rate of spontaneous hydrolysis (~ 20 min-1).
2.5.3 Assay of UAL Overall Activity
The UC-AH coupling activity and substrate channeling of UC and AH was
assayed using the glutamate dehydrogenase coupling reaction, by mixing UC and AH at
different ratios. The reaction was carried out in a buffer containing 50 mM HEPES pH
7.3 and 50 mM NaCl, in the presence of 0.15 mM NADH, 8 mM MgSO4, 50 mM urea,
100 µM ATP, 8 mM NaHCO3, 10 mM 2-oxoglutarate and 20 units of glutamate
dehydrogenase.
For all continuous spectrophotometric assays, the decrease of absorbance at 340
nm was monitored for ~ 10 min and the slope of the linear portion of decrease was
recorded as the initial velocity. One enzyme unit is defined as the amount of enzyme
required to hydrolyze 1 µmol of substrate per minute at 25°C. Enzyme kinetic constants
were estimated by nonlinear curve-fitting using GraphPad Prism 3.02 software
(GraphPad Software Inc., San Diego, CA). The apparent Km and kcat values were
determined by fitting to the Michaelis-Menten equation for single-enzyme systems.
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CHAPTER 3: STRUCTURE AND SUBSTRATE SPECIFICITY OF
ALLOPHANATE HYDROLASE
3.1 Introduction
Multi-functional enzymes work as exquisite pipelines in complex cellular
metabolism. Therefore, ensuring proper function and specificity of each individual step is
a critical theme for multi-functional enzymes. Enzymes lower the activation energy of
chemical reactions through the specific architecture of the active site(s). They are ideally
structured by positioning catalytic residues and substrates in an optimal orientation, so as
to recognize the substrate(s) in the ground state and to stabilize the altered substrate(s) in
the transition state. This chapter is aimed to relate the enzyme structure with substrate
specificity at molecular level. The AH domain of UAL serves as a good target to study
this question.
Allophanate hydrolase (AH, EC 3.5.1.54) catalyzes the hydrolysis of allophanate
to ammonia and carbon dioxide (Figure 3.1 A). It belongs to the amidase signature (AS)
family, characterized by a highly conserved stretch of up to 130 amino acids rich in serine
and glycine (Koo et al. 2000, Chebrou et al. 1996). AS family enzymes are currently
known to include over 200 different enzymes, in organisms ranging from bacteria to
plants and mammals (Shin et al. 2003). They catalyze the hydrolysis of amide bonds in a
wide range of substrates. Therefore, they participate in diverse biological activities,
including the hydrolysis of malonamate by malonamidase in nitrogen transport from the
bacteroid to the plant during nitrogen fixation (Figure 3.1 B) (Kim, Kang 1994), the
formation of Gln-tRNAGln by GatCAB by glutamyl aminoacyl-tRNA amidotransferases
subunit A in a subset of bacteria (Figure 3.1 C) (Wu et al. 2009), the catabolism of
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neuromodulatory fatty acids in mammals by fatty acid amide hydrolase (Figure 3.1 D)
(Boger et al. 2000) and the formation of the plant development regulator, indole-3-acetic
acid, by nitrile hydratase (Ohtaki et al. 2010). In addition, AS family enzymes have been
implicated in a variety of industrial applications, such as the degradation of nylon
polymers (Figure 3.1E) (Yasuhira et al. 2010, Heumann et al. 2009) and the amidation of
synthetic peptides (Cerovsky, Kula 2001).
A.

B.

O
HO

D.

O

NH2
O-

NH
O

O

NH2

C.

O

O

E.

N

N
O

O
N

Figure 3.1 Reaction of AH and substrates of AS family enzymes.
(A) Reaction catalyzed by allophanate hydrolase. (B-E) Structures of substrates of four
AS family enzymes were shown. The common amide groups in the substrates are
highlighted in red in each molecule. (B) The substrate of malonamidase, malonamate. (C)
The substrate of glutamyl aminoacyl-tRNA amidotransferases subunit A, glutamine. (D)
The substrate of fatty acid amide hydrolase, anandamide. (E) The substrate of 6aminohexanoate cyclic dimer hydrolase, 6-aminohexanoate cyclic dimer.
While reacting with a wide varieties of substrates, the AS family enzymes utilize a
conserved Ser-cisSer-Lys triad to catalyze amide bond hydrolysis. Nucleophilic attack by
catalytic serine results in a covalent tetrahedral intermediate that is stabilized by an
oxyanion hole. After displacement of ammonia, the covalent intermediate is hydrolyzed
into the final product. Several AS family enzymes catalyze reactions on substrates that
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are structurally very similar to allophanate, such as malonamate and glutamine (Figure
3.1 B and C), while other substrates are significantly different (Figure 3.1 D and E). Due
to the wide range of substrates acted upon by AS family enzymes, this family serves as an
excellent paradigm for relating molecular architecture to substrate specificity.
This chapter focused on the determination of the X-ray crystal structure of the AH
domain of UAL and on subsequent studies to determine factors contributing to substrate
specificity in this domain. In bacteria, UC and AH exist as two separate enzymes. AH
from four different bacterial species, Pseudomonas syringae, Wolinella succinogenes,
Verminephrobacter eiseniae and Granulibacter bethesdensis were independently purified
and set to crystallization trials. Of them, only AH from Granulibacter bethesdensis
(GbAH) was amenable to crystallization and, thus, its crystal structure was determined.
The GbAH structure represents the first crystal structure of AH. Two structures,
both with and without a bound substrate analog, malonate, in the active site were
determined. The structure of AH confirms the location of the Ser-cisSer-Lys catalytic
triad conserved throughout the AS family. Comparison of the AH structure to those from
other AS family enzymes offers insights into substrate specificity determinants in AH.
Two amino acids, Tyr299 and Arg307, are conserved in AH and are within hydrogen
bonding distance to the substrate analog. Steady-state kinetic analysis of Tyr299 and Arg307
site-directed mutants reveals that the specificity constant (kcat/Km) ratios for the substrate
analog, biuret, compared to allophanate, increase by three to four orders of magnitude for
Tyr299 mutants, and that the R307A and R307M mutants are nearly inactive. These results
suggest a role for these residues in providing substrate and intermediate stabilization in
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AH. Overall, studies in this chapter is helpful to understand the mechanisms of substrate
specificity in the AH domain and the features of multi-functional enzyme as a whole.
3.2 Materials and Methods
3.2.1 Construction of pET28a-(His)8-TEV-GbAH Vector
To clone the pET28a-(His)8-TEV-GbAH, AH gene was amplified by PCR from
Granulibacter bethesdensis genomic DNA, using primers #356 and #357 (Appendix 3).
The PCR product was digested by PstI and XhoI and ligated into the similarly digested
pET28a-(His)8-TEV vector (Lietzan et al. 2011), downstream of the T7 promoter, Nterminal (His)8-tag and rTEV protease recognition sequence. The Tyr299 and Arg307 single
and double mutants were generated by QuikChange site-directed mutagenesis following
the protocol in section 2.2.1. Primers used for mutagenesis were: #554/#555 for Y299F,
#556/#557 for R307A, #623/#624 for Y299A, #625/#626 for R307M (Appendix 3).
3.2.2 Protein Crystallography Methods
3.2.2.1 Protein Crystallization
Crystals of GbAH, both with and without malonate, were grown at room
temperature by the hanging-drop vapor diffusion method. The crystals of GbAH with
malonate were grown from a well solution of 100 mM PIPES pH 6.5 and 1.04 M sodium
malonate. The crystals of apo GbAH were grown from a well solution of 100 mM
HEPES pH 7.5, 24% PEG 4K and 50 mM MgCl2. In both cases, the protein solution (4
mg/ml) and reservoir solution were mixed in a 1:1 ratio to a final volume of 5 µL. The
initial GbAH crystal grew spontaneously from a well solution of 100 mM PIPES pH 6.5
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and 1.04 M sodium malonate after 2 months. Subsequently, all drops were micro-seeded
with pulverized GbAH crystals ∼24 h after mixing. The resulting diamond shaped GbAH
crystals grew within 5-7 days of seeding. After 10-15 days, the crystals of GbAH with
malonate were transferred to a cryoprotectant solution consisting of 6 M sodium
malonate, 100 mM PIPES pH 6.5. The crystals of apo GbAH were transferred to a
cryoprotectant solution consisting of 100 mM HEPES pH 7.5, 35% PEG 4K and 50mM
MgCl2. All crystals were flash-cooled in a nitrogen gas stream at 100 K. The crystals
belonged to the space group P61, with two subunits in the asymmetric unit and the unit
cell parameters were a = 78 Å, b = 78 Å, c = 395 Å, α = β = 90°, γ = 120°.
3.2.2.2 Data Collection, Structure Determination and Refinement
X-ray diffraction data were collected at Sector 21 (LS-CAT) of the Advanced
Photon Source (APS, Chicago, IL). The diffraction data for GbAH with malonate were
collected using beamline 21-ID-D with a MAR 300 CCD detector at a wavelength of
1.033 Å. The diffraction data for apo GbAH were collected using beamline 21-ID-F with
a MAR 225 CCD detector, at a wavelength of 1.033 Å. Diffraction images were
processed with HKL2000 (Zbyszek Otwinowski 1997). The structure of GbAH with
malonate was solved by molecular replacement using a putative amidase protein (PDB
ID: 2DC0) as the search model using the program AutoMR (McCoy et al. 2007) from the
Phenix software suite. The apo GbAH structure was solved by molecular replacement
using GbAH with malonate as the search model with AutoMR. The initial models were
subsequently built by the program AutoBuild (Terwilliger et al. 2008), extended by
several rounds of manual model building with COOT (Emsley, Cowtan 2004) and refined
with Phenix.Refine (Afonine et al. 2005). Water molecules were added to the model in
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COOT with subsequent manual verification. Data collection and processing statistics are
summarized in Table 3.1. The long unit cell axis of 395 Å resulted in some overlapping
reflections. This was particularly problematic for data collected on the MAR 225 CCD
detector on LS-CAT-21-ID-F, used for GbAH apo structure. Consequently, the values for
Rmerge and some refinement statistics are slightly elevated but still fall well within the
acceptable range.
Table 3.1 Data Collection and Refinement Statistics

PDB code
Space group
Cell dimensions
a, b, c (Å)
α, β, γ (°)
Resolution range (Å)
Redundancy
Completeness(%)
Rmerge (%)
Average I/sigma
Rwork
Rfree
No. reflections
No. atoms
Protein
Others
Water
Wilson B factor
Average B factors (Å)
Protein
Ligand
Solvent
Ramachandran (%)
Favored
Allowed
Generous
Disallowed
R.m.s.deviations
Bond lengths(Å)
Bond angles(°)
a

GbAH + NaMalonate

GbAH apo

4GYS
P61

4GYR
P61

78, 78, 395
90, 90, 120
50 - 2.2
9.2(6.6)a
97.2(96.2)
11.5(33.2)
21.2(4.9)
0.174(0.218)
0.202(0.275)
66210
7294
6840
28
426
31.5

78, 78, 398
90, 90, 120
50 - 2.8
9.0(4.6) a
99.9(100)
11.4(17.1)
20.8(18.1)
0.256(0.296)
0.307(0.363)
33600
6930
6814
0
116
40.3

32.4
36.3
35.7

40.0
-35.7

89.0%
11.0%
0 %
0 %

85.5%
14.3%
0.3%
0 %

0.011
1.28

0.005
0.91

Values in parentheses are for the highest resolution bin.

39
3.3 Results
3.3.1 Overall Structure of AH
GbAH that was crystallized both in the presence and absence of malonate formed
octahedral crystals (Figure 3.2 A). The X-ray crystal structure of GbAH with malonate
was determined by molecular replacement using a putative amidase (PDB ID: 2DC0,
32% sequence identity with GbAH) as a search model and was refined to 2.2 Å
resolution. The apo GbAH structure was determined to 2.8 Å (Table 3.1). In both cases,
the GbAH crystal lattice is composed of a homodimer in the asymmetric unit (Figure 3.2
B). In the malonate-bound GbAH, each subunit includes 461 residues (3-463) while in
the apo GbAH structure, each subunit includes 462 residues (2-463). In all cases, the
subunits consist of a globular amidase domain comprised of 15 α-helices and 11 βstrands, consistent with structures from other AS family enzymes (Shin et al. 2002a). The
N-terminal poly-His tag and the C-terminal residues 463-592 were not defined in the
electron density of either the apo or malonate-bound structure and are not included in the
models. SDS-PAGE of isolated GbAH crystals grown in the presence of malonate
demonstrated that the complete 65 kDa protein was intact in the crystals (Figure 3.2 C).
Therefore, the undefined C-terminus results from a lack of direct phasing information
combined with intrinsic disorder in this region.
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Figure 3.2 The crystal structure of GbAH.
(A) Picture of an octahedral-shaped crystal of GbAH. (B) Overall structure of AH. The
overall structure is shown in cartoon representation. Malonate binding at the active sites
is shown in CPK-colored spheres. The three subdomains in each subunit are individually
colored: N-terminal subdomain (blue), the amidase signature sequence (Phe71-Leu182)
subdomain (hot pink), and the C-terminal subdomain (yellow). The corresponding
subdomains in the second subunit are colored light blue, light pink and light yellow. (C)
SDS-PAGE gel showing the molecular weight of dissolved malonate-bound GbAH
crystal (Lane 1). The corresponding band for GbAH dissolved crystal is indicated by
arrow.
Structural alignments the GbAH monomer with other AS family enzymes show
conservation of the overall structure in monomer despite low sequence similarities,
ranging from 9-32% (Figure 3.3). Analysis of the AH structure using the DALI server
(Holm, Rosenstrom 2010) confirms that AH is homologous with several AS family
member enzymes (Table 3.2). The Glutamyl-tRNA amidotransferase subunit A (GatA) is
the most closely related in structure, as measured both by z-score and root mean squared
deviation.
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Figure 3.3 Structural comparisons for the GbAH monomer with other AS family
enzymes.
Structural superimposition of the GbAH monomer (cyan) with other AS family enzymes.
(A) Alignment of GbAH and Staphylococcus aureus GatA (PDB ID: 2F2A, salmon). (B)
Alignment of GbAH and Bradyrhizobium japonicum malonamidase (MAE2, PDB ID:
1OCL) subunit A (white). (C) Alignment of GbAH and rat fatty acid amide hydrolase
(FAAH, PDB ID: 1MT5) subunit A (magenta).

Table 3.2 Results from analysis of the GbAH structure using the DALI server
Enzyme1
PDB ID Z score
r.m.s.d
Sequence identity (%)
GatA
3h0m
51.3
2.0
28
Probable amidase 2dc0
49.4
2.1
32
MAE2
1ock
44.9
2.5
28
NylA
3a2q
41.6
2.6
26
PAM
1m21
41.5
2.5
15
FAAH
1mt5
35.6
2.9
8.9
1
GatA: Aquifex aeolicus GatA; Probable amidase from Thermus thermophilus; MAE2:
Bradyrhizobium japonicum Malonamidase E2; NylA: Arthrobacter sp. 6-aminohexanoate
cyclic dimer hydrolase; PAM: Stenotrophomonas maltophilia peptide amidase; FAAH,
Rattus norvegicus fatty-acid amide hydrolase.
Analytical gel filtration analysis of GbAH indicated that the native enzyme has a
molecular weight of ~ 130kDa (Figure 3.4), while SDS-PAGE revealed a ~ 65kDa
monomer (Figure 3.2 C), confirming that the biological unit is a dimer, consistent with
characterization of other AH enzymes (Kanamori et al. 2005, Shapir et al. 2005)
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Figure 3.4 Size exclusion chromatography results of wild-type and site-directed
mutants of GbAH.
Representative chromatograms for wild-type GbAH (GbAH wt) and site-directed mutants.
The peak at elution volume of 15 mL corresponds to the predicted molecular weight for
the wild-type GbAH dimer (MW = 130kDa). The elution profiles for Tyr299 and Arg307
mutants match that of the wild-type enzyme. The column was calibrated with molecular
weight standards as previously described (Lietzan et al. 2011).
The dimerization interface was analyzed using the PDBe PISA server (Krissinel,
Henrick 2007). Three dimerization interfaces were identified as having a large buried
surface area and favorable ΔG. The biological dimer was determined to be that with the
largest buried surface area and the most favorable ΔG (Figure 3.5 and Table 3.3). Of the
three possible interfaces, this dimerization interface is most similar, though not identical,
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to the dimerization interface of the AS family enzymes fatty acid amide hydrolase and
malonamidase (Figure 3.5). The dimerization interface was formed by one α-helix, with
close hydrophobic interaction between Ser377-Phe342 (Figure 3.6). Sequence alignment
shows these residues are quite conserved in all AH (Appendix Figure 2.1). The distance
between the dimerization interface to the substrate binding site is ~ 20 Å. Two active site
residues directly contacting substrates, Tyr299 and Arg307 are located on an α-helix right
next to the α-helix comprised of the dimerization interface. The distance between the two
helices is within hydrogen bond distance (Figure 3.6). While the interface is located in
close proximity to the active sites, analytical gel-filtration confirmed that mutations in the
active site residues located near the interface (i.e. Ser172, Tyr299, Arg307) did not alter the
oligomerization state of the enzyme (Figure 3.4).
	
  

Interface 2

Interface 3

Interface 2

Interface 3

Interface 1

Interface 1

Figure 3.5 Predicted dimerization interfaces of GbAH.
Stereo figures showing the alignments of the 3 predicted dimerization interfaces of
GbAH, with malonamidase (PDB ID: 1OCL) and fatty acid amide hydrolase (PDB ID:
1MT5). Interface 1 is colored cyan, interface 2 is colored orange, and interface 3 is
colored green. Fatty acid amide hydrolase and malonamidase are colored magenta and
grey, respectively, with the corresponding chains in the second subunit colored in light
cyan, light magenta and light grey.
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Table 3.3 Dimerization interface analysis for GbAH
Interface
Interface area (Å)
AH
1
1092.9
2
812.1
3
792.4
MAE21
1
1493.1
2
445.1
FAAH2
1
1607.0
2
385
1
Malonamidase from B. japonicum (PDB ID: 1OCL).
2
Fatty acid amide hydrolase from rat (PDB ID: 1MT5).

ΔG (kcal)
-13.7
-7.3
-4.8
-6.8
4.0
-18.5
-4.5

Figure 3.6 The dimerization interface of GbAH.
Stereo view of the GbAH dimerization interface. GbAH is shown in cartoon, with
malonate bound shown in CPK-colored spheres. The subunit A and B are colored cyan
and pale cyan, respectively. The two residues directly interacting with malonate, Tyr299
and Arg307 are colored yellow. The residues that are on the dimerization interface, Ser337,
Ala338, Val339, Asp340, Ala341 and Phe342 are shown in sticks and colored purple in subunit
A and pink in subunit B.

3.3.2 GbAH Active Site Architecture
AH shares a common catalytic mechanism with other AS family members, using
a conserved Ser-cisSer-Lys triad to catalyze amidolysis of allophanate (Shapir et al. 2005,
Shapir et al. 2006) (Appendix Figure 2.1). Similar to other AS family members, three
conserved residues, Ser172, cis-Ser148 and Lys74, form the expected catalytic triad in
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GbAH with an oxyanion hole formed by the backbone amide nitrogen atoms of Asp168,
Thr169, Ala170 and Gly171. When GbAH was crystallized in sodium malonate (1.04 M),
one molecule of malonate was bound at the active site and a second molecule was bound
at the protein surface. In crystals grown in the absence of malonate, no electron density
corresponding to a bound ligand was observed at either location. The binding of malonate
in the active site did not result in any structural rearrangements compared with the apo
enzyme (Figure 3.7 A). The nucleophilic Ser172 points away from malonate in the bound
structure, but is oriented toward the active site cavity in the apo enzyme (Figure 3.7 B).
The Ser148 adopts an unusual cis configuration because it allows the two direct hydrogen
bonds interaction with Lys74 and Ser172 (Figure 3.8). The reaction mechanism was
proposed based on homologous AS family enzymes and analysis of inactivated and
mutated AH enzymes (Shapir et al. 2006, Shapir et al. 2005). First, the Ser172
nucleophilically attacks the amide carbon on allophanate, forming the transition-state
intermediate which is stabilized by the oxyanion hole. Second, the Ser148 in cis
conformation acts as the catalytic acid to donate a proton to the leaving amino group,
forming ammonia. The deprotonated form of Ser148 is subsequently maintained by Lys74
through a hydrogen bond. The reactions yield a Ser172-dicarboxylated amide and one
molecule of NH3 (Figure 3.8). It is not clear whether the dicarboxylated amide further
decomposes by a second active site in the C-terminal domain of AH or is hydrolyzed
intact from the enzyme and subsequently spontaneously decomposes in solution (see
Chapter 6). The size of the active site cavity is relatively small compared to other AS
family enzymes. Measurement of the active site cavity using VOIDOO (Kleywegt, Jones
1994) reveals that the cavity size is closest to GatA, which uses glutamine or asparagine
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as a substrate. The cavity size comparison shows a pronounced difference between AH
and malonamidase, an AS family enzyme which hydrolyzes a very similar substrate,
malonamate.

A.

B.

Figure 3.7 Structural superposition of GbAH apo with the malonate-bound
structure.
(A) Superimposition of the GbAH monomer with (purple) and without (cyan) malonate
reveals no significant conformational changes accompanying substrate binding. Malonate
is shown in CPK-colored spheres. (B) A stereo figures showing the structural
superimposition of the active sites of apo GbAH (cyan) and the malonate-bound GbAH
(purple). A simulated annealing omit map for malonate, contoured at 3.0 σ, is shown in
green. The 2Fo-Fc map, contoured at 1.0 σ, is shown in grey. For clarity, only side chains
are displayed for Tyr299, Arg307, Ser148, Ser172 and Lys74. Only main-chain atoms are
displayed for the oxyanion hole.
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Figure 3.8 Reaction mechanism of AH.
The Ser-cisSer-Lys catalytic triad and oxyanion hole were shown. Residues are numbered
according to GbAH.

3.3.3 GbAH Enzyme Activity
Steady-state kinetics was used to study the activity of wild-type GbAH and
corresponding mutants. Generally, the initial velocity at each substrate concentration was
determined from the slope of the early part of the curve, which represents the amount of
NH3 formed as a function of time under initial velocity conditions. The initial velocity
was plotted as a function of substrate concentration and the resulting curve was fitted by
non-linear regression analysis to the standard Michaelis-Menten equation, where kcat and

48
Km were obtained. The kcat for wild-type GbAH is 18.2 s-1, the Km is 0.10 mM and kcat/Km
is 1.8 × 105 s-1 M-1 (Table 3.4). This falls in a range of kcat/Km values previously
determined for AH from Oleomonas sagaranensis (2.7 × 106 s-1 M-1) (Kanamori et al.
2005), AtzF from Pseudomonas sp. strain ADP (1.1 × 104 s-1 M-1) (Shapir et al. 2005) and
TrzF from Enterobacter cloacae strain 99 (8.8 × 103 s-1 M-1) (Shapir et al. 2006).

Table 3.4 Kinetic data of GbAH wild-type with allophanate
kcat (s-1)*
GbAHwt
18 ± 1
*Mean ± standard deviation (n=3).

Km (mM) *
0.10 ± 0.002

kcat/Km (s-1 M-1)
(1.8 ± 0.03)×105

3.3.4 Substrate Specificity
AH has been shown to exhibit high specificity for allophanate (Shapir et al. 2006,
Kanamori et al. 2005). To assess the substrate specificity of GbAH, the rate of ammonia
release was measured for a series of allophanate analogs, including biuret, malonamide,
acetyl-urea, hydantoic acid, L-glutamine and L-asparagine (Figure 3.9). Activity was only
detected with biuret and malonamide, consistent with previous reports (Shapir et al.
2006). The plot for GbAH activity with biuret and malonamide are provided in Figure
3.10. The rate and comparison with the activity for allophanate was summarized in Table
3.5.
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Figure 3.9 Chemical structures of substrate and substrate analogues used in this
study.
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Figure 3.10 Representative initial velocity vs. [substrate] plots for GbAH wild-type
with substrate analogs using the phenol hypochlorite assay.
Activity of GbAH wild-type with (A) biuret and (B) malonamide. The data was fitted to
the Michaelis-Menten equation for single-enzyme systems. The kcat/Km are estimated
from the slope of the regression line for vi vs. substrate concentration at low substrate
concentration (i.e. [S] << Km). The insets display representative raw data for [ammonia]
vs. time at varying initial concentrations of substrate analogs.

60

50
Table 3.5 Kinetic data of GbAH wild-type with substrate analogs
Biuret
kcat/Km(biuret)
-1
-1
kcat/Km (s M ) *
kcat/Km(allophanate)
GbAHwt 0.30 ± 0.01
(1.7 ± 0.1) × 10-6
Malonamide
kcat/Km(malonamide)
-1
-1
kcat/Km (s M ) *
kcat/Km(allophanate)
GbAHwt 0.38 ± 0.01
(2.1 ± 0.2) × 10-6
*kcat/Km estimated from slope of vi vs [S] at [S] <<Km; mean ±	
 standard deviation (n=3).

The crystal structures of GbAH with and without malonate provide insights into
the molecular basis for substrate specificity in GbAH. Alignment of AH and other AS
family enzyme structures shows that the substrate-binding residues are different among
the individual active sites (Figure 3.11). In the GbAH structure with malonate bound in
the active site, Tyr299 and Arg307 are within hydrogen bonding distance of one carboxylate
moiety of malonate. Sequence alignments reveal that Arg307 is conserved in all AH
enzymes but are not conserved across the AS family, while Tyr299 is conserved in all AH
enzymes, but also exist in some of other AS family enzymes (Appendix Figure 2.1). This
suggests a role for these residues in dictating the substrate specificity in AH.
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Figure 3.11 Comparison of substrate binding residues at the active sites of GbAH
with other AS family enzymes.
(A) Alignment of malonate-bound GbAH (cyan) and malonate-bound Bradyrhizobium
japonicum malonamidase (PDB ID 1OCL; white). (B) Alignment of malonate-bound
GbAH (cyan) and Staphylococcus aureus GatA with covalently bound glutamine (PDB
ID 2F2A; salmon). (C) Alignment of malonate-bound GbAH (cyan) and benzamidebound Rhodococcus sp. N-771 amidase (PDB ID 3A1I; yellow). (D) Alignment of
malonate-bound GbAH (cyan) with rat fatty acid amide hydrolase (PDB ID 1MT5; pink)
with the bound inactivator methoxy arachidonyl fluorophosphonate (MAY). Residues
and substrates are shown as sticks, labeled and colored according to their structure.
Therefore, both Tyr299 and Arg307 were mutated in GbAH to investigate the role of
these two residues in catalysis. A series of single mutants (Y299F, Y299A, R307M,
R307A), and double mutants (Y299A/R307M, Y299F/R307M, Y299A/R307A, and
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Y299F/R307A) were assayed for catalytic activity. From size-exclusion chromatography,
all of the mutants behaved identically to the wild-type protein (Figure 3.4), suggesting the
changes in activities were not due to inappropriate protein folding. The kinetic constants
measured with allophanate revealed a ~ 400 fold and ~ 250 fold reduction in kcat for
Y299F and Y299A, respectively, and a ~ 5,000 fold and ~ 7,500 fold reduction in kcat/Km
for Y299F and Y299A, respectively (Table 3.6). By comparison, mutations at Arg307 had
a much more dramatic effect on the rate of catalysis. The kcat/Km is estimated at 2-4 × 10-3
s-1M-1 for Arg307 mutations, resulting in a decrease in kcat/Km of eight orders of magnitude
compared to that of wild-type. In addition, the Tyr299/Arg307 double mutants showed
similar activities as Arg307 single mutants, even a little bit faster than single mutants. This
suggests that the structural changes in active site for the double mutant brought in a
reverting effect compared to single mutants. The representative plots for double mutants
were provided in Figure 3.12.

Table 3.6 Kinetic data of GbAH site-directed mutants with allophanate
kcat (s-1)*
(4.2 ± 0.1)×10-2
(7.1 ± 0.2)×10-2

Km (mM) *
1.2 ± 0.1
3.0 ± 0.4

Y299F
Y299A
R307A
R307M
Y299A/R307M
Y299F/R307M
Y299A/R307A
*Mean ± standard deviation (n=3).
**kcat/Km estimated from slope of vi vs [S] at [S]<<Km.

kcat/Km (s-1 M-1)
35 ± 3
24 ± 3
(1.7 ± 0.2)×10-3 **
(3.6 ± 0.8)×10-3 **
(1.9 ± 0.1)×10-2 **
(7.1 ± 0.6)×10-3 **
(2.7 ± 0.2)×10-2 **
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Figure 3.12 Representative initial velocity vs. [substrate] plots for GbAH
Tyr299/Arg307 double mutants with allophanate using the phenol hypochlorite assay.
Activity of GbAH Tyr299/Arg307 double mutants with allophanate. The data was fitted to
the Michaelis-Menten equation for single-enzyme systems. The kcat/Km are estimated
from the slope of the regression line for vi vs. substrate concentration at low substrate
concentration (i.e. [S] << Km). The insets display representative raw data for [ammonia]
vs. time at varying initial concentrations of allophanate.
In addition, the mutants were measured using substrate analogs, with
representative data provided in Figure 3.13. The ratio of kcat/Km for biuret compared to
allophanate increased by three orders of magnitude in Y299F and four orders of
magnitude in Y299A. Similar results were obtained with malonamide (Table 3.7). These
suggested that the mutations in Tyr299 altered the enzyme’s discrimination between
substrates, increasing the specificity constants for biuret and malonamide relative to
allophanate. No activity was observed for Arg307 mutants with biuret or malonamide.
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Figure 3.13 Representative initial velocity vs. [substrate] plots for GbAH Tyr299
mutants with substrate analogs using the phenol hypochlorite assay.
Activity of GbAH Tyr299 single mutants with biuret (A-B) or malonamide (C-D). The
data was fitted to the Michaelis-Menten equation for single-enzyme systems. The kcat/Km
are estimated from the slope of the regression line for vi vs. substrate concentration at low
substrate concentration (i.e. [S] << Km). The insets display representative raw data for
[ammonia] vs. time at varying initial concentrations of substrate analogs.

Table 3.7 Kinetic data of GbAH mutants with different substrate analogs
Biuret
kcat/Km(biuret)
Ratio to
-1
-1
kcat/Km* (s M )
kcat/Km(allophanate)
wild-type
-2
Y299F 0.35 ± 0.02
(1.0 ± 0.1) × 10
6.1 × 103
Y299A 1.0 ± 0.02
(4.3 ± 0.6) × 10-2
2.6 × 104
Malonamide
kcat/Km(malonamide)
Ratio to
kcat/Km*(s-1 M-1)
kcat/Km(allophanate)
wild-type
-3
Y299F 0.12 ± 0.01
(3.5 ± 0.1) × 10
1.6 × 103
-2
Y299A 0.36 ± 0.02
(1.5 ± 0.2) × 10
7.2 × 103
*kcat/Km estimated from slope of vi vs [S] at [S]<<Km, mean ± standard deviation (n=3).
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3.4 Discussion
3.4.1 AS Family Enzymes and Substrate Specificity
Enzymes react with their substrates specifically by shape complementary, charge
or hydrophobic/hydrophilic interactions within their active sites. This is an extremely
important property, as it enables enzymes to perform highly specific reactions and
contribute to an organized overall metabolic network within the cell. Enzyme substrate
specificity can be categorized to range from strict to broad: 1, absolute specificity, which
means that the enzyme will catalyze only one reaction and have a strict preference for a
specific substrate or substrates; 2, group specificity, which means that the enzyme
recognizes sets of molecules sharing common chemical functional groups; 3, linkage
specificity, which means that the enzyme acts on specific chemical linkages, regardless of
the structure for the rest of the molecule. One intriguing feature of the Amidase Signature
family enzymes (E.C. classification group 3.5.1) is that they catalyze the hydrolysis of
amide bonds in a wide range of substrates. Several enzyme superfamilies with unrelated
sequence and structure have converged on this common enzymatic function, including
the amidohydrolase, nitrilase and amidase signature (AS) superfamilies. The AS
superfamily enzymes catalyze amidolysis without the assistance of a metal ion, instead
using a nucleophilic Ser and oxyanion hole to mediate the formation and stabilization of
the tetrahedral intermediate. The superfamily was originally identified and characterized
by a signature block of 130 amino acids rich in conserved Gly and Ser residues (Chebrou
et al. 1996). Subsequent structural and kinetic studies of AS family enzymes revealed a
conserved Ser-cisSer-Lys catalytic triad that is essential for catalysis (Shin et al. 2002a,
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Valina et al. 2004, McKinney, Cravatt 2003, Shin et al. 2002b). The structures for a few
well-characterized members of the AS family have been reported in recent years,
including GatA (Nakamura et al. 2006), malonamidase (Shin et al. 2002a), fatty acid
amide hydrolase (Bracey et al. 2002), and peptide amidase (Labahn et al. 2002). These
structures have confirmed a common catalytic core and revealed a diverse active site
architecture that accommodates both stringent and promiscuous activities over a wide
range of substrates.
AH is a typical AS family enzyme using a Ser-cisSer-Lys catalytic triad to
hydrolyze allophanate to NH3 and CO2. In some bacterial strains, AH works in
conjunction with cyanuric acid amidohyrolase (EC 3.5.2.15) and biuret amidohydrolase
(EC 3.5.1.84) to catalyze the final steps of s-triazide degradation (Shapir et al. 2005,
Shapir et al. 2006, Garcia-Gonzalez et al. 2005). Of particular interest to the current
study, AH also functions in concert with urea carboxylase to degrade urea in a subset of
fungi and prokaryotes (Strope et al. 2011, Lombard, Moreira 2011). Prior to this
investigation, no structure of AH had been reported. Several studies described a high
degree of substrate specificity in AH (Kanamori et al. 2005, Shapir et al. 2005, Shapir et
al. 2006) but, in the absence of structural insights, the molecular basis for specificity has
not been defined. In this chapter, the AH structure was determined and two residues that
contribute to substrate specificity were studied using steady-state kinetics and structure.
3.4.2 General Features of the AH Structure
Both the overall fold and the position of the catalytic triad in GbAH superimpose
well with other members of the AS family. However, comparison of the AH dimer with
homologous structures reveals that the superfamily exhibits a surprising plasticity at the
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dimerization interface. A structural alignment of GbAH with dimeric superfamily
members shows that the dimerization interface varies between enzymes, leading to a
wide variation in the distance between active sites, ranging from 33 to 60 Å (Figure
3.14). The absence of a conserved dimerization interface in the AS family suggests that
dimerization does not play an essential role in catalysis and that the individual active sites
most likely function independently. Indeed, some AS family members do not form
homodimers: GatA, the glutamine amidohydrolase component of GatCAB, makes up a
heterotrimer with GatB and GatC subunits (Wu et al. 2009) and in vivo and in vitro
studies of Arabidopsis amidase-1 have concluded that there is no interaction between the
amidase monomers (Pollmann et al. 2003). Nevertheless, the relationship between
dimerization and catalytic activity in AH warrants further investigation considering that
the essential active site residues Tyr299 and Arg307 are positioned near the dimerization
interface (Figure 3.6). A connection between dimerization and substrate specificity has
been proposed for the nitrile amidase from Rhodococcus sp. N-771, where a modified
dimerization interface reduces the width of the substrate binding tunnel, thereby limiting
the access of larger substrates (Ohtaki et al. 2010).

A.

B.

Figure 3.14 Structural comparisons of GbAH dimer with other AS family enzymes.
Structural superimposition of the GbAH dimer (cyan) with other AS family enzyme
dimers: (A) MAE2 (white); (B) FAAH (magenta).
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Comparison of the apo and malonate bound structures of GbAH reveals no
structural rearrangements accompanying ligand binding in the active site (Figure 3.7 A),
consistent with other AS family enzymes (Yasuhira et al. 2010, Shin et al. 2002a). Thus,
from X-ray structures, it appears that the active sites of AS enzymes are rigid assemblies
and that substrate discrimination arises by limiting substrate access to the active site and
by the design of specific architectures that are complementarity to the substrate(s). This
apparent rigidity of AS active sites makes the superfamily particularly amenable to
functional predictions by in silico ligand docking, as described in a recent review (Gerlt
et al. 2012).
3.4.3 Specificity Determinants in AH
Previous studies on AH cloned from Enterobacter cloacae and Pseudomonas sp.
Strain ADP confirmed the identity of the Ser-cisSer-Lys catalytic triad and documented a
detectable promiscuous activity with the alternate substrates biuret, malonamide and
malonamate (Shapir et al. 2005, Shapir et al. 2006). TrzF has a specific activity of 0.5
nmol min-1mg-1 with biuret and 1.5 nmol min-1mg-1 with malonamide (Shapir et al. 2006).
GbAH has a similar activity of 8.3 nmol min-1mg-1 with biuret and 2.3 nmol min-1mg-1
with malonamide. Conversely, AH from Oleomonas sagaranensis had no detectable
activity with biuret or malonamide substrates (Kanamori et al. 2005). Whereas the
identity of the catalytic triad and the low tolerance for analogous substrates has been
documented in AH, the active site residues contributing to substrate recognition have not
been described owing to a lack of structural information. In the current study, the
structure of the GbAH-malonate complex combined with kinetic analysis of GbAH
modified by site-directed mutagenesis has revealed an important role for two conserved
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residues: Tyr299 and Arg307. The side chains for these amino acids are within hydrogen
bonding distance of the carboxylate moiety of the substrate analogue, malonate (Figure
3.7 B). Mutations at Arg307 result in a nearly complete loss of catalytic activity while
mutations at Tyr299 substantially decrease kcat and kcat/Km for allophanate and reduce the
substrate preference of AH for allophanate compared with biuret and malonamide (Table
3.6 and 3.7).
Based on the GbAH structure and the kinetic analysis of GbAH with site-directed
mutations, Tyr299 is proposed to donate a hydrogen bond to the deprotonated carboxylate
of allophanate. Hydrogen bond donation from Tyr299 would facilitate discrimination
between the carboxylate moiety of the bona fide substrate, allophanate, and the amide
substituent of the substrate analogues, biuret and malonamide. The reduced
discrimination between allophanate and malonamide/biuret in Tyr299 mutations is
consistent with this proposal. In addition, the nearly complete loss of catalytic activity
observed in site-directed mutations at Arg307 suggests that this residue interacts with the
substrate carboxylate via a salt bridge, in a manner analogous to interactions with
substrate carboxylate moieties in malonamidase and GatA. A salt bridge with the
substrate would serve both to bind and orient the substrate in proximity to the catalytic
triad and also to assist in stabilizing developing negative charge in the transition state.
The inability of AH to form a salt bridge with the alternate substrates biuret and
malonamide further accounts for the poor reactivity of these substrates. Substrate
discrimination in AH, therefore, originates from anchoring the carboxylate moiety of
allophanate in the active site opposite the catalytic triad and, thus, properly positioning
and orienting the amide portion of the substrate for nucleophilic attack. Substrate
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analogues such as biuret, malonamide and asparagine are anchored improperly and,
consequently, the terminal amide of these substrates is improperly positioned for attack
by the Ser172 nucleophile of the catalytic triad (Figure 3.15).

A.

B.

Figure 3.15 Arg307 and Tyr299 are proposed to position and orient the substrate for
optimal nucleophilic attack.
(A) Allophanate binding in the active site of GbAH is facilitated by formation of a salt
bridge with Arg307 and donation of a hydrogen bond from Tyr299. This results in proper
positioning and orientation of the amide bond relative to the catalytic triad, Ser172, and the
oxyanion hole. (B) When an alternate substrate such as biuret is bound in the GbAH
active site, interactions with Arg307 and Tyr299 are suboptimal, resulting in misorientation
of the amide bond relative to the catalytic triad and a reduction in the efficiency of
nucleophilic attack by Ser172. This effect is exaggerated for illustrative purposes.
Malonamate is a structural analogue of allophanate and the substrate of the AS
family enzyme, malonamidase (Figure 3.1 B). Given the similarity between the substrates
and the slow hydrolysis of malonamide by AH, these two enzymes might be expected to
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share similar active site architectures. However, structural and phylogenetic analyses
reveal that malonamidase and AH are distantly related AS superfamily members (Shapir
et al. 2005). Instead, AH is most closely related to GatA, the bacterial glutamyl-tRNA
amidotransferase subunit A (Table 3.2). Interestingly, all three of these enzymes position
an Arg side-chain for salt-bridge formation with the substrate carboxylate moiety. In
malonamidase, this residue (Arg158) is located on the opposite side of the active site
compared with AH and GatA, resulting in a completely different substrate binding
orientation (Figure 3.11 A and B). This Arg is replaced by a Val in AH and a glutamine in
GatA. In addition, an active site loop (amino acids 119-125 in GbAH) present in most AS
family enzymes adopts a variety of conformations and contributes to substrate specificity
by dictating the orientation of the substrate in the active site (Figure 3.11). In
malonamidase, this loop adopts an atypical conformation, forcing the substrate into a
different binding orientation (Figure 3.11 B and Figure 3.16).

Ser148/Ser131
Arg307

Ser148/Ser131
Arg307

Tyr299

Lys74/Lys62
malonate

1Å"

Lys74/Lys62

1Å"

malonate
Ser172/Ser155

Tyr299

Arg158

malonate

1Å"

malonate

1Å"

Arg158

Ser172/Ser155

Figure 3.16 The position of the specificity loop in GbAH compared to malonamidase.
Stereo figures showing the alignment of GbAH and B. japonicum malonamidase (PDB
ID: 1OCL) active sites. AH carbon atoms are colored in cyan and malonamidase carbon
atoms are colored in white. The active site residues and bound malonate are represented
as CPK-colored sticks. The specificity loop in each enzyme is presented in cartoon
format. The clashes that would arise between the AH specificity loop and malonamidase
side chains and substrates are measured and labeled in black.
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The substrate binding orientation and the position and identity of the side-chains
responsible for substrate binding are very similar between GatA and AH (Figure 3.11 B).
In the GatA structure, an alanine replaces the Arg307 of GbAH. However, GatA positions
a different arginine side-chain at a similar location in the active site, allowing the
guanidinium side chain to form a salt bridge with the substrate carboxylate. This
guanidinium group is 7 Å further removed from the catalytic triad in GatA relative to
GbAH, allowing the longer substrates, asparagine and glutamine, to be properly
positioned in the triad of GatA. It is notable that AH does not catalyze the hydrolysis of
either glutamine or asparagine. The difference in the Arg side-chain position explains this
discrimination, accounting for the specificity of GatA for longer substrates and AH for
shorter substrates.
3.4.4 Comparison on Structure of GbAH with KlAH
Following our publication of the GbAH structure (Lin, St Maurice 2013), a
second AH crystal structure, from Kluyveromyces lactis (KlAH) was reported (Fan et al.
2013). Compared to the bacterial strain Granulibacter bethesdensis, Kluyveromyces lactis
is Kluyveromyces yeast and it harbors full-length UAL, which contains AH and UC on
one polypeptide chain. The KlAH was cloned independently in pursuit of its structure.
The structures of both KlAH wild-type (PDB ID: 4ISS) and the nucleophilic serine
mutant, KlAHS177A (PDB ID: 4IST), were solved. No significant structural differences
were observed in the S177A mutant compared to wild-type. In the KlAH structures, the
N-terminal amidase domain as well as the C-terminal domain was characterized.
Sequence alignment of GbAH and KlAH reveals a 45% sequence identity and, structure
alignment of GbAH and KlAH shows that their amidase domains are very similar, with a
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z score of 56.6 and r.m.s.d. of 1.9 Å (Figure 3.17). While the structure of the C-terminal
domain is missing from the GbAH structure, its potential function will be discussed in
Chapter 6.

Figure 3.17 Structure alignment of GbAH and KlAH.
Superimposition of the GbAH with malonate bound structure (PDB ID: 4GYS, cyan)
with KlAH apo structure (PDB ID: 4ISS, pale green). Both structures are shown in
cartoon and the malonate bound in GbAH are shown in CPK-colored spheres, indicating
the position of active site in amidase domain.

Structural superimposition of the GbAH and KlAH active sites of the amidase
domain shows that most helices and loops are positioned in a nearly identical manner
between the two structures. The Ser-cisSer-Lys catalytic triad and the oxyanion hole are
closely aligned between the two structures. However, the two identified substrate
specificity determinant residues, Tyr299 and Arg307 in GbAH (corresponding to Tyr305 and
Arg313 in KlAH) exhibit different conformations between the two structures (Figure 3.18),
although both are conserved in primary sequence (Appendix Figure 2.1). The
guanidinium group of Arg313 in KlAH adopts a different conformation from Arg307 in
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GbAH, despite remaining within hydrogen bonding distance to the substrate analog. Most
strikingly, the Tyr residues adopts a completely different conformation in the two
structures: while Tyr299 in GbAH is observed to form a hydrogen bond with substrate,
Tyr305 in KlAH is oriented away from the active site. While it is possible that this might
be an open conformation as compared to the GbAH structure with malonate bound, it is
hard to get to this conclusion because the structures of KlAH with substrate or analog
bound were not available. In addition, in solved structure of GbAH with and without
substrate analog, there is no change in the conformation of the Tyr299. Therefore, this
might represent a difference between mechanism of substrate specificity between KlAH
and GbAH.

Figure 3.18 Structural superimposition of GbAH and KlAH active sites.
Stereo figures of the structure alignment of GbAH wild-type (cyan) with KlAH (PDB ID:
4ISS, pale green). Malonate bound in GbAH active site is shown in CPK-colored sticks.
The side chains of three residues in catalytic triad, along with the side chains of Tyr299
and Arg307 in GbAH and corresponding Tyr305 and Arg313 in KlAH are shown in sticks.
Concluded from above, the combination of protein structure and site-directed
mutagenesis was used as a powerful tool to probe the detailed function of specific
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residues, which were rationally picked from region of interest. However, while the major
focus was on the hotspots, such as active sites of enzymes, the bulk part of the enzymes
were largely ignored. Therefore, an investigation of the roles of the all residues in an
unbiased manner will be more thorough to further understand the mechanisms of multifunctional enzymes. The subsequent chapter will describe a yeast genetic screen
developed to fulfill this goal.
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CHAPTER 4: DEVELOPMENT OF A YEAST GENETIC SCREEN
FOR UREA AMIDOLYASE
4.1 Introduction
From structural and kinetic analyses, two critical residues for substrate
recognition in AH were characterized in Chapter 3. Both Tyr299 and Arg307 were identified
based on their proximity and orientation relative to the substrate analog, malonate, and
steady-state kinetic results supported their roles in providing substrate recognition and
specificity. This demonstrates the power of a rational approach to investigate protein
structure-function relationships. However, such an approach has its limitations. For
example, aside from the residues that are observed to directly interact with the substrate,
are there other residues that contribute to catalysis? What, if anything, is the function of
residues that lie beyond the active site? Is it possible to move beyond a narrow focus on
the individual active sites of a multifunctional enzyme in order to unveil the residues that
are important for inter-domain interactions, coordination and communication? To better
understand the relationship between structure and function of multi-functional enzymes,
this chapter describes a genetic approach that investigates critical residues in yeast UAL
in an unbiased manner.
The DUR1,2 gene encodes UAL in yeast and is essential for urea-dependent
growth. If this gene is deleted or mutated to render a non-functional UAL, the resulting
yeast are unable to grow on media when urea is the sole nitrogen source (Ghosh et al.
2009). This simple concept forms the basis for a genetic tool to screen functionally
relevant residues of UAL.
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In this screen, the chromosomal DUR1,2 gene in Saccharomyces cerevisiae was
knocked out. The dur1,2 knockout strain was complemented by wild-type or randomly
mutated DUR1,2 genes. Mutagenic PCR was used to amplify a region of interest, with
the rate of mutation adjusted to yield one mutated base pair per gene to ensure that the
phenotype reflects the functions of single amino acid residues. The mutated DUR1,2
library was re-introduced into the dur1,2 knockout background and a growth defect
phenotype served to identify those mutant strains impaired in UAL function. Analyzing
sequences of the selected mutants identified functionally important residues. In theory,
this screen can be targeted to investigate functional residues in any desired region of UAL
and, therefore, offers a powerful tool to study the catalytic mechanism of UAL. In this
study, two separate domains were screened: the first is the allophanate hydrolase domain
and the second is the B subdomain lid of the BC domain.
From the structure of AH described in Chapter 3, the residues within hydrogen
bonding distance from the bound substrate analog were identified. However, the
functions of residues besides the catalytic residues are not known. Therefore, a screen of
the AH domain was initiated to identify more functionally critical residues and to resolve
the role of residues distant from the active site.
A second domain was also targeted for screening: the B sub-domain of the BC
domain. According to structural studies, the BC domain is comprised of three
subdomains. The A and C subdomains form the core of the enzyme, and the B-subdomain
exists as a flexible lid. In the absence of nucleotide, the B-subdomain is in an open
conformation and splays away from the main body of the enzyme (Chou et al. 2009).
Upon ATP binding, there is a ~ 45°overall rotation of the B-subdomain lid relative to the
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core formed by the A and C subdomain (Waldrop et al. 1994). As the mechanism of Bsubdomain lid movement is ubiquitous across all ATP grasp enzymes and, in particular, is
highly conserved in all biotin-dependent carboxylases, a genetic screen focused on this
region might serve to uncover the mechanisms governing lid movement and closure that
can be extended to many other enzymes of the biotin-dependent enzyme family.
Results from screening both the AH domain and the BC subdomain served to
validate the power of this yeast genetic screen. Several amino acids with known function
were identified using these screens. Moreover, some previously unrecognized
functionally important amino acids were revealed. The functional role of these residues is
further discussed, based on sequence conservation and protein structure. Now validated,
this screen can be further applied further to other regions of UAL in order to further
elucidate the catalytic mechanisms and inter-domain relationships in this multi-functional
enzyme.

4.2 Materials and Methods
4.2.1 Construction of Plasmids
To clone ScUAL into the pESC-URA vector, the S. cerevisiae DUR1,2 gene was
cloned from yeast strain MLY40α (MATα ura3-52), PCR amplified using primer #552 and
#553 (Appendix 3). The PCR product was digested by SalI and NheI and ligated into the
pESC-URA vector digested by XhoI and NheI. The cloned DUR1,2 gene in pESC-URA
vector is with the myc tag sequence at N-terminus, under the control of the GAL
promoter.
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To clone ScUAL into the YCplac33 yeast low copy vector, the native promoter
was cloned along with the DUR1,2 gene. To ensure that the full regulatory sequence was
covered, ~ 500 and ~ 1,000 bp of the flanking region both upstream and downstream of
the gene were included. The genomic DNA from yeast strain MLY40α (MATα ura3-52)
was extracted as the PCR template. Two sets of primers were used. Primers #794 and
#795 (Appendix 3) were used to amplify the UAL region with ~ 1000 bp flanking region
at both ends. Primers #792 and #793 (Appendix 3) were used to amplify the UAL region
with ~ 500 bp flanking region at both ends. Primer pairs #794 and #793 (Appendix 3)
were used to amplify the UAL region with ~ 1,000 bp upstream and 500 bp downstream
of the DUR1,2 gene. The ligated plasmids were named YCplac33-DUR1,2 (1) (1000
upstream, 1000 downstream), YCplac33- DUR1,2 (2) (500 upstream, 500 downstream),
YCplac33- DUR1,2 (3) (1000 upstream, 500 downstream), respectively.
4.2.2 Mutagenic PCR
The constructed pESC-URA-DUR1,2 plasmid was used as template for mutagenic
PCR. Primers that cover ~ 100 bp outside the gapped sites were used for mutagenic PCR,
specifically, #631/#632 were used for AH domain and #832/#833 were used for B
subdomain of BC domain (Appendix 3). The PCR reaction mixture (100 µl) contained 1
× Standard Taq Buffer, 30 pmole of each of the two primers, 500 ng template DNA, 7
mM MgCl2 and 5 units of Taq DNA polymerase. The final concentration of dGTP and
dATP was 0.2 mM; the concentration of dTTP and dCTP was 1 mM. MnCl2 was present
in the reaction ranging from a final concentration of 0 mM to 0.5 mM. Also, to reduce the
accumulation of identical mutations accumulating from early stage misincorporations, the
PCR mixture was aliquoted into 8 tubes, with 25 µl in each tube.
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The reaction mixture was cycled according to the following protocol: 95°C for 2
min, followed by 30 cycles of 95 °C for 1 min, 50 °C for 1 min, 72 °C for 5 min; finally
ended with elongation of 72 °C for 5 min. The overall size of the PCR product is ~ 2,500
bp for AH domain mutants and ~ 400 bp for B subdomain mutants. The amplified DNA
was analyzed on 1% agarose gel. The bands of the correct size were gel-extracted and
purified using the standard PCR purification kit. The DNA was quantified by the
absorbance at 260 nm using a UV-Visible spectrophotometer.
4.2.3 Analysis of Mutation Rate
To analyze the mutation rate, the PCR products were ligated into a pGEM-T-Easy
vector for sequencing analysis. The pGEM®-T Easy Vector Systems kit (Promega,
Madison, WI) was used. First, polyA sequence were added to the ends of PCR product by
mixing 7 µl of PCR products with 1 µl of 10× Taq Standard Buffer, 1 µl of 2 mM dATP
and 5 units of Taq DNA polymerase. The reaction mixture was incubated at 70°C for 20
min. The resulting PCR product, polyadenylated at both ends, was then ligated into the
pGEM-T-Easy vector. Briefly, 5 µl of 2 × T4 DNA Buffer, 50 ng of pGEM-T vector, 125
ng PCR product and 1 µl of T4 DNA ligase were mixed, ddH2O was added to a total
volume of 10 µl. The mixture was incubated at 4ºC overnight. Then, 1 µl of the ligated
DNA was transformed into E. coli Top10 cells, and spread on plates containing 0.04
mg/ml IPTG solution (4 µl of 200 mg/ml in 20 ml plate) and 0.04 mg/ml X-Gal (40 µl of
20 mg/ml in 20 ml plate). White colonies were selected and the plasmids were purified.
The target region was fully sequenced for the selected clones. The number of mutations
on the gene was analyzed. The average rate of mutation was calculated by dividing the
total number of mutations by the number of mutants sequenced.
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4.2.4 Construction of a Yeast Library Expressing Randomly Mutagenized Regions in UAL
A gap-repair protocol was used to generate a library of yeast clones expressing
randomly mutagenized urea amidolyase (Forsburg 2001). Specifically, the high-copy
yeast expression plasmid, pESC-URA, was digested by BamHI and BlpI, thus removing
a 2,175 bp restriction fragment. For the yeast low-copy expression plasmid YCplac33
harboring wild-type DUR1,2 gene, two restriction sites. SacI and NgoMIV were
introduced into the plasmid by site-directed mutagenesis. The primers #828/#829
(Appendix 3) were used to introduce the SacI site, primers #848/#849 (Appendix 3) were
used to introduce the NgoMIV site. The plasmid with double mutations was subsequently
digested by SacI and NgoMIV. The resulting gapped vector (500 ng) and mutagenized
PCR fragment (3 µg) were co-transformed into the double knockout yeast strain. After
transformation, the ends of the mutagenized PCR product recombine with the
homologous ends of the gapped vector to regenerate circular plasmids expressing
randomly mutated DUR1,2 gene.
4.2.5 Yeast Genetic Screen for UAL mutants
The yeast expression library expressing DUR1,2 mutants was plated onto uracildeficient Sc medium (Sc-URA) to select for transformants with Ura-containing plasmids.
After incubating the plates at 30 °C for two days, the colonies were transferred by replica
printing onto galactose phosphate urea plates. As a control, the same plate was also
printed onto glucose phosphate urea plates and then glucose phosphate ammonia plates. A
total of ~ 10,000 yeast clones expressing random mutations in the AH domain of UAL
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were screened. For screening of the B subdomain, a total of ~ 300 yeast clones were
screened. The mutants were then subject to further analysis.
4.2.6 Yeast Growth Test: Serial Dilution Spot Test and Replica Printing
For the serial dilution spot test, yeast strains were grown to saturation at room
temperature. The OD600 of the culture was measured using a UV-Visible
spectrophotometer. The culture was diluted to OD600 = 1. Subsequently, three serial 10fold dilutions were created using sterile ddH2O, making a gradient of OD600= 0.1, 0.01,
0.001, 0.0001. A total of 5 µl from each dilution was spotted on designated plates and
incubated at 30 ºC or other temperatures to test for the growth phenotype.
For phenotypic analysis, the yeast strains were patched with a toothpick onto YPD
or appropriate selective media and were allowed to grow overnight at 30 ºC. The patches
were replica printed onto the indicated media and incubated at appropriate temperatures
to test their growth phenotype (Cramer, Davis 1979).
4.2.7 Preparation of Yeast Protein Extracts and Western Blotting
Solutions for TCA extraction were prepared according to Table 4.1. The yeast cells
were harvested and then resuspended in ice-cold TCA buffer. Glass beads and ice-cold
20% TCA were added to the cell suspension. For the calculation of the reagents amount,
100 µl of TCA buffer, 100 µl of glass beads and 100 µl of ice-cold 20% TCA were used
per 7.5 OD600 units of cells. To disrupt the cells, the tubes were vortexed vigorously at
room temperature for a total of 4 min, with a 30 sec interval between each 30 sec vortex.
The tubes were kept on ice during the intervals. The supernatant was transferred to a 1.5
mL centrifuge tube, and held as the first cell extract. To obtain the second TCA extract,
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500 µl of an ice-cold, 1:1 mixture of 20% TCA and TCA buffer was added to the pellet.
The tubes were vortexed again for 2 × 1 min at room temperature, with 30 sec interval
between two vortexes on ice. The supernatant from the second cell extract was combined
with the first cell extract. The proteins were pelleted using a microcentrifuge at 15,871 ×
g for 10 min at 4°C. After removing the supernatant, the pellet was resuspended in TCALaemmli loading buffer with a ratio of 10 µl of loading buffer per OD600 unit of cells.
Table 4.1 Solutions used in TCA methods for protein extraction
Solution
20% w/v TCA
TCA buffer
SDS/glycerol stock
solution
Tris/EDTA solution
TCA-Laemmli
loading buffer

Component
20% w/v TCA in ddH2O
20 mM Tris-HCl pH 8; 50 mM Ammonium acetate; 2 mM
EDTA; 50 µl/ml protease inhibitor solution
7.3% w/v SDS; 29.1% v/v Glycerol; 83.3 mM Tris-base,
not pH-adjusted; Bromophenol blue Spatula tip-full
200 mM Tris-base, not pH-adjusted; 20 mM EDTA;
In 1 ml buffer: 480 µl SDS/glycerol stock solution; 400 µl
Tris/EDTA solution; 50 µl β-mercaptoethanol.

For western blotting, the anti-myc antibody was diluted to a concentration of 0.21 µg/ml. The proteins were separated on a 6% SDS-PAGE gel and subsequently
transferred using transfer buffer (96 mM glycine; 12 mM Tris Base, pH 8.3; 0.1% SDS;
20% methanol). After transfer, the blot was wetted and rinsed briefly in PBS buffer (8 g
NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4, pH 7.4, to a total volume of 1 L),
blocked in 5% milk in PBS for 1 hour at room temperature. Then the blot was rinsed in
PBS at room temperature for 5 min and incubated with 2 µl/10ml (antibody/milk)
antibody for 2 hours at room temperature. The blot was developed with ECL reagents
[Reagent 1: for 5 ml each, 265 µl of 1.875M Tris-HCl, pH 8.8; 50 µl luminol (44 mg/ml
DMSO); 22 µl ρ-coumaric acid (15 mg/ml DMSO); 4.66ml of ddH2O were added;
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Reagent 2: for 5 ml each, 265 µl of 1.875 M Tris-HCl, pH 8.8; 3 µl of 30% H2O2
solution; 4.73 ml of ddH2O were added]. The reagent 1 and 2 were combined and
dispensed over the protein side of blot and incubated for 1min. Finally the blot was
drained, exposed to film for 1s-5 min, depending on the strength of the signal, and finally
developed.
4.3 Results:
4.3.1 Construction of UAL Knockout Strain and Complementation by Plasmids
The Saccharomyces cerevisiae strain MLY40α (MATα ura3-52) and D273-10B
(MATα mal) were used as the host for knockout of the DUR1, 2 gene. The chromosomal
DUR1, 2 gene was replaced by a kanamycin resistance gene using PCR based
chromosome integration as described in Section 2.3.3. The kanamycin gene was PCR
amplified with ~ 50 flanking sequence from DUR1,2 gene, and the PCR product was
used to knockout the DUR1,2 gene on chromosome. The two dur1,2Δ mutants were
selected on YPD-kan media. The result of knockout was verified by PCR, using genomic
DNA extracted from mutants as template. The size of the DUR1, 2 gene is ~ 4 kb, and the
size of the kanamycin gene is ~ 1.5 kb. Therefore, after knockout of the DUR1, 2 gene,
only ~ 1.5 kb band can be observed after PCR reaction. The wild-type D273-10B strain
was used as a control for the PCR reaction (Figure 4.1).
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Figure 4.1 Construction of DUR1,2 knockout strain in Saccharomyces cerevisiae.
Agarose gel results from (A) PCR product of kanamycin gene, with ~ 50 bp homologous
sequence with DUR1,2 gene flanking region. The PCR product is indicated with arrow.
Lane M is standard DNA marker. Lane 1-4 corresponds to PCR products using different
melting temperatures: 60 °C, 56 °C, 50 °C, 44 °C, respectively. The target PCR product
of ~ 1.5 kb was indicated by arrow. (B) PCR product from reactions to verify the
successful knockout of the DUR1,2 gene. Lane M is standard DNA marker. Lane 1-3
represent the PCR products using genomic DNA from 1, wild-type D273-10B strain; 2,
MLY40 dur1,2Δ strain; 3, D273-10B dur1,2Δ strain. The PCR products from wild-type
and two dur1,2Δ strains were indicated by arrows.
The growth phenotype of the dur1,2 knockout mutants was tested on defined media.
The nitrogen source and uracil are two selective reagents for the test, because MLY40
exhibits a defect in URA3 expression and thus can only grow on plates supplemented
with uracil. The DUR1,2 knockout mutant cannot utilize urea and therefore only grow
when ammonia is the nitrogen source. So on glucose-phosphate urea media, a defined
minimal media using urea as sole nitrogen source, the D373 wild-type strains can grow,
but the dur1,2Δ mutant of D273 can not grow. On the glucose-phosphate-urea-uracil
plate, the MLY40 can grow but MLY40 dur1,2Δ strain can not. When ammonia is
supplemented as a nitrogen source instead of urea, all dur1,2Δ strains grow (Figure 4.2).
These results confirmed that the phenotype of the knockout strains on urea plates were
solely due to the modification of DUR1,2 gene.
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Figure 4.2 Growth test of DUR1,2 wild-type and mutant strains.
The growth condition of DUR1,2 knockout and wild-type strains on different media are
shown on the left. The plates and the specific strains types are indicated in the right table.
To complement the knockout strain, the dur1,2Δ mutant was transformed with a
yeast high-copy vector, pESC-URA, harboring the DUR1,2 gene, to generate the
complement strain (MLY40 dur1,2Δ :: pESC-URA-DUR1,2). The expression of DUR1,2
gene is under control of the GAL1 promoter, allowing the expression of UAL to be
induced by galactose and suppressed by glucose. The complement strain can grow on
galactose-phosphate-urea plate, but not glucose-phosphate-urea plate. As a negative
control, the empty vector pESC-URA was transformed into the knockout strain. The
complemented mutant strain (dur1,2Δ :: pESC-URA) did not grow on glucose-phosphateurea plate or galactose-phosphate-urea plate (Figure 4.3). Overall, this system offers a
clear tool to distinguish non-functional mutants from functional UAL.

Figure 4.3 Growth test of complemented DUR1,2 mutant strains.
Spot growth test results showing the growth condition of different strains on three types
of plates. Both the wild-type and DUR1,2 knockout strains are complemented with either
empty yeast high copy vector pESC-URA or pESC-URA expressing wild-type DUR1,2
gene. The dilution spot test results are shown, plate types are indicated above.
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4.3.2 Optimizing the Mutation Rate for Error-prone PCR
PCR conditions were optimized for misincorporation by adjusting the
concentrations of MnCl2 and MgCl2, along with unbalancing the available nucleotide
pool, in order to obtain an optimized mutation rate of 1 mutation/PCR reaction. The rate
of mutations/PCR reaction was determined by sequencing a pool of 16 reactions and the
average rate of mutation was calculated. For the mutations in 2.5 kb regions of AH
domain, 0.05 mM MnCl2 was chosen as appropriate concentration for mutation. 4
mutants were sent for full sequencing and all of them were single mutants. For the
mutation in ~ 200 bp B subdomain of BC domain, 0.2 mM MnCl2 was used. Among 17
total mutants, 6 had 0 mutations, 4 had single mutations, 2 had double mutations, and 3
had triple mutations. Therefore, the average mutation rate was 1.13 ± 1.19. These
conditions were chosen for subsequent genetic screens.
4.3.3 Yeast Genetic Screen of the AH Domain of UAL
The MLY40 dur1,2Δ strain was transformed with a randomly mutagenized PCR
library and with a gapped pESC-URA vector. The transformed yeast were grown on ScURA plates for 2 days following replica printing on galactose-phosphate ammonia and
galactose-phosphate urea minimal media plates. The growth conditions of the colonies
were compared. Under these conditions, the wild-type and mutants showing normal UAL
activity will grow on both galactose phosphate urea plates and glucose phosphate
ammonia plates, but not on glucose phosphate urea plates. Those mutants with defects in
UAL activity are unable to grow on galactose phosphate urea plates and glucose
phosphate urea plates, but will grow on glucose phosphate ammonia plates (Figure 4.4).
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In the screen of the ~ 1,700 bp AH domain, a total of ~ 10,000 colonies were screened;
162 of those colonies were initially picked as mutants. In the screen of the ~ 200 bp B
subdomain, a total of 300 colonies were screened and 121 were initially picked as
mutants.

Galactose-phosphate-ammonia plate

Galactose-phosphate-urea plate

Figure 4.4 Screen for functional mutations in the AH domain of UAL.
The replica printed plates showing comparison of growth on galactose-phosphateammonia and galactose-phosphate-urea plates. Shown is one group of representative
plates. Arrows indicate the colonies identified as functionally defective by the loss of
growth phenotype on the galactose-phosphate-urea plate.
Those colonies that exhibited growth defects were further characterized to
exclude false positives. The first step was to confirm the phenotype of the selected
mutants. The growth status of all mutants was confirmed using spot tests on galactosephosphate-urea and galactose-phosphate-ammonia plates. Only those mutants with the
strongest growth defect were chosen. The second step was to isolate the plasmid from the
mutants and re-transform them back into a ura3Δ dur1,2Δ strain. This was performed in
order to confirm that the growth defect was dependent on the plasmid and not due to any
modifications on the yeast chromosome (Figure 4.5 A). The third step was to detect the
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UAL expression levels of mutants by SDS-PAGE and Western blot analysis (Figure 4.5 B
and C). There were two major reasons for this: 1, the mutagenic PCR may introduce
premature stop codons that lead to nonsense mutations that are of no value to this study;
2, certain mutations might lead to decreased levels of protein expression or improper
protein folding. These types of mutants were excluded for subsequent analysis. Most of
the 162 mutants were excluded after these steps, only 17 mutants were finally sent for
sequencing. These mutants displayed a significant growth defect despite maintaining
wild-type levels, full-length urea amidolyase expression.
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Figure 4.5 Validation of mutants obtained from yeast genetic screen.
(A) Yeast patch replica printing results showing the growth phenotype of plasmid
retransformed mutants (1-7), along with (P) positive (ura3Δ dur1,2Δ:: pESC-URADUR1,2) and (N) negative controls (ura3Δ dur1,2Δ:: pESC-URA). (B-C) Detection of
UAL expression level of selected mutants. The total protein from yeast was extracted and
the corresponding band for UAL was shown by (B) SDS-PAGE gel and (C) western blot
against myc-tag.

80
4.3.4 Analysis of AH Domain Mutants
The mutations obtained were characterized on structure, to further explore the
relationship between protein structure and function. The ScUAL gene was aligned with
the GbAH gene sequence (Appendix Figure 2.1) and, the corresponding positions of the
point mutations were identified based on the GbAH structure (Table 4.2 and Figure 4.6).
The mutations obtained from the screen broadly distributed across the entire GbAH
structure. Based on their sequence conservation and locations on structure, these
mutations can be divided into four groups. The first two groups of mutations are in the
active site. The third group belongs to the second shell residue. The last group of
mutations locate distant from the active site.
Table 4.2 Summary of the yeast genetic screen results in AH domain of UAL
Number of AH mutants
Mutations in ScUAL (GbAH)*
10, 122
K87N (K74N)
74
K87E (K74E)
36
R321C (R307C)
73
A135V (A122V)
12
L227Q (V214Q)
42
I90F (I77F)
43
S206F (S193F)
53
P175Q (A162Q)
119
I439T (V423T)
51
S54L (A42L)
123, 76, 159
G141D (G127D)
111
A122E (A110E)
101
P384S (P368S)
* The first residue numbers indicate the residues numbered in ScUAL. The
numbers in parentheses represent corresponding residue numbered in GbAH.
Purple dots represent mutations conserved in AH and UAL.
Green reverse triangles represent non-conserved mutations.
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Figure 4.6 Extrapolate the mutation sites from the yeast UAL on the structure of
GbAH.
The GbAH dimer is shown in cartoon representation colored cyan. Mutation sites are
mapped on one monomer. The malonate binding at the active site is shown in CPKcolored spheres. All mutations are in sticks, colored red.
Most notably, the screen returned several active site residues whose functions
were well characterized and were previously confirmed by site-directed mutagenesis and
enzyme kinetics. The mutations belong to this category include the K74N/E, and R307C
(Figure 4.7 A). Lys74 is part of the catalytic triad in AH, and serves to stabilize the
deprotonated form of Ser148 during catalysis. Mutation of this catalytic lysine results in
<1% activity (Shapir et al. 2005). Arg307 is one of the critical substrate specificity
determinants and interacts directly with the substrate carboxylate moiety (see Chapter 3).
Mutation of this residue results in an eight orders of magnitude reduction in kcat/Km (see
Section 3.3.4). The identification of these two residues is consistent with results obtained
in kinetic assays and serves to validate the screen. However, not all previously recognized
catalytic residues were identified in this screen, such as the two residues in catalytic triad,
Ser172 and Ser148. This is likely due to the fact that the screen did not saturate all possible
mutations.
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Figure 4.7 Extrapolate the active site mutations obtained from the yeast UAL on the
structure of GbAH.
(A-B) The structure of GbAH active site is shown in cartoon, colored cyan. Malonate
bound at the active site are shown as CPK-colored sticks. The specific residues identified
from the screen: (A) The two residues with known function (Arg307 and Lys74); (B) The
two residues identified on the active site loop (Ala122 and Gly127), are shown as sticks and
highlighted red. (C) Structural superposition of GbAH structure with malonate (cyan),
malonamide (pink) and allophanate (yellow) bound at the active site. Ala122 in three
structures are shown as sticks.
The screen also identified two mutations in the active site that had not previously
been characterized: A122V and the G127D (Figure 4.7 B). Both Ala122 and Gly127 are
conserved in AH (Appendix Figure 2.1). According to the GbAH structure, both are on an
active site loop that spans the substrate in the active site. The distance from the backbone
carbonyl oxygen of Ala122 to the bridging carbon of malonate is 3.4 Å. It is likely the
Ala122 directly interacts with the bridging nitrogen when allophanate is bound at the
active site. The Gly127 mutation is also located on the same active site loop and the
G127D mutation might also disrupt the active site loop conformation. Two very recent
structures of the GbAH S172A mutant with allophanate or malonamide bound at the
active site, solved in collaboration with Katelyn Stine, an undergraduate student in the St.
Maurice lab, is consistent with a functional role for the active site loop. A structural
alignment of GbAH with malonate, malonamide and allophanate bound in the active site
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shows that allophanate adopts a different conformation as compared to malonate and
malonamide. The bridging nitrogen of allophanate is 2.7 Å away from the backbone
amide of Ala122, at a perfect distance and orientation for hydrogen bond (Figure 4.7 C).
A third group of residue belongs to second shell residues. The first shell residues
are defined as the amino acids directly in contact with the substrate. The second shell
residues are the amino acids that directly contact the first shell residues. One mutation,
I77F, was identified in the screen, and the residue Ile77 locates on the second shell from
structure (Figure 4.8). Second shell residues can influence the conformation of the first
shell residues and manipulate enzyme activity by providing structural stabilization
(Brodkin et al. 2011, DeChancie, Houk 2007). Sequence alignment reveals that Ile77 is
conserved among all AH and AS family enzymes (Appendix Figure 2.1). Therefore, it is
also possible this residue plays a stabilizing role common to all the AS family enzymes.

Ile77

Figure 4.8 Structure of GbAH monomer showing the first shell residues, second shell
residues and identified mutation residue.
The structure of GbAH monomer is shown in cartoon, colored grey. The bound malonate
is shown as a, CPK-colored sphere, highlighting the position of the active site. The first
and second shell residues are shown as sticks, colored as salmon and yellow, respectively.
The second shell residue identified in the yeast genetic screen, Ile77, is indicated by arrow
and shown as sticks, colored red.
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A fourth group of residues identified from the screen are distant from the active
site (Figure 4.9). These residues are not conserved in AS family enzymes and AH
(Appendix Figure 2.1). Therefore, the functions of these residues are difficult to explain
based on sequence homology. However, it is attempted to extrapolate the function of
these residues according to their relative locations on structure. The Val214 is located on
α-helix close to the C-terminus. The V214Q mutation might disrupt the structure of the
C-terminus loops. The Ala162 is located on the turn to the N-terminal loop. The A162Q
mutation is likely to interfere the structure of the N-terminal α-helices. The Pro368 is in
the proximity to the Tyr299. The P368S mutation possibly leads to a conformational
change in the active site. The Ala42 is located on the protein surface. It is attempted to
speculate that the mutation of A42L might disrupt the interactions of AH with other
proteins.

Figure 4.9 Extrapolate the mutations distant from the active site on the structure of
GbAH.
The structure of GbAH monomer is shown in cartoon, colored cyan. The bound malonate
is shown in CPK-colored spheres, highlighting the position of the active site. The
residues distant from the active site identified from the screen are colored yellow and the
side chains are displayed as sticks.
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4.3.5 Analysis of B Subdomain Mutants
In the yeast genetic screen on the AH domain of UAL, a yeast high copy vector
was used, which resulted in over-expression of the UAL in MLY40 dur1,2Δ mutant
strain. Overexpression can lead to two potential problems: 1, mutations that have minor
or moderate effects on UAL activity can not detected and only the mutations which
dramatically impair UAL activity can be identified in such a screen; 2, overexpression of
UAL might result in disruption of normal metabolism compared to native conditions.
Therefore, to attempt a more sensitive screen of functional mutations in the B subdomain
of the BC domain, a low copy number centromeric vector, YCplac33 was employed. In
yeast, the expression of DUR1,2 is induced by urea as nitrogen source and is prevented
when other more readily used nitrogen sources such as asparagine, ammonia or glutamine
are available (Cooper, Lawther 1973). Thus, to mimic the endogenous expression level in
yeast, the native promoter from UAL was cloned along with the DUR1,2 gene. As there
is no clear definition for the promoter region of the DUR1,2 gene, the upstream 500 bp or
1,000 bp and downstream 500 bp or 1,000 bp were cloned. According to Figure 4.8, the
ScUAL with 1,000 bp both upstream and downstream was able to complement the
dur1,2Δ phenotype, similar to that of the yeast high copy vector harboring wild-type
ScUAL.
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Figure 4.10 Growth test for UAL expressed in yeast low copy vector.
The growth test for UAL constructs on galactose-phosphate-urea plate. Shown on the
plates are growth of the MLY40 dur1,2Δ strain complemented with: 1, yeast high copy
vector harboring wild-type DUR1,2 gene (MLY40 dur1,2Δ :: pESC-URA-DUR1,2); 2,
yeast high copy vector harboring empty high copy vector (MLY40 dur1,2Δ :: pESCURA); 3-5, yeast low copy vector harboring wild-type DUR1,2, along with different
lengths of upstream/downstream sequence. 3, MLY40 dur1,2Δ :: YCplac-DUR1,2 (1)
(500 bp upstream, 500 bp downstream); 4, MLY40 dur1,2Δ :: YCplac-DUR1,2 (2) (1,000
bp upstream, 500 bp downstream); 5, MLY40 dur1,2Δ :: YCplac-DUR1,2 (3) (1,000 bp
upstream, 1,000 bp downstream).
From the screening of ~300 colonies, a total of 30 mutations were obtained (Table
4.3), distributed in 24 mutants. 6 mutants harbor double mutations, which complicated
the interpretation of results. Therefore, focus was placed on the 18 remaining mutants that
have a single mutation. Furthermore, according to sequence alignment results of
Rhizobium etli pyruvate carboxylase (RePC), Saccharomyces cerevisiae UC (ScUC),
Candida albicans UC (CaUC), Kluyveromyces lactis UC (KlUC), mutations in nonconserved residues were excluded. A total of 6 mutations were chosen as residues
conserved in both UC and pyruvate carboxylase (PC), while 11 mutations were in
residues conserved in UC but not PC (Appendix Figure 2.2). RePC (PDB ID: 3TW6) was
chosen for mapping these correspondingly conserved B subdomain mutations (Figure
4.11), because in this structure, the B subdomain lid is in a closed conformation, and both
biotin and ADP are bound at the active site, which is helpful to visualize the direct
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substrate binding residues (Chou et al. 2009, Lietzan et al. 2011). Moreover, the BCCP
domain and tethered biotin are bound in the BC domain, revealing the interface between
the BC and BCCP domain, which assists in interpreting the functions of the mutations.
Table 4.3 Summary of yeast genetic screen results in B subdomain of BC domain
Mutant
Mutation in ScUC
Mutant
Mutation in ScUC
number
number
3
E179V/ Q213R
4/28
T191A
6
M157R
7
V198A / M215K
8
I167F
11
Q188R
19
E183V/ H187L
20
E176D
22
F193Y
23
F182S
25
V158A
33
F199L
35
K159E
36
L169M/ Q188L
39
L169S
40
K171R
43
V172D
46
L200P
49
G168D
50
T161A
52
F199S
53
A162T
57
M157I/ D177G
59
H209A
61
I181N/ L214P
Purple dots represent mutations conserved in UC and PC
Green reverse triangles represent mutations conserved only in UC.

Figure 4.11 Structure of BC domain of RePC showing all the mutations obtained.
The BC and BCCP domain of RePC (PDB ID: 3TW6) are shown in cartoon. The BCCP
domain is colored in light green. The A- and C- subdomain of BC domain is colored light
blue. The B-subdomain of BC domain is colored in light yellow. The ADP and biotin
binding at the active site are shown in sticks, colored cyan and dark blue, respectively.
The mutations obtained from the yeast genetic screen are shown in sticks, red.
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The 6 mutations were grouped into three classes based on their location and
proposed function. The first group of mutations includes M157R, K159E and G168D
(Figure 4.12). These three residues directly contact ADP. The side chains of Met157 and
Lys159 are within H-bonding distance to the adenine ring of ADP, therefore it is expected
that mutation of these two residues might interfere with ATP binding in reaction. The
Gly168 is located on the T-loop, the glycine rich loop forming the conserved GGGGXG
motif (amino acid 163-168) (Appendix Figure 2.2) (Waldrop et al. 1994). Although no
mutation was identified for the four consecutive glycine residues, the identification of
G168D is consistent with a functionally important role for the T-loop in ATP binding and
catalysis.

Gly168

Met157

Lys159

ADP

Figure 4.12 Structure of BC domain showing the mutations in the active site.
The BC and BCCP domain are shown in cartoon representation. The A- and Csubdomain of BC domain is colored light blue. The B-subdomain is colored light yellow.
The ADP binding at the active site is shown in sticks, colored cyan. The three mutations
at the active site, Met157, Lys159 and Gly168 are shown in sticks, colored red.
The second group of mutations did not involve residues directly interacting with
the substrate. The L200P mutation was another conserved mutation but is located distant
from the substrate-binding site (Appendix Figure 2.2). Leu200 is on the β-sheet, facing
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toward the main α-helix in the B subdomain, which forms the BC-BCCP interface
(Figure 4.13). The functional role of this residue is not clear. One possibility is that it
alters the conformation of the BC-BCCP interacting loop and, thus, interferes with the
location of the BCCP tethered biotin in the BC domain, a critical step for the biotin
carboxylation reaction.

Leu200

ADP

Figure 4.13 Structure of BC domain showing the mutation distant from the active
site.
The BC and BCCP domain of RePC are shown in cartoon. The BCCP domain is colored
light green. The A- and C- subdomain of BC domain is colored light blue. The Bsubdomain is colored light yellow. The ADP binding at the active site is shown in sticks,
colored cyan. The mutation distant from the active site, Leu200 is shown in sticks, colored
red.
The third type of mutation is represented by H209A (Figure 4.14). His209 is
located on the hinge region of the B subdomain, which links the B and C subdomain. The
identification of this mutation indicates that the His209 potentially contributes to the loop
flexibility.
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ADP

His209

biotin

Figure 4.14 Structure of BC domain showing the mutation in the hinge region.
The BC and BCCP domain of RePC are shown in cartoon. The BCCP domain is colored
light green. The A- and C- subdomain of BC domain is colored light blue. The Bsubdomain is colored light yellow. The ADP and biotin binding at the active site are
shown in sticks, colored cyan or dark blue, respectively. The mutation on the hinge
region, His209, is shown in sticks, colored red.
4.4 Discussion
4.4.1 Rational Versus Unbiased Screen to Study Protein Structure and Function
The relationship between protein structure and function is a critical theme of protein
sciences and there are two primary approaches that can be used to unveil functionally
important residues in a protein. The first approach is to use rational methods. Typically,
site-directed mutagenesis introduces single point mutations or small insertions or
deletions at specific, defined regions in the protein. This approach is extensively used to
test specific, functional hypotheses (see, for example, the investigation of function for
Tyr299 and Arg307 described in Chapter 3). Using this approach, clues about functionally
relevant residues obtained from sequence and structure data can be verified
experimentally by site-directed mutagenesis. For example, by analyzing the amino acid

91
sequence, the signature residues that belong to certain protein subfamilies can be
identified based on sequence homology. The Ser-cisSer-Lys catalytic triad of the AS
superfamily described in Chapter 3 is one such example. Also, by studying the protein
structure, performing structural alignments with other proteins and analyzing the residues
at specific positions of the structure, functionally important residues occupying particular
positions can be identified. Such approaches are powerful but are limited to studying the
roles of only a small group of prominent residues. This approach ignores the functional
contribution from the vast majority of other residues in the polypeptide chain.
A second approach to studying protein structure and function relationships
involves an unbiased sampling of every residue in the protein, in order to expand the
understanding of enzyme mechanism beyond those residues that directly participate in
substrate binding and catalysis. A recently introduced example of such an approach is
seen in the application of molecular dynamics to protein functional studies. Molecular
dynamics combined with quantum mechanical calculations (QM/MM) can simulate the
overall dynamic nature of the protein while calculating the energetics of catalysis,
allowing the role of every individual residue in the catalytic transformation to be
calculated (Johansson, Lindahl 2006). These analyses are thorough and can offer
significant insights into protein structure and function, but they are limited by the huge
amount of data processed and the lack of experimental validation. An alternative
unbiased approach to assessing the structure-function relationships across the entire
protein, therefore, is to adopt a genetic approach, where random mutagenesis is combined
with phenotypic analysis and screening to unveil functionally important residues that
might not otherwise be obvious. The yeast genetic screen for UAL described in this
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chapter, therefore, offers a complementary tool for investigating functionally important
residues in UAL. Through the unbiased sampling of all amino acids in the AH domain,
for example, many new functionally relevant residues have been uncovered that would
not otherwise have been discovered using a rational approach.
4.4.2 Advantages of the Yeast Genetic Screen for UAL
There are several advantages of the yeast genetic screen developed in this study
compared to other ways to study protein structure-function relationships. 1. Compared to
site-directed mutagenesis, the unbiased method can functionally screen across wider
sequence region of the protein. It is able to identify residues distant from the active site.
2. Yeast has several advantages over other model systems. First, yeast endogenously
harbors the DUR1,2 gene, which is essential for viability when urea is the sole nitrogen
source. Second, yeast has a haploid life cycle. Therefore, compared to other eukaryotic
systems, it can conveniently distinguish between dominant and recessive mutations.
Furthermore, yeast has a high rate of homologous recombination and is readily amenable
for genetic manipulation such as transformation and plasmid extraction (Forsburg 2001).
It is an ideal and safe system for culturing in the laboratory. 3. Compared to most other
biotin-dependent enzymes, UAL is involved in a less central metabolic network, enabling
simple genetic manipulation without significantly disturbing central metabolic processes
(Cheng et al. 2005, Ghosh et al. 2009, Andersen et al. 2008). Therefore, UAL is an
accessible model system that offers a great opportunity to unveil mechanistic features that
are common to all biotin-dependent carboxylase enzymes.
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4.4.3 Limitations of the Yeast Genetic Screen for UAL
Although the yeast genetic screen described in this chapter offers a powerful tool
to study the function of specific residues in UAL, there are several limitations. One
potential problem for this screen is that it will not distinguish between soluble and
insoluble proteins. The total protein was extracted from the yeast and the level of UAL
over-expression was shown both by SDS-PAGE and Western blot. The results might
indicate that the mutant proteins were appropriately folded so that the myc-tag is
accessible as wild-type proteins, but the possibility cannot be excluded that the mutant
protein might be insoluble, leading to the null-function phenotype. To totally clarify this
question, a further protein purification may be necessary to disaggregate correctly folded
and soluble mutant proteins from those that are insoluble.
Another shortcoming for the genetic screen is that, because random mutagenesis
often generates a large mutant library, a highly efficient screening system is required.
Like in our screening of the ~ 1,700 bp AH domain, although over 10,000 colonies were
screened, it still did not reach saturation, because typically to reach saturation requires a
screen of 10 times colonies as compared to the length of the target gene. Therefore, the
screening of large regions is extremely laborious. Although the screen identified
mutations in some functionally characterized residues, several functionally important
residues (i.e. the two catalytically essential Ser residues) did not come up in the screen.
This indicates that our screen did not fully saturate all of the possible mutations and that
potentially many more functionally important residues remain unidentified.
In addition, this screen leads to several concerns about the mutants obtained such
as defects in protein expression, folding and solubility because the screen was targeted
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for loss of functions. Thus it requires substantial following up studies to validate the
mutants. Instead, if the screen could be designed to be a gain of function screen, where
only the properly folded and expressed mutants could be identified, the screen would be
more effective. Such examples were seen in several studies (Myers et al. 2008,
Boukalova et al. 2014).
4.4.4 Mutants Obtained from the Yeast Genetic Screen of UAL
To facilitate the studies into structure-function relationship in UAL, I developed a
system that expresses UAL in a genetically modified yeast strain that requires full
complementation of the enzyme activity. In the heterologous expression system, mutation
in certain functionally critical residues leads to failure in complementation of the
knockout strain.
UAL is a particularly large enzyme with several domains fused into a single
polypeptide chain. In the present study, we investigated two regions. The first is the AH
domain, and the second is the B subdomain of the BC domain. The goal of studying the
AH domain is to probe beyond the known catalytic residues, to investigate the roles of
supporting residues in catalysis. The results of our genetic screen fall into five distinct
categories. According to previous kinetic results, mutation of Arg307 reduced the catalytic
rate for eight orders of magnitude. Mutation of corresponding lysine in AH results in
<0.1% activity compared to wild-type (Shapir et al. 2005). Both mutations dramatically
reduce, but do not eliminate, the enzyme activity. These results suggest that, although
UAL was highly overexpressed under the GAL promoter, the genetic screen was
sufficiently sensitive to identify mutations that retain low levels of catalytic activity.
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The second group of mutations highlights the role of the active site loop in
catalysis. In Chapter 3, the conformation of this active site loop was compared to other
amidase signature family enzymes (Figure 3.11). Notably, in malonamidase, which
catalyzes a very similar reaction to AH, the conformation of this loop is dramatically
different. Therefore, this loop might contribute to the substrate specificity of these
enzymes (Figure 3.16). The Ala122 and Gly127 mutations support the notion that this loop
conformation is a critical element of catalysis. It is presumed that the backbone carbonyl
oxygen of Ala122 forms a hydrogen bond with the bridging amide of allophanate such that
this loop contributes a substrate specificity determinant in addition to Tyr299 and Arg307
described in Chapter 3. The hydrogen bonding interaction with the backbone amide can
distinguish the bridging amide nitrogen of allophanate from several other substrate
analogs (i.e. malonamide and glutamine), which may bind Tyr299 and Arg307 with similar
conformations as allophanate, but which contain a carbon atom in place of nitrogen at the
bridging position (Figure 3.11 and Figure 4.7 C). This reiterates the power of the yeast
genetic screen, because the interaction of Ala122 with the substrate is through the
backbone carbonyl oxygen, making it difficult to study the role of Ala122 through
traditional site-directed mutagenesis methods. Further experiments such as truncations of
this loop are desperately needed in order to confirm its role in substrate binding and
catalytic turnover.
A third group of mutations reveals the importance of second sphere residues.
Typical biochemical studies on enzymes often focus on residues that directly interact with
substrates. In recent years, several studies have begun highlighting the role of second
shell residues in catalysis. For example, one hypothesis suggests that a tradeoff exists
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between enzyme activity and stability. In a detailed study, several second shell residues
were identified which served to manipulate enzyme activity by providing structural
stabilization (Drawz et al. 2009). Also, second shell effects can be explained by the
proposal of amino acid coupling networks. Compared to traditional view that the amino
acids interact locally and form dense network, the new theory support the existence of
long-range amino acid interactions which a broader communication, named amino acid
coupling network. It has been shown to play a role in allostery and enzyme catalysis
(Boehr et al. 2013, Reetz et al. 2009, Roston et al. 2014). In the AH active site, the
backbone nitrogen of Ile77 forms hydrogen bonds with both backbone oxygen atoms of
both Asn76 and Lys74, this Lys74 further hydrogen bonds with Ser148 and Ser172 that form
the catalytically essential Ser-cisSer-Lys catalytic triad (Figure 4.15). Therefore, the I77F
mutation is consistent with a role of the second shell residue in supporting and coupling
the first shell residues. Further mutagenesis and structural studies on this mutation might
unveil the specific role of this residue.
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Figure 4.15 Hydrogen bond network for the Ile77.
The catalytic active site of GbAH is shown in cartoon, colored white, with malonate bond
shown in sticks, colored purple. The Ser172-cisSer148-Lys74 catalytic triad and the main
chain of oxyanion hole are shown as sticks, colored salmon. The Ile77 and Asn76 are
shown as sticks, colored red and yellow, respectively. The distances for potential
hydrogen bond network are shown in dashed line. The measured distances are indicated.
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The functional roles of the fourth group of mutations are more difficult to
interpret. Interestingly, previous studies on another amidase signature family enzyme
have also revealed functional defects originating from mutations distant from the active
site. In a directed evolution experiment performed on mandelamide hydrolase (MAH),
only a few point mutations were necessary to significantly alter the substrate specificity
of the enzyme from its bona fide substrate, mandelamide (Wang et al. 2009). Two rounds
of random mutagenesis and screening were used. In the first round of mutagenesis, a
double mutant, Q207H/Q382E displayed higher activity toward lactamide while retaining
activity toward mandelamide. The structure of MAH is currently not available. However,
mapping of the corresponding residues on the structure of GbAH show that the Gln207
(corresponding to Val175 in GbAH) and Gln382 (corresponding to Leu348 in GbAH) are
both distant from the active site in MAH (Figure 4.16). A second round of random
mutagenesis leads to an additional mutation on the active site residue, Gly202
(corresponding to Ala170 in GbAH), enabling the complete conversion of MAH into an
enzyme that is active with lactamide but is inactive with mandelamide (Wang et al.
2009). The Ala170 is part of the oxyanion hole and interacts with substrate directly. These
findings are consistent with the results obtained from the yeast genetic screen,
demonstrating that mutations distant from the active site can exert an allosteric influence
on the catalytic activity and substrate specificity.
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Ala170

Figure 4.16 Mapping of mandelamide hydrolase mutated residues on GbAH
structure.
The structure of GbAH monomer is shown in cartoon, colored cyan. The malonate bond
at the active site is shown as CPK-colored spheres. The two distant residues, Val175 and
Leu348 are shown as sticks, colored light pink. The active site residue Ala170 is colored red.
Obtaining these distant mutations might represent an allosteric regulation
mechanism for enzymes, while the distant residues are also show dramatic influence on
catalysis. Recent works on amino acid coupling network is consistent with our finding.
Besides influencing the protein static structure of the active site, remote mutation also
could impact protein dynamics motions (Shi et al. 2014). These hypothesis about the
mutations obtained could be further tested. One possible route to resolve the function of
these residues is to obtain crystal structures of the mutants and, through alignment with
wild-type AH, this may determine whether distant residues influence the active site
architecture. Another possibility is that, beyond the function of AH itself, these mutations
might be involved in protein-protein interactions, interfering with the communication or
interaction of AH with other proteins or molecules. To test this hypothesis, it is necessary
to study the protein interaction profile for AH domains and BC domains. Chapter 5 is
focused on studying these potential inter-domain interactions and coordination in detail.
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The goal of studying the B subdomain of BC domain was to identify possible “hot
spots” for mutagenesis that would correspond to functionally important regions, such as
the G-rich loop, the hinge region and the active site. Because one characteristic feature
for the B subdomain lid is its conformational change upon binding of ATP, it is intriguing
to study whether mutations on the hinge region change the movement of the B subdomain
lid. According to sequence alignment, the hinge region is quite conserved, with a
conserved ARHVE sequence (Appendix Figure 2.2). But the H209A is the only mutation
identified located on the hinge region. However, the closest distance of the imidazole ring
to the oxygen atom on the sugar is ~ 2.4 Å, which means that there might be direct
contact of this His side chain with the substrate. This complicates the interpretation of the
role of His209. One residue of interest is Leu200, which potentially interacts with the αhelix on the BC-BCCP domain interface. This is an example of a residue distant from the
active site potentially influencing an important protein-protein interaction. Interestingly,
while one Gly on the T-loop was identified, none of the conserved consecutive four Gly
in the G-rich loop was identified. Further screens could be performed to identify the
function of the specific regions of interest.
4.4.5 Further Application of this Yeast Genetic Screen
It is possible to apply this screen to other regions of interest in UAL. 1. This
screen can be used to study the key residues in the CT domain of UAL. The CT domain is
the most non-conserved domain as compared to the BC, and BCCP domains. As such,
little is known about the identity of the active site residues or the catalytic mechanism in
this domain. The yeast genetic screen is an ideal method to uncover functionally
important residues in this domain. 2. This screen can be further applied to the directed
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evolution of enzymes. For example, the pyruvate carboxylase gene (along with a gene
encoding AH) could be introduced into the UAL knockout strain, and with random
mutation, it may be possible to “evolve” pyruvate carboxylase into urea carboxylase, by
directed evolution. By doing this, it is likely to gain more insights into enzyme catalysis
and protein evolution, especially for the biotin-dependent enzymes. Above all, the yeast
genetic screen developed in this work is very useful to further probe the catalytic
mechanism of UAL, and has many potential applications for studying the broader family
of biotin-dependent enzymes.
Finally, as mentioned above, the screens identified several peripheral residues that
are likely to involve in protein-protein interaction. However, these results are hard to
interpret at this stage because it is largely unknown whether AH interact with other
proteins or how does these mutations imply on UAL as a multi-functional enzyme.
Therefore, next chapter will focus on potential protein interactions and domain
coordination within UAL.
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CHAPTER 5: STUDIES INTO DOMAIN COORDINATION
BETWEEN UREA CARBOXYLASE AND ALLOPHANATE
HYDROLASE
5.1 Introduction
Chapter 3 and 4 centered on the catalytic mechanisms in individual domains of
UAL. Multi-functional enzymes have been shown to form well-regulated modules in
order to efficiently carry out sequential reactions in complex metabolic pathways
(Thoden et al. 1997). Many examples of multi-functional enzymes, such as carbamoyl
phosphate synthetase (Thoden et al. 1997), phospholipase Cβ2 (Weinstein, Scarlata 2011)
and polyketide synthases (Khosla et al. 2014), all harbor well coordinated domains that
work in an assembly line fashion for biosynthesis. Therefore, it is intriguing to speculate
whether UAL as a multi-functional enzyme catalyzes urea degradation in a coordinated
fashion.
UAL is unique in its domain arrangement compared to other biotin-dependent
carboxylases as it incorporates the additional AH domain. Recently, the X-ray crystal
structures of AH (Lin, St Maurice 2013, Fan et al. 2013) and UC (Fan et al. 2012) were
determined in isolation, but the spatial relationship between these two enzymes and their
mechanism of intermediate transfer is not known. In fungi, the UAL gene is found in two
Ascomycota classes (Sordariomycetes and Saccharomycetes), and exists as a fusion of
UC and AH genes (Whitney, Cooper 1972). In bacteria, UC and AH exists as two
separate enzymes (Kanamori et al. 2004). The only bacterial specie, which has been
reported to harbor a full-length UAL, is Pantoea ananatis (De Maayer et al. 2010).
However, this report turned out to be an erroneous conclusion based on the result of a
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sequencing error. Appendix 1.4 shows that, when the Pantoea ananatis UAL was cloned
and re-sequenced, it actually has a stop codon between the UC and AH genes. Therefore,
all bacterial versions of UAL exist as two separate enzymes, UC and AH, and no fulllength UAL is known to exist in bacteria.
While UC and AH are never fused into a single gene, phylogenetic analysis
indicate that, in 14 out of 17 bacteria studied, genes encoding UC and AH localize
adjacent to each other (Strope et al. 2011). This implies that the two genes belong to a
single operon, and are very likely transcribed and translated at the same time. Bacterial
genes localized on the same operon are likely to have similar local concentrations to
enable efficient catalysis. It has been reported that the UAL gene in fungi arrived from
bacteria through a horizontal gene transfer from -β, -γ or related species of
proteobacteria, in an example of opportunistic genome evolution (Strope et al. 2011).
Furthermore, it has been suggested that gene fusion is a way to increase co-localization of
enzymes, in that the covalent linkage boosts the effective concentration of the protein
domains with respect to each other, greatly exceeding the typical concentration that
would be achieved in cells (Kuriyan, Eisenberg 2007).
UC and AH catalyze consecutive reactions in the urea degradation pathway. In
addition to its role in urea degradation, AH also participates in the cyanuric acid
breakdown pathway in atrazine degrading bacteria (Govantes et al. 2009, Shapir et al.
2005). Evolutionary studies indicate that this pathway evolved only over the past ~ 50
years, since the introduction of this herbicide into the environment (Shapir et al. 2007).
Previous studies have shown that, in prokaryotes, while UC and AH exist separately, their
activity is tightly coupled between ATP breakdown in UC and ammonia release from AH
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(Kanamori et al. 2004), indicating an efficient transfer of the allophanate intermediate
between AH and UC. Therefore, it is tempting to speculate that UC and AH functionally
interact in a way that leads to the direct transfer of an intermediate between them, through
a process commonly referred to as “channeling”. Channeling serves to carry out multistep reactions more efficiently and to prevent the loss of unstable intermediates to bulk
solvent (Zhang 2011). Allophanate is a relatively unstable intermediate that can easily be
hydrolyzed to CO2 and urea under high buffer concentrations or acidic conditions (Cheng
et al. 2005). The spontaneous hydrolysis of allophanate would contribute to an inefficient
reaction and a waste of energetically expensive ATP. This leads to the hypothesis that UC
and AH function to directly channel the allophanate from UC to AH.
A variety of methods have been used to probe the channeling of substrates
between enzymes. For example, transient-time analysis captures the time course of
intermediate transfer and product release; isotope dilution uses radioactive isotopes to
trace the dilution of the intermediate by the bulk phase; intermediate trapping uses a third
enzyme to react with and divert any intermediate released into bulk solvent (Spivey,
Ovadi 1999). Although these traditional methods have been extensively applied in
substrate channeling studies, there are numerous practical problems and limitations
associated with applying these methods to the AH and UC system. For example, there is
no other known enzyme that can act on allophanate as a substrate and compete with the
activity of AH. Instead, a novel and definitive method to study substrate channeling was
reported by Geck and Kirsch, which uses kinetic competition to study substrate
channeling (Geck, Kirsch 1999, James, Viola 2002).
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Here, the Kirsch method for assessing substrate channeling was combined with
additional kinetic methods to study the channeling of the allophanate intermediate
between UC and AH. The results from these studies do not support substrate channeling:
no stable complex was detected between AH and UC and kinetic assays offered no
evidence for transient interactions. In addition, two potential scaffolding proteins were
shown neither to assist in complex formation nor to assist in substrate channeling.
Finally, to determine whether fusion of AH and UC contributes to catalytic efficiency, the
G. bethesdensis UC and AH were re-cloned to generate a single, fused polypeptide chain
and the full-length UAL from S. cerevisiae and C. albicans were purified and assayed.
Enzymes that incorporate both UC and AH on a single polypeptide chain did not have a
higher catalytic efficiency than those that exist separately. Therefore, our results indicate
an absence of substrate channeling between UC and AH.

5.2. Materials and Methods:
5.2.1 Construction of Expression Vector for PsAH, PsUC, UAAP1, UAAP2, GbAH-UC,
ScUAL and CaUAL.
The Pseudomonas syringae urea carboxylase gene (GenBank: ZP_07230257.1)
was amplified using primers #201 and #202 (Appendix 3). The PCR amplified fragment
was digested with NheI/SalI and ligated into the similarly digested pET28a-(HIS)8-TEV
vector, downstream of the T7 promoter, N-terminal (His)8-tag and rTEV protease
recognition sequence. The allophanate hydrolase gene (GenBank: NP_794005) was
amplified using primers #203 and #204 (Appendix 3). The PCR amplified fragment was
digested with SbfI/NheI and ligated into the PstI/NheI digested pET28a-(His)8-TEV
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vector, downstream of the T7 promoter, N-terminal (His)8-tag and rTEV protease
recognition sequence.
To eliminate the coding of N-terminal poly-His tags from the pET28a-(His)8TEV-PsUC and pET28a-(His)8-TEV-PsAH vectors, a NcoI site was introduced
immediately downstream of the codons encoding the His-tag. The sequence CTAGTG
was mutated into an NcoI site (CCATGG) by QuikChange site-directed mutagenesis
using primers #707 and #708 (Appendix 3) as described in Section 2.2.1. As there is also
an NcoI site upstream of the His-tag sequence, the modified vectors were digested with
NcoI, gel-purified and re-ligated to eliminate the intervening His-tag sequence.
The cloning of the genes for the two proteins of unknown function, PSPTO_4242
(UAAP2) in pET28a-(His)8-TEV and PSPTO_4241 (UAAP1) in pKLD66nCBP vector
was performed by Cody Boese, an undergraduate student in the lab. To generate the
pET28a-(His)8-TEV-UAAP2 vector, the gene encoding UAAP2 (GenBank: NP_794003)
was amplified by PCR from P. syringae genomic DNA using primers #748 and #749
(Appendix 3), digested by NcoI and XhoI and ligated into the NcoI/XhoI digested
pET28a-(His)8-TEV vector, downstream of T7 promoter, N-terminal (His)8-tag, and
rTEV protease recognition sequence. The gene encoding UAAP1 (GenBank:
NP_794002) was PCR amplified using primers #850/#851, digested by KpnI and SbfI
and ligated into the KpnI/SbfI digested pKLD66nCBP vector (Rocco et al. 2008).
To clone the GbAH-UC fusion protein, first, the genes of AH and UC from
Granulibacter bethesdensis (strain ATCC BAA-1260/CGDN1H1) was separately PCR
amplified and cloned into pET28a-(His)8-TEV vector, downstream of T7 promoter, Nterminal (His)8-tag, and rTEV protease recognition sequence. The cloning of pET28a-
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(His)8-TEV-GbAH was as described previously in Chapter 3. To clone the pET28a(His)8-TEV-GbUC, the UC gene was amplified by PCR from Granulibacter bethesdensis
genomic DNA, using primers #354 and #355 (Appendix 3). Both the PCR product and
pET28a-(His)8-TEV vector were digested by PstI and XhoI and ligated into the digested
pET28a-(His)8-TEV vector. Second, a HindIII site was introduced in pET28a-(His)8TEV-GbAH vector, using mutagenesis primers #635 and #636 (Appendix 3). Then the
GbUC gene was PCR amplified using primers #664 and #702, which harbor a HindIII
site and PsiI site respectively. The linker region adapted from CaUAL was also present
on primer #664. Then the pET28a-(His)8-TEV-GbAH vector was digested by HindIII and
PsiI, yielding fragments of 6500 bp and 500 bp. The ~ 6,500 bp fragment was gel
extracted and ligated with the similarly digested PCR product of ~ 4,200 bp. The two
fragments, once ligated, generated a ~ 10.7 kb pET28a-(His)8-TEV-GbAHUC vector.
To clone for expression of (His)8-tagged UAL from S. cerevisiae and C. albicans,
first, the DUR1,2 genes from S. cerevisiae and C. albicans were separately cloned into
the pESC-URA vector, with N-terminal myc-tag, or into pET28a-(His)8-TEV vector, with
N-terminal (His)8-tag. Specifically, cloning of S. cerevisiae pESC-URA-DUR1,2 vector
was described in Chapter 4. To clone S. cerevisiae DUR1,2 gene into pET28a-(His)8-TEV
vector, primers #407 and #408 (Appendix 3) were used, the PCR products and vector
were digested by SalI/NotI and ligated. To clone the C. albicans DUR1,2 gene into
pESC-URA vector, the C. albicans DUR1,2 gene was PCR amplified using primers #409
and #410 (Appendix 3), digested by NotI and BglII and ligated into the similarly digested
pESC-URA vector. To clone the C. albicans DUR1,2 gene into pET28a-(His)8-TEV
vector, the gene was PCR amplified using primers #405 and #406 (Appendix 3), followed
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by digestion with SalI and PstI and ligated with similarly digested pET28a-(His)8-TEV
vector. Second, the myc-tag was switched for a (His)8-tag. For C. albicans, the Nterminal His-tagged DUR1,2 gene was amplified using primers #779 and #780, then the
PCR product and the pESC-URA vector were both digested by NotI and BglII, followed
by ligation. For S. cerevisiae, a SmaI site was introduced into the pET28a-(His)8-TEVDUR1,2 vectors by QuikChange site-directed mutagenesis using Pfu Turbo polymerase
and primers #709 and #710 (Appendix 3) as described in Section 2.2.1. Then, the pESCURA-myc-DUR1,2 vector and the pET28a-(His)8-TEV-SmaI-DUR1,2 vector were both
digested by SmaI and HindIII. The digested products were purified using agarose gel
electrophoresis and the digested fragments were recovered using the Promega Wizard®
SV Gel and PCR Clean-Up System (Madison, WI). The >10,000bp fragment from
digestion of pESC-URA-myc-DUR1,2 vector and the ~ 1,800 bp fragment from digestion
of pET28a-(His)8-TEV-SmaI-DUR1,2 vector were ligated to generate the pESC-URA(His)8-DUR1,2 vector. The PsAH S179A mutant was generated by QuikChange sitedirected mutagenesis using primers #397/ #398 (Appendix 3) as described in Section
2.2.1.
5.2.2 Co-purification of UC and AH
The purification of PsUC and PsAH, in the presence or absence of UAAP1/2, was
performed by Ni2+-NTA purification. (His)8-tagged and non (His)8-tagged PsAH were
over-expressed by IPTG induction, (His)8-tagged and non(His)8-tagged PsUC were cooverexpressed with biotin protein ligase, BirA, encoded on the pCY216 vector. The
harvested cells were disrupted by sonication in buffer containing 50 mM HEPES pH 8.0,
300 mM NaCl, 0.1 mM EGTA, 5 mM imidazole and centrifuged at 15,871 × g, 4 °C. To
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mix the supernatant of His-PsAH/PsUC, His-PsUC/PsAH, PsAH/PsUC, His-PsAH/HisPsUC, in the presence or absence of UAAP1/2, the 0.5 ml of supernatant of each was
combined and incubated by shaking gently at 4 °C for 30 min. The co-purification was
performed according to the protocol outlined in the QIAexpressionist™ manual
(Valencia, CA). Specifically, 1 ml of combined supernatant was loaded onto a column
containing 100 µl Profinity IMAC Ni2+-charged resin. The column was washed three
times using 1 ml of the above buffer containing 20 mM imidazole and the protein was
eluted from the column using 1 ml of the above buffer containing 300 mM imidazole.
The protein compositions of the loaded and eluted samples were analyzed by SDS-PAGE.

5.3 Results
5.3.1 Overexpression and Purification of Full-length UAL in Bacteria and Yeast
The fusion protein of GbAH-UC was purified to homogeneity through Ni2+-NTA and
Q-sepharose ion exchange columns (Figure 5.1A). The UAL from S. cerevisiae (ScUAL)
and C. albicans (CaUAL) were each cloned into the pESC-URA vector (see Chapter
4.2.1), allowing the expression of UAL in the S. cerevisiae MLY40 dur1,2Δ yeast strain
to be induced by galactose. UAL cloned from both species included a recombinant Nterminal (His)8-tag. Abundant over-expression in yeast was observed for both ScUAL and
CaUAL in GPU media with 2% galactose (Figure 5. 1B). After Ni2+-affinity purification,
both ScUAL and CaUAL were purified to homogeneity (Figure 5.1 C, D).
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Figure 5.1 UAL overexpression and purification.
SDS-PAGE results showing (A) purification of GbAH-UC protein: Cell lysate loaded
onto Ni2+ column and elution from the Ni2+-NTA column was resolved on the SDS-PAGE
gel; (B) overexpression of UAL from S. cerevisiae and C. albicans in S. cerevisiae
dur1,2Δ strain. The total protein extract were prepared from corresponding yeast strains.
S. cerevisiae dur1,2Δ strain transformed with pESC-URA vector was used as negative
control. The overexpression of myc-tagged ScUAL, (His)8-tagged ScUAL and CaUAL
are shown. (C-D) Protein purified from S. cerevisiae through Ni2+-NTA column. (C)
(His)8-tagged ScUAL and (D) (His)8-tagged CaUAL.
5.3.2 PsUC and PsAH Do Not Form a Stable Complex In Vitro
To test whether UC and AH associate in vitro, P. syringae UC (PsUC) and AH
(PsAH) were separately over-expressed in E. coli BL21 (DE3). Size exclusion
chromatography and co-affinity purification were used to determine whether the two
enzymes are capable of forming a stable complex. When AH and UC were co-applied to
a size exclusion column, no peak mobility shift was observed relative to that of the
individual enzymes (Figure 5.2A). This strongly suggests that the two enzymes do not
form a stable complex under these conditions (Schreiber 2002). Furthermore, untagged
PsAH does not co-purify with (His)8-tagged PsUC, nor does untagged PsUC co-purify
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with (His)8-tagged PsAH (Figure 5.2B). These results strongly suggest that UC and AH
do not form a stable complex in vitro.
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Figure 5.2 Urea carboxylase and allophanate hydrolase do not associate in vitro.

(A) Representative chromatograms from size exclusion chromatography. A 200 µl of 1
mg/ml PsAH, 1 mg/ml PsUC and 1 mg/ml PsAH/PsUC together was loaded separately.
The peak at an elution volume of 15 mL corresponds to the predicted molecular weight
for the wild-type PsAH dimer (MW = 130kDa), and the PsUC monomer (MW=130
kDa). Co-application of both PsAH and PsUC on the size exclusion column does not
alter the elution profile, indicating that a stable complex is not formed between PsAH and
PsUC. The column was calibrated with molecular weight standards as previously
described (Lietzan et al. 2011). (B) SDS-PAGE gel showing that PsUC and PsAH do not
co-purify in vitro. Samples before and after Ni2+-purification were resolved on a 12%
SDS-PAGE gel. The cell lysates loaded onto the Ni2+- column, prior to purification, are
shown as “Ni2+-NTA load” and the proteins eluted from the column are shown as “Ni2+NTA elution”. The lanes correspond to cell lysates containing overexpressed (His)8tagged UC (His-UC), (His)8-tagged AH (His-AH), untagged UC (UC) or untagged AH
(AH). The corresponding mixtures of (His)8-tagged and untagged lysates are also
indicated.
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Given that the formation of some protein complexes have been shown to be
substrate-induced (Thanabalu et al. 1998), the (His)8-tag from the Ni2+-affinity purified
PsAH and PsUC was cleaved using TEV protease (see Chapter 5.2.1). The (His)8-tag
cleaved PsAH and His-tagged PsUC were incubated in the presence of all reaction
substrates, and these substrates were also included in all loading, wash and elution
buffers throughout the purification on the Ni2+-affinity columns. Despite the presence of
substrates under all of these conditions, no co-purification was observed between the two
enzymes (Figure 5.3).

Figure 5.3 Co-purification of AH and UC is not dependent on the presence of
substrates.
SDS-PAGE gel showing that a substrate induced complex is not observed. Purified UC
and AH with and without (His)8-tag were mixed accordingly, incubated in buffer
containing 8 mM MgSO4, 1 mM ATP, 8 mM NaHCO3, and 20 mM urea and eluted from
Ni2+-NTA column. The proteins loaded onto the Ni2+-column are shown as “Ni2+-NTA
load” and the proteins eluted from the column are shown as “Ni2+-NTA elution”. Each
lane corresponds to a mixture of purified AH and UC either with the (His)8-tag cleaved or
intact. The labels correspond to (His)8-tagged UC (His-UC), (His)8-tagged AH (His-AH),
untagged UC (UC) or untagged AH (AH).
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5.3.3 No Complex Was Detected Between PsUC and PsAH in the Presence of Two
Putative Scaffolding Proteins
In most bacterial strains, the genes for two small, putatively cytoplasmic proteins
are located in close proximity to the genes encoding AH and UC. For example, this is the
case in Pseudomonas syringae, Wolinella succinogenes and Granulibacter bethesdensis
(Figure 5.4). Also, the genes encoding these two proteins are absent in fungi where, in
most cases, UAL is fused into a single polypeptide chain (Strope et al. 2011). The
functions of these two proteins are unknown. They have been annotated as either
“hypothetical protein” or “urea amidolyase/ carboxylase related protein”. In prokaryotes,
proteins encoded on the same operon have a higher tendency to exist in a complex
(Bratlie et al. 2010) Therefore, it is hypothesized that these two proteins of unknown
function serve to mediate AH-UC complex formation in bacteria. The two potential
scaffolding proteins from P. syringae PSPTO_4241 and PSPTO_4242 (named “urea
amidolyase associated proteins 1 and 2”; UAAP1 and UAAP2) were cloned, overexpressed and co-purified by Cody Boese, an undergraduate independent researcher
working in the St. Maurice lab. Previous studies reported the effect of ionic strength on
protein-protein interaction (Ianeselli et al. 2010, Dumetz et al. 2007). To exclude the
influence of salt concentration on protein complex formation, two different NaCl
concentrations (50 mM and 150 mM) were used. Identical experiments to those described
in the previous section were performed to co-purify UC and AH in the presence of
UAAP1 and UAAP2. No stable complex of PsAH and PsUC was detected, even in the
presence of the putative scaffolding proteins under two different NaCl concentrations
(Figure 5.5).
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Figure 5.4 Map of two putative UAL associating proteins on genome.
Cartoon representation of genes encoding UC and UAAP1/2 on the genome of P.
syringae pv. tomato strain DC3000. The genes were annotated according to their nametag
in NCBI. The three ABC transporter genes are colored green; the two hypothetical
proteins UAAP1 and UAAP2 are colored purple; the gene encoding UC (PSPTO_4243)
is colored red; the gene encoding AH (PSPTO_4244) is colored blue; other upstream and
downstream genes are colored grey.

Figure 5.5 UC and AH from Pseudomonas syringae do not form a complex in the
presence of two putative UAL associating proteins.
SDS-PAGE gel showing elution profiles for co-purification of UC and AH in the
presence of UAAP1 and UAAP2. Purified UC, AH and UAAP1/2 were incubated with
substrate as in Fig.4.3. Samples eluted from Ni2+-purification were resolved on a 12%
SDS-PAGE gel. The lanes correspond to 1. Co-purification of untagged UC and (His)8tagged AH; 2. Co-purification of (His)8-tagged UC and untagged AH 3. Co-purification
of (His)8-tagged UC and untagged AH in the presence of UAAP1 and UAAP2; 4. Copurification of untagged UC and (His)8-tagged AH in the presence of UAAP1 and
UAAP2; 5. Co-purification of (His)8-tagged UC and (His)8-tagged AH; 6. Co-purification
of untagged UC and untagged AH. The purifications were carried out in buffer containing
50 mM NaCl (left panel) and 150 mM NaCl (right panel), respectively.
5.3.4 AH and UC from Pseudomonas syringae Do Not Influence Each Other’s Enzyme
Activities.
Previous research has indicated kcat and Km of enzymes change upon formation of
a protein complex (Hettwer, Sterner 2002). Therefore, if PsUC and PsAH coordinate
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their activities during catalysis through intermediate channeling or through a direct
physical interaction, it is possible that their activities could be altered in the presence of
the other enzyme (Baker et al. 2012). To assess this possibility, the breakdown of ATP by
PsUC was measured at varying concentrations of urea, both in the presence and absence
of a 10-fold molar excess of PsAH. Similarly, the allophanate hydrolase activity of PsAH
was measured at varying allophanate concentrations, both in the presence and absence of
a 10-fold molar excess of PsUC. For both enzymes, neither the kcat nor Km values were
significantly changed by the presence of the other (Figure 5.6), indicating that, for the
enzymes from Pseudomonas syringae, UC and AH do not influence the enzyme activities
of the other.
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Figure 5.6 Velocity vs. [substrate] plots for PsAH and PsUC, in the presence and
absence of the other enzyme.
(A) Assay of ATP breakdown activity of PsUC, in the presence (dotted line) and absence
(solid line) of PsAH. (B) Assay of allophanate hydrolysis activity of PsAH, in the
presence (dotted line) and absence (solid curve) of PsUC. All data are fit to MichaelisMenten equation.
5.3.5 Allophanate Is Not Channeled from PsAH to PsUC
Although there is no evidence to support the formation of a stable protein-protein
complex between AH and UC, consistent with literature reports (Kanamori et al. 2005),

115
this does not preclude the possibility, however, that AH and UC transiently interact
during catalytic turnover to directly channel allophanate from UC to AH. To investigate
the possibility of direct substrate channeling between PsUC and PsAH, an in vitro
substrate channeling assay was employed (Geck, Kirsch 1999, James, Viola 2002). This
assay can capture even transient interactions between enzymes, offering a distinct
advantage in sensitivity over more traditional methods that probe protein-protein
interactions. Wild-type PsUC (PsUCwt) and wild-type PsAH (PsAHwt) were purified,
along with an inactive variant of PsAH that was mutated at the essential nucleophilic
serine 179 of PsAH (PsAHS179A) (Shapir et al. 2005). Kinetic assays were performed to
confirm that PsAHS179A exhibited less than 0.03% activity compared to the wild-type
enzyme. Full forward reaction rates were measured using a UC-AH coupled assay where
a 1:1 ratio of PsUC and PsAH were added to the reaction mixture. The rate of NH3
production was quantified using a glutamate dehydrogenase coupled assay (see Chapter
2.4.2). Subsequently, increasing ratios of PsAHS179A, from 0-100 fold molar excess over
PsAH, were titrated into the reaction system. It is expected that, if allophanate is
channeled through a direct interaction between PsUC and PsAH, the addition of inactive
PsAHS179A will reduce the overall catalytic activity by binding to PsUC. If there is no
channeling between the two enzymes, increasing amounts of PsAHS179A should not alter
the overall activity (Figure 5.7). No significant rate reduction was observed in the
presence of increasing molar ratios of PsAHS179A, (Figure 5.8).
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Figure 5.7 Model of substrate channeling assay of UC and AH.
(A) The cartoon representation of the substrate channeling model. (B) Theoretical curves
for substrate channeling assay. The expected curve for the absence of channeling is
shown in solid line. The expected curve for channeling is shown in dotted line.

Figure 5.8 Substrate channeling assay results of PsAH and PsUC.
Shown in the plot are measurement of PsAH and PsUC overall activity with increasing
amount of PsAHS179A mutant in the absence (solid line) and presence (dotted line) of
PEG4K as crowding agent. The velocity is reported as µmol min-1 per mg of PsUC.
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The in vitro channeling assay may not accurately represent the situation in vivo,
where both specific and nonspecific interactions in the crowded and complex cellular
environment may serve to promote the direct channeling of allophanate between these
two enzymes. Crowding agents are often added to in vitro assays as a mimic of the
crowded cellular environment (Phillip, Schreiber 2013). PEG4K is commonly used as a
crowding agent (Kulkarni et al. 2000, Katari et al. 2013) and therefore, the substrate
channeling assays described above were repeated in the presence of PEG4K. Initial trials
at PEG4K concentrations in excess of 25% v/v resulted in precipitation of the enzymes
and significant reduction of their individual catalytic activities. At 22% v/v PEG4K, the
enzymes were stable and the turnover rates were unaffected. At this concentration of
PEG4K, the rates remained insensitive to increasing concentration of PsAHS179A (Figure
5.8). Therefore, there is no evidence for substrate channeling between PsUC and PsAH,
even in the presence of a crowding agent.
To study the substrate channeling in full length UAL, the UAL from
Saccharomyces cerevisiae (ScUAL) were used in the channeling assay. The mutant of
catalytic serine of GbAH, GbAHS172A, was purified, which showed less than 0.02%
activity compared to the wild-type enzyme. GbAHS172A was titrated into the ScUAL, to a
ratio of 100:1. Similar to the results seen in PsAH/UC, no rate reduction was observed
(Figure 5.9).

Substrate channeling assay
for ScUAL
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Figure 5.9 Substrate channeling assay result of ScUAL.
Shown in the plot are the measurements of ScUAL overall activity with increasing
amount of GbAH S172A mutant. The velocity is reported as µmol min-1 per mg of
ScUAL.
5.3.6 A fusion of UC and AH from G. bethesdensis Does Not Generate a More Efficient
Enzyme
One evolutionary advantage gained through gene fusion events is the increase in
the local concentration of intermediates and, therefore, a higher catalytic efficiency for
the functionally related fused proteins (Kuriyan, Eisenberg 2007). In this study, the UC
and AH from G. bethesdensis were artificially fused into a single polypeptide, joined by
the short linker that connects the AH and BC domains in CaUAL. The fused GbAH-UC
was purified from E. coli BL21 (DE3) and the catalytic activity was compared to the
activities of the individual components. Compared with the activity of GbAH in isolation,
the fusion of AH to UC did not significantly alter the kcat and Km for the allophanate
hydrolysis reaction, indicating that the close physical proximity of UC to AH have little
influence on the rates of substrate binding and product release in AH (Table 5.1). Also,
the kcat and Km for ATP breakdown, allophanate hydrolysis and urea amidolysis in the
fused GbAH-UC were very similar to the activity of a (1:1) mixture of PsUC and PsAH
(Table 5.1).

*Mean ± standard deviation n=3

Table 5.1 Kinetic data for PsUC, PsAH, GbAH, GbAHUC, CaUAL and ScUAL
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5.3.7 The Efficiency of Domain Coordination in UAL is Low in Both Bacterial UC/AH
and Yeast
UAL.
To study the coupling efficiency between UC and AH, the activity of the first
reaction, ATP breakdown in the BC domain (consumption of ATP), was compared to the
overall activity (production of NH3) in the presence of ATP, NaHCO3 and urea. The
NH3/ATP ratio reflects the coupling efficiency between ATP breakdown in the BC
domain and allophanate amidolysis in the AH domain. When the ratio of UC: AH was
1:1, both ATP breakdown and NH3 production increased with increasing urea
concentration (Figure 5.10 A). At this ratio, the coupling efficiency between the two
active sites showed an increase under very low urea concentration, but then dropped
significantly to reach the level of ~ 0.2 at saturating urea concentrations (Figure 5.10 B).
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Figure 5.10 Assay of coupling efficiency for PsUC and PsAH reaction.
(A) Assay of PsUC and PsAH ATP breakdown (solid curve) and production of NH3
(dotted curve and dash-dotted curve) as a function of urea concentration. The dotted line
represents the production of NH3 when PsUC and PsAH are at 1:1 molar ratio. The dashdotted line represents the production of NH3 when PsUC and PsAH are at 1:10 molar
ratio. The curves in (A) are fitted to Michaelis-Menten equation. (B) Replot of NH3
production rate divided by ATP breakdown rate in (A) when the molar ratio of PsUC and
PsAH is at 1:1 (dotted curve) and 1:10 (solid curve), respectively. The curves in (B) are
fitted to an equation describing classic, competitive substrate inhibition.
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In Saccharomyces cerevisiae, UC and AH are fused on a single polypeptide chain.
To determine whether the coupling efficiency is higher in this context, ScUAL was
purified and the coupling efficiency was assessed as described above. However, the
domain coupling efficiency was also very low for ScUAL (Figure 5.11, Table 5.1).
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Figure 5.11 Assay of coupling efficiency for ScUAL reaction.
(A) Assay of ScUAL ATP breakdown (solid curve) and production of NH3 as a function
of urea concentration (dotted curve). The curves in (A) are fitted to Michaelis-Menten
equation. (B) Replot of NH3 production rate divided by ATP breakdown rate in (A).
Curve was fitted to exponential decay equation.
To investigate the reason for the low coupling efficiency, the optimal ratio of
UC:AH in the overall reaction was determined. The PsAH activity was measured while
titrating higher concentrations of PsUC. In reverse, the PsUC ATP breakdown activity
was measured while titrating higher concentrations of PsAH. Both reactions reach a
maximum velocity above a 10:1 molar ratio (Figure 5.12). Consequently, NH3 production
was re-measured as a function of urea concentration when the UC:AH ratio was 1:10,
such that catalysis of UC is rate limiting. At the ratio of 1:10, the coupling efficiency
between ATP breakdown and NH3 production was still low (Figure 5.10 A), and showed
similar pattern in replot curve as when the ratio was 1:1 (Figure 5.10 B). The result
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suggests that the lack of coupling efficiency is primarily a result of an inefficiency of
domain coordination within UC.
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Figure 5.12 Assay of the PsUC and PsAH overall reaction as a function of each
other.
(A) The activity of PsUC was measured titrating increasing amount of PsUC or PsAH.
(B) The activity of PsUC was measured titrating increasing amount of PsUC or PsAH.
The curves are fitted to Michaelis-Menten equation.
5.4 Discussion
5.4.1 Rationale for the Presence of Substrate Channeling Between UC and AH Or Not
Our substrate channeling results did not show evidence for presence of substrate
channeling between UC and AH. In addition to that, there are a few more rationales for
the absence of channeling. First, a common phenomenon observed in substrate
channeling systems is the absence of a lag phase in the reaction (Singh et al. 2014). In
several substrate channeling enzymes, the coupled reactions do not exhibit a lag phase.
Conversely, the UC and AH coupled assays did exhibit a lag phase in the coupling
reactions of about 10 to 50 seconds prior to the linear phase of the reaction. While there
are many possible reasons for the observation of a lag phase in an enzyme-catalyzed
reaction, it is consistent with an absence of substrate channeling. In the absence of direct
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channeling, the product of the first reaction must build up in solution before the second
reaction can catalyze the reaction on its substrate at an appreciable rate, resulting in an
observable lag phase in the initial velocity kinetics.
Second, in enzymes that participate in substrate channeling, reaction coupling is
typically observed between distinct domains. For example, if one active site is mutated,
the activity in other active site is affected (Thoden et al. 1997, Moxley et al. 2014). Such
experiments were not directly carried out in UAL due to the considerable difficulties
associated with purifying inactive mutants of full-length UAL from yeast or bacterial
expression systems. However, Chapter 5 describes experiments showing that the presence
of bacterial UC or AH does not influence the activity of the other enzyme. Even
physically fusing UC and AH in Granulibacter bethesdensis does not significantly alter
the AH activity. These results are consistent with a lack of coupling and physical
interactions between UC and AH.
Third, the efficiency of reaction coupling in UAL is very low. In the substrate
channeling enzyme carbamoyl phosphate synthase, 100% coupling was observed, with a
stoichiometry of 2 mol of MgADP and 1 mol of glutamate consumed for mol of
carbamoyl phosphate synthesized (Raushel et al. 1998). The coupling efficiency for AH
and UC is much lower, and actually decreases with increasing urea concentration (Figure
5.10). Therefore, a large body of in vitro evidence all points to an absence of substrate
channeling in UAL.
Finally, structural analysis can also provide insights into the question of substrate
channeling. However, as no structure for full-length UAL is currently available (see
Appendix 1), modeling and docking methods serve as the only means to model a
potential interaction interface between UC and AH. In another AS family enzyme, the
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heterotrimeric GatCAB complex, an ammonia channel runs from the GatA glutaminase
active site to the transamidase catalytic pocket in GatB (Wu et al. 2009, Nakamura et al.
2006). This same channel is present in GbAH and may serve as an exit channel for the
release of the ammonia (Figure 5.11). However, it is not possible to conclusively identify
a tunnel through which allophanate may enter the active site. To the contrary, the active
site of AH has very wide opening with access to the bulk solvent. These structural
observations do not support the existence of tunneling (Figure 5.13). All four
observations above further supported our conclusion for absence of channeling between
UC and AH.
A.

B.

Figure 5.13 An ammonia exit tunnel may be present in GbAH.
(A) Overall structure alignment of a GbAH monomer with Staphylococcus aureus
GatCAB (PDB ID: 2F2A). Tunnels in GbAH are calculated using CAVER (Petrek et al.
2006, Damborsky et al. 2007). AH is colored cyan, GatA is colored in pink, GatB is
colored brown and GatC is colored purple. The two tunnels in GbAH are displayed as
transparent surfaces. The substrate enters the active site through the yellow-colored
tunnel, and ammonia may be released through the grey-colored tunnel. (B) A magnified
view of the GbAH active site, showing the accessibility of the two tunnel entrance sites.
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5.4.2 Studies on Protein Complex and Potential Pitfall for Current Substrate Channeling
Assays
Based on the stability of the protein-protein interaction, there are three ways that
substrates and intermediates can be channeled between active sites on separate proteins:
(1) formation of a stable complex; (2) formation of a transient complex; (3) formation of
a catalytically induced enzyme complex (Zhang 2011, Spivey, Ovadi 1999). To study
whether substrate channeling takes place between AH and UC, all three of these
possibilities were considered. However, in the studies of each potential interaction, there
are caveats. For example, co-purification and size exclusion chromatography were used
to study whether a stable or catalytically induced enzyme complex can form in vitro, in
the presence or absence of the substrates. Both of these methods show unambiguous
negative results, but these still do not completely exclude the possibility of channeling,
because of the limitation of sensitivity in each technique. Also, all of the experiments
were performed were at designated in vitro conditions, which might not reflect the
phenomenon in cellular environment. To compensate for these caveats, several other
well-described methods could be applied for studying protein-protein interactions.
However, there are pros and cons in every method and many of these may not be
applicable to the current system. For example, yeast-two-hybrid assays are widely used in
probing protein-protein interactions in vivo. The yeast-two-hybrid assay is able to detect
even weak and transient interactions, but there is a trade-off between detecting weak
interactions and getting false positive results (Rocco et al. 2008, Van Criekinge, Beyaert
1999). While this technique reveals protein-protein interactions, it does not demonstrate
substrate channeling. In this study, a substrate channeling assay was used to study
whether a transient or substrate-induced complex exists. This assay can provide a clearer
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answer to the question of channeling, but still leaves open the possibility that the in vitro
assay conditions do not appropriately mimic the real cellular environment. What’s more,
if we could use radiolabelled urea, and trace the production of allophanate and the release
of allophanate into bulk solvent, it will be very helpful for following intermediate
transfer. Other possible methods are cross-linking, which can capture very transient
interactions in vitro and in vivo and Förster Resonance Energy Transfer (FRET), which
uses fluorescence to detect the proximity of proteins. But these experiments lie beyond
the scope of the present work.
5.4.3 Studies on Potential Scaffolding Proteins
From the discussion above, one of the greatest caveats for this study is, although
there are clear results demonstrating that UC and AH do not associate in vitro, the
possibility of substrate channeling in vivo can not be excluded. For example, an as yet
unidentified scaffolding protein(s) might be present in vivo to assist in the formation of a
complex between UC and AH.
In this study, two genes were identified that are located in close proximity to AH
and UC in a great many bacterial species. However, co-purification and kinetic assays do
not support a function for these proteins in promoting the AH and UC interaction and
their functions remain unclear. This does not exclude the possibility that other scaffolding
proteins or larger scaffolding networks exist to promote the AH-UC interaction. For
example, three additional genes are also located in close proximity to the four genes
encoding UAAP1, UAAP2, UC and AH and, in most species, these genes have been
annotated as “ABC-transporter associated gene”. There have been reports of ABC-type
urea transporters (Valladares et al. 2002), and it is plausible that these three genes
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function in transporting urea. Therefore, one possibility is that UAAP1 and UAAP2 work
together with the ABC transporter in vivo. Another possibility is that the UAAP1 and
UAAP2 assists AH and UC to interact with the ABC transporter or other complexes.
To more rigorously study whether proteins might form a complex with AH and
UC in vivo, organisms that endogenously express AH and UC as separate polypeptides
should be employed. Rhizobium etli is identified as a species harboring AH and UC genes
and is amenable to culture in the laboratory. A co-immunoprecipitation experiment in R.
etli might serve to identify natural binding partners of AH and UC. The UC from R. etli
can be pulled-down by avidin-based biotin-binding affinity resins. The gene encoding
Rhizobium etli AH can be cloned into the pFAJ1708 vector (Dombrecht et al. 2001), with
and without N-terminal His-tag. Ni2+-affinity chromatography can be used to purify Histagged AH. If there is any interacting protein or proteins, it is expected that an interaction
with these and with UC could be identified. One potential problem for this method is the
protein overexpression level may not be sufficient for pull-down experiment. The
induction condition should be carefully manipulated to ensure successful and detectable
results.
This chapter describes a series of experiments that consistently fail to provide in
vitro evidence to support the association or coordination of individual domains of UAL.
The most straightforward conclusion from these results is that there is no association or
coordination between the individual domains of UAL. Given that this is a relatively
unusual finding for a multi-functional enzyme, it is worth emphasizing that several in
vivo experiments are ultimately required before conclusively demonstrating that AH and
UC have no functional interaction. As an initial attempt at obtaining more in vivo
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evidence for UAL function, the following chapter describes both in vivo and in vitro
assays to study a conserved domain of unknown function in UAL.
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CHAPTER 6: THE FUNCTIONAL ROLE OF THE C-TERMINAL
DOMAIN OF ALLOPHANATE HYDROLASE
6.1 Introduction
The protein “domain” is the basic unit of protein function. Previous studies have
indicated that UAL is comprised of four domains with two independent enzymatic
activities. Three of these domains lie within UC (the BC, CT and BCCP domains) while
the fourth is the AH domain. However, in determining the GbAH structure, a previously
un-identified C-terminal domain of AH was discovered (Lin, St Maurice 2013). While the
structures in the presence and absence of malonate defined the N-terminal 462 amino
acid globular amidase domain, the C-terminal 128 amino acids were disordered in both
structures (Figure 6.1). This suggests that an additional, less ordered domain of unknown
function resides at the C terminus of AH. The AH domain is a member of the amidase
signature family based on the conserved Ser-cisSer-Lys catalytic triad. However, the Cterminal 128 amino acid domain is conserved only within the AH enzymes and UAL
(Appendix Figure 2.1). A sequence homology search of this domain did not reveal any
significant homology with any domains of known function. A recent report has suggested
that the C-terminal domain of AH harbors a second active site that hydrolyzes the Ncarboxycarbamate released from the AH active site (Fan et al. 2013). However, this
hypothesis requires further investigation because the N-carboxycarbamate rapidly breaks
down to CO2 and NH3 instantaneously in yeast under physiological conditions (Fan et al.
2013). The very rapid non-enzymatic breakdown of the carboxycarbamate intermediate
raises doubts that a separate enzyme active site serves any role in enhancing the overall
catalytic efficiency of UAL. Alternatively, the C-terminal domain of AH may be involved
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in influencing the amidase domain substrate specificity, the regulation of overall UAL
activity or AH-UC domain coupling. This chapter describes studies aimed at unveiling
the function of the C-terminal subdomain of AH, both in vitro and in vivo, by truncating
these 128 amino acids from AH and UAL. Enzyme activity and growth phenotypes of
AH/UAL, with and without this C-terminal domain, were investigated in order to gain an
insight into the function of this domain.

A.
Amidase domain dimer

~120 amino acid Cterminal domain of AH

B.

C-terminal
domain of AH

Figure 6.1 The C-terminal domain of AH.
(A) Structure of the amidase domain of GbAH with a cartoon representation showing the
missing C-terminal domain, depicted as blue ovals encircled by a dotted line. (B)
Schematic representation of the domain arrangement of AH, urea carboxylase, urea
amidolyase and other AS family enzymes.
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6.2 Materials and Methods
6.2.1 Construction of Expression Vectors for AH C-terminal Domain Truncation Mutants
of UAL
To construct the GbAH C-terminal domain truncation mutant, the C-terminal 128
amino acids were truncated by introducing two stop codons immediately following the
last ordered residue from the crystal structure, Thr462. The primers #544 and #545 were
used for the site-directed mutagenesis.
For cloning of the AH C-terminal domain truncation of UAL in the pESC-URA
vector, the sequence upstream of the C-terminal domain of AH was PCR amplified using
the primer #552 and downstream primer #667 (Appendix 3), which harbors a HindIII
site. Second, the sequence downstream of the C-terminal domain of AH was PCR
amplified using the upstream primer #666 (Appendix 3), which harbors a HindIII site in
the primer, along with #553 (Appendix 3). Then the upstream PCR products of ~ 2,000
bp was digested by SalI and HindIII, the downstream PCR product of ~ 4,000 bp was
digested by NheI and HindIII, the pESC-URA vector was digested by SalI and NheI and
the recombinant vector was constructed by three-piece ligation.
To clone the AH C-terminal domain truncation of UAL in the YCplac33 vector,
first, the sequence upstream of the C-terminal domain of AH was PCR amplified using
primer #794 along with reverse primer #667 (Appendix 3), which harbors a HindIII site.
Second, the sequence downstream of the C-terminal domain of AH was PCR amplified
using the forward primer #666, which harbors a HindIII site in the primer, along with
primer #794 (Appendix 3). Then the upstream PCR products of ~ 2,000 bp was digested
by SalI and HindIII, the downstream PCR product of ~ 4,000 bp was digested by BamHI
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and HindIII, the YCplac33 vector was digested by SalI and BamHI and the recombinant
vector was constructed by three-piece ligation.
6.2.2 Yeast Growth Curve
Yeast growth curves were generated by plotting the turbidity of the cell
suspension, which reflects the total number of cells, against time. The turbidity was
monitored by absorbance at OD600 using a UV-Visible spectrophotometer. The saturated
culture was inoculated into selected media to an OD600 = 0.1. The culture tubes or flasks
were incubated in the shaker with appropriate temperature. The OD600 of the culture was
recorded at regular intervals over a total of 50-80 hours. Un-inoculated fresh media was
used as the blank for OD600 reading. The growth rate and doubling time can be obtained
by calculating the slope of the linear portion of the curve.
6.3 Results
6.3.1 Contribution of the C-terminal Domain to AH Enzyme Activity
To determine whether the C-terminal domain influences the overall amidase
activity, the C-terminal 128 amino acids were truncated from GbAH by introducing two
stop codons immediately following the last ordered residue from the crystal structure,
Thr462. The C-terminal domain truncated enzyme was over-expressed and purified and
the molecular weight was confirmed to be ~ 50 kDa by SDS-PAGE (Figure 6.2 A),
compared to the full-length ~ 65 kDa wild-type enzyme. The truncated enzyme
maintained its ability to dimerize, as measured by analytical gel filtration (Figure 6.2 B).
It was reported that the dimerization interfaces were contributed by both amidase domain
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Figure 6.2 Characterization of C-terminal domain truncated mutant of GbAH
(A) SDS-PAGE gel showing the purified GbAH wild-type and GbAH C-terminal
truncated mutant. The lanes corresponds to M, standard marker; 1, purified wild-type
GbAH, with size of ~ 65 kDa; 2, purified C-terminal truncated mutant of GbAH, with
size of ~ 50 kDa. Arrows indicate the corresponding bands. (B) Size exclusion
chromatography of C-terminal domain truncated mutant of GbAH. The peak fraction runs
at an elution volume of 15.5 ml, corresponding to the dimer for the GbAH C-terminal
domain truncated mutant (MW = 100 kDa). The column was calibrated with molecular
weight standards as previously described (Lietzan et al. 2011).
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Figure 6.3 Allophanate amidolysis assays of GbAH wild-type compared with the Cterminal truncated mutant of GbAH.
(A) Initial velocity (sec-1) as a function of allophanate concentration (mM) for both the
wild-type (purple) and C-terminally truncated versions (yellow) of purified GbAH. (B)
Kinetic constants for the GbAH C-terminal domain truncated mutant and wild-type with
allophanate. All data are shown with mean ± standard deviation (n=3).

Table 6.1 Kinetic constants for GbAH wild-type and the C-terminal domain
truncated mutant with substrate analogs

wt
Cdel*

Biuret
kcat/Km** (s-1 M-1)
0.30 ± 0.01
0.59 ± 0.02

kcat/Km(biuret)
kcat/Km(allophanate)
(1.7 ± 0.1) ×10-6
(8.6 ± 0.4) ×10-6

Ratio to wt
1
5.2

Malonamide
kcat/Km(malonamide)
Ratio to wt
kcat/Km**(s-1 M-1)
kcat/Km(allophanate)
wt
0.38 ± 0.01
(2.1 ± 0.2) ×10-6
1
-2
Cdel*
0.35 ± 0.01
(5.1 ± 0.2) ×10
2.4
* Cdel indicate the C-terminal domain truncated mutant of GbAH
**kcat/Km estimated from slope of vi vs [S] at [S]<<Km; mean ± standard deviation (n=3).
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Figure 6.4 Representative initial velocity vs. [substrate] plots for GbAH C-terminal
domain truncated mutant with substrate analogs using the phenol hypochlorite
assay.
The data was fitted to the Michaelis-Menten equation for single-enzyme systems. The
kcat/Km are estimated from the slope of the regression line for vi vs. substrate
concentration at low substrate concentration (i.e. [S] << Km). The insets display
representative raw data for [ammonia] vs. time at varying initial concentrations of
allophanate or substrate analogs. Activity of GbAH C-terminal domain truncated mutant
with biuret (A) and malonamide (B).
6.3.2 In vivo Functional Assays of AH C-terminal Domain Truncations in UAL Using the
pESC-URA High-Copy Vector
Given that the C-terminal subdomain did not influence the AH activity and
substrate specificity in vitro, we investigated the role of this domain in the overall
function of UAL. The C-terminal domain of AH was removed from the DUR 1,2 gene
and cloned into the yeast high copy vector, pESC-URA (Figure 6.5 A). Western blots
against the N-terminal myc-tag were used to confirm that the expression level of the
domain-truncated UAL was comparable to the wild-type enzyme (Figure 6.5 B).
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Figure 6.5 Construction of the AH C-terminal domain truncated mutant of UAL.
(A) Cartoon representation showing the domain structure of wild-type and the AH Cterminal domain truncated UAL from Saccharomyces cerevisiae, indicated by ScUAL
and ScUAL AHC_del, respectively. (B) Western blot against the myc-tag showing overexpression level of wild-type and the AH C-terminal domain truncated UAL, indicated by
ScUAL and ScUALAHC_del, respectively.
To monitor the differences in growth of the wild-type and mutant, cell dilution
spot tests and growth curve analyses were simultaneously performed. The overexpression of UAL from the pESC-URA vector is subject to galactose induction and
glucose repression. Studies have shown that by changing the amount and ratio of the
glucose and galactose in media, the expression level of genes under the GAL promoter
control can be manipulated (Chung et al. 1997, Brown et al. 2000). Therefore, in order to
tune the expression levels of UAL, different levels of carbon sources were titrated into
the media: 2% galactose, 1% galactose, 1% galactose + 1% glucose, 1% galactose+0.1%
glucose and 0.1% galactose were used in growth assays.
Cell growth was monitored using OD600 for up to 70 hours. At 30 °C, the growth
of both strains were similar in media containing 2% galactose and 1% galactose. In 1%
galactose media, the OD600 did not reach the same maximum density as in the 2%
galactose condition, and the OD600 falls slightly after 50 hours, presumably due to limited
carbon availability for growth. A similar effect was observed for 1% galactose+0.1%

137
glucose. When the carbon source was reduced to 0.1% galactose, no significant growth
was observed in either strain. However, in media containing 1% galactose+1% glucose,
the wild-type strain grew normally but the AH C-terminal domain truncated mutant
showed little growth. Results from spot tests on plates containing equivalent media
reflected the same pattern of differences (Figure 6.6). These results indicate that, at
particular levels of protein expression, the truncation in the C-terminal domain
contributes to a growth defect compared to the wild-type strain.
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Figure 6.6 Comparison of growth between wild-type and AH C-terminal domain
truncated mutant of UAL, overexpressed from the pESC-URA vector at 30 °C.
Growth Curve of OD600 versus time (hours). The red curves correspond to the strain
expressing the AH C-terminal domain truncation mutant and the black curve corresponds
to the strain expressing wild-type UAL. Specific induction conditions are indicated above
the curves. The plates below the growth curves show the corresponding cell dilution spot
test results under the same conditions, where “1” represents the strain MLY40 dur1,2Δ ::
pESC-URA-DUR1,2Δ and “2” represents the strain MLY40 dur1,2Δ :: pESC-URADUR1,2(AH C domain truncated).
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To explore the function of the AH C-terminal domain further, cells were grown at
different temperatures to assess for possible temperature sensitive phenotypes. In addition
to monitoring growth at 30°C, the permissive temperature for yeast growth, growth at
16 °C and 37 °C were also examined. Little growth was observed at 16 °C for either
strain, even up to an incubation time of more than 10 days. However, at 37 °C, the
differences between wild-type and AH C-terminal domain truncation mutant were very
dramatic. Except for the 0.1% galactose condition, where little growth was observed for
either strain, in all other conditions the growth of mutants was always significantly lower
than the wild-type. The same phenotype was confirmed in the spot test assay (Figure 6.7).

Figure 6.7 Comparison of growth between wild-type and AHC truncated mutant of
UAL, overexpressed in pESC-URA vector at 37 °C.
Growth Curve of OD600 versus time (hours). Red curve is AHC truncation mutant and
Black curve wild-type. Specific conditions were indicated above the curves. The plates
below shows the cell dilution spot test results at corresponding conditions above. 1
represents the strain MLY40 dur1,2Δ :: pESC-URA-DUR1,2Δ ; 2 represents the strain
MLY40 dur1,2Δ :: pESC-URA-DUR1,2(AH C domain truncated).
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These results suggest that either the function of the AH C-terminal domain is
more crucial at 37 °C, or the loss of the domain contributed to protein instability, whose
effect is more dramatic at higher temperatures. Unfortunately, the specific influence of
the carbon source is difficult to define, due to the complicated and competing regulatory
effects of glucose and galactose. Consequently, it is not presently possible to
unambiguously interpret this data in a way that provides clear insights into the function of
the AH C-terminal domain.
6.3.3 Study The Function of the AH C-terminal Domain in UAL Using Low-copy Vector
The overexpression of UAL on the pESC-URA vector can contribute to metabolic
imbalances that can potentially impact the cell in a variety of ways. To reduce the
possibility of introducing a significant metabolic imbalance from over-expression of
UAL in yeast, a low-copy vector was used to measure the growth differences between
wild-type and AH C-terminal domain truncated mutants. The DUR1,2 gene was cloned
with its own promoter into the YCplac33 vector, enabling endogenous levels of protein
expression in yeast (Figure 4.12). Similar growth tests as above were performed for both
wild-type and mutant strains. Different concentrations of urea and ammonia were used at
two different temperatures (30°C and 37°C), because it was reported that UAL expression
is induced when urea was the sole nitrogen source, and was repressed by ammonia, due
to the effect nitrogen catabolite repression (Whitney et al. 1973). In order to test whether
there was any differences in growth, low-copy plasmids encoding either the wild-type or
AH C-terminal domain truncation of UAL were transformed into yeast, which were then
grown in the presence of 10, 5, 1 mM urea or 10 mM NH3. There was a slight difference
in growth between cells complemented with wild-type and the C-terminal truncated
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mutant over the first 30 hours. Those yeast complemented with mutant grew to a higher
density than did those complemented with the wild-type, but the differences are slight.
From the same spot test, slight differences in growth were observed, especially in the
presence of 5 mM, 1 mM and 0.2 mM urea (Figure 6.8). These experiments were
repeated in triplicate, and these same results were obtained reproducibly.

Figure 6.8 Comparison of growth between wild-type and AH C-terminal domain
truncated mutant of UAL, overexpressed in yeast low copy vector at 30 °C.
Growth Curve of OD600 versus time (hours). Red curve is AH C-terminal domain
truncation mutant and Black curve wild-type. Specific conditions were indicated above
the curves. The plates below shows the cell dilution spot test results at corresponding
conditions above. 1 represents the strain MLY40 dur1,2Δ :: YCplac33-DUR1,2Δ ; 2
represents the strain MLY40 dur1,2Δ :: YCplac33-DUR1,2(AH C domain truncated).
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At 37 °C, no growth was observed for either of the strains. These results,
combined with the observations in the high copy pESC-URA vector, suggest that the AH
C-terminal domain is functionally important for UAL in vivo.

6.4 Discussion
More than 20% of all protein domains are annotated as “domains of unknown
function”. However, evolutionary conservation suggests they might still play important
roles in biological functions (Goodacre et al. 2013). Traditional sequence-based domain
assignment is largely reliant on universal conservation of sequence and function across
species, and thus is limited in identifying domains in proteins that have low sequence
homology. In this study, a previously unrecognized domain was identified at the Cterminus of GbAH. To explore the function of this domain, both in vitro and in vivo
methods were used. Truncating the AH C-terminal domain did not alter the activity or
specificity in AH, but the truncation mutant in UAL resulted in some noticeable effects
on the growth of yeast. This initial result is intriguing and suggests that further
experiments should be done to further probe the function of this domain.
6.4.1 Controversy on the Role of the C-terminal Domain in AH
The structure of AH from KlAH was recently determined and, in this structure,
the C-terminal domain was well ordered and could easily be modeled within the electron
density (Fan et al. 2013). Although no sequence homology was identified by blasting the
sequence of the AH C-terminal domain against the NCBI database, a structural homology
search by Fan et al yielded two homologous structures: glutamyl cyclotransferase and
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glutamylamine cyclotransferase. The r.m.s.d between the C atoms in KlAH and glutamyl
cyclotransferase and glutamylamine cyclotransferase are 2.8 and 2.3 Å, respectively. The
glutamyl cyclotransferase converts glutamylamines to free amines and 5-oxoproline. It
utilizes a conserved Glu as both a general acid and base to deprotonate the amino group of
the glutamyl moiety, which further nucleophilically attacks the amide carbon atom (Oakley

et al, 2010). Based on this structure similarity, Fan et al proposed that the function of the
AH C-terminal domain was to harbor a second active site which can hydrolyze the Ncarboxycarbamate intermediate (Fan et al. 2013). Using mass spectrometry, this group
supported this hypothesis by demonstrating that the N-carboxycarbamate intermediate
could be captured at 0 °C, but only in mutants where the C-terminal domain was missing
or where the proposed C-terminal domain catalytic residues where mutated.
If we analyze the evolution of the Amidase Signature family enzymes, the
hypothesis put forward by Fan et al seems reasonable, because the amidolysis reaction
catalyzed by AH is unique among AS family enzymes in requiring a downstream
chemical step to further hydrolyze the amidolysis products into CO2 and NH3. This
correlates with the unique presence of the C-terminal domain exclusively among the AH
enzymes. However, the evidence in support of this hypothesis is taken entirely from mass
spectrometry assays performed at 0 ºC. At temperatures that are closer to “normal”
physiological temperatures (C. albicans, for example, must perform this reaction at 37 ºC
in order to evade the host immune response), the intermediate will be rapidly and
spontaneously degraded, without ever requiring a catalytic contribution from the AH Cterminal domain. In fact, Fan et al confirm that there is no accumulation of the Ncarboxycarbamate intermediate at 30 ºC, even in the absence of the C-terminal domain.
Irrespective of whether the C-terminal domain contributes to hydrolysis of the N-
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carboxycarbamate intermediate at 0 ºC, it is clear that this catalytic role is not important
to the function of the enzyme at higher temperatures. This raises the question: why would
the enzyme have evolved a conserved second active site which is not even required under
most physiologically relevant temperatures?
Fan et al. proposed a catalytic function for the C-terminal domain based on the
accumulation of the N-carboxycarbamate intermediate at low temperatures for C-terminal
domain truncated construct, but there are alternative interpretations for their data. One
perfectly reasonable alternative explanation is that truncation of the C-terminal domain
might influence catalysis in the allophanate active site. The results outlined in Chapter 4
clearly support the notion that mutations distant from the AH active site can alter AH
enzyme function and this may be another such case. For example, truncation of the Cterminal domain and residues contained therein could alter the rate limiting chemical step
in the AH active site, leading to hydrolysis of the intact N-carboxycarbamate before the
covalent intermediate can decarboxylate on the enzyme (Figure 6.9 A). Conversely, the
optimally oriented active site of the wild-type enzyme could be structured to first
promote decarboxylation of the intact N-carboxycarbamate covalent intermediate prior to
hydrolyzing the resulting covalently tethered carbamate (Figure 6.9 B). Both of these
chemical steps are expected to be very fast, either on or off the enzyme. Consequently, it
is very difficult to determine the order in which these steps take place on the enzyme
(Shapir et al. 2005). A subtle perturbation of the active site, influenced by mutations
and/or truncations distant from this site, could be sufficient to alter the individual
microscopic rate constants and promote N-carboxycarbamate hydrolysis to a slightly
faster rate than N-carboxycarbamate decarboxylation, leading to the results obtained by
Fan et al.
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Figure 6.9 Proposed intermediate dissociation mechanisms of C-terminal domain
truncated mutant and wild-type AH.
(A) In the C-terminal domain truncated mutant of AH, the covalent bond between Ncarboxycarbamate and enzyme is broken, then the released intermediate dissociates
through non-enzymatic activity. (B) In wild-type AH, the N-carboxycarbamate is
decarboxylated first, followed by release of covalently tethered carbamate.
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In the steady-state kinetic assays described in Figure 6.3, the AH C-terminal domain
truncation does not influence the rate of NH3 release at room temperature. It is not
possible from these assays, however, to determine the microscopic chemical rates. To
clarify the ambiguity described above, detailed enzymology must be performed, in the
hopes of more clearly determining the role of the AH C-terminus in the activity of AH.
For example, pre-steady state kinetics and kinetic isotope effects can be performed to
investigate the influence of the C-terminal domain on formation and consumption of
enzyme–substrate intermediates. Also, additional substrate analogs can be tested to see
whether the C-terminal domain plays a role in gating the entry of substrates, thereby
influencing the substrate specificity. To further test the Fan et al hypothesis, the cleanest
experiment is to purify the C-terminal domain of AH, and incubate it with the Ncarboxycarbamate. Only if hydrolysis is observed to take place at a greater rate in the
presence of the C-terminal domain than in its absence can their hypothesis be validated.
On the other hand, to resolve the controversy, it may be possible to co-crystallize AH
without the C-terminal domain with allophanate at 0 ºC. Ideally, if the intermediate could
be captured in the structure, the contribution of the C-terminal domain to catalysis will be
further unveiled.
6.4.2 Explanation of Yeast Genetics Experiment Results from This Study
In our in vivo studies for the function of this wild-type and AH C-terminal domain
truncated mutant, a growth defect was observed when the UAL mutant was expressed in
a high copy vector at both 30 ºC and 37 ºC. The differences observed at 37 ºC are
relevant in light of C. albicans, where the capability to sense the temperature upshift and
start morphogenesis is critical to its virulence. An elevated temperature of 37°C is tightly
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linked to the ability for this pathogen to undergo the yeast to hyphae switch (Sudbery et
al. 2004). Therefore, the increased protein stability that results from the C-terminal
subdomain of AH could be highly relevant to the viability of C. albicans. Decreases in
protein stability and solubility could certainly account for the dramatic change in growth
phenotype observed at 37 °C. This leads to a hypothesis that the C-terminal domain of
AH contributes to supporting the overall structural integrity of the UAL enzyme.
At 30 ºC, a growth defect was observed when the UAL mutant was expressed in a
high copy vector and grown in the presence of 1% galactose + 1% glucose. This suggests
a loss of function of UAL in the truncated mutant. However, interpretation of this
experiment is hindered by the way the experiment was performed and the conditions used
for growth and induction. Firstly, the protein expression level was not monitored
throughout the experiment. Therefore, it is not known whether the growth defect in 1%
glucose + 1% galactose arises from increased or decreased overexpression levels.
Presumably, UAL overexpression should decrease in the presence of 1% glucose and,
therefore, this defect might result from the inability of the UAL C-terminal domain
truncation mutant to rescue activity when the overall protein expression levels drop
below a critical level. Of course, a second possibility for the growth disorder is that the
expression level of UAL is higher when grown in 1% galactose + 1% glucose. Gal
promoters are very strong promoters, and it is normally very difficult to finely tune the
levels of induction and expression. Furthermore, in addition to turning on and off the Gal
promoter, both galactose and glucose are used as the carbon source to support growth and
can lead to very different metabolic states. Glucose is the preferred primary energy
source compared to galactose. A previous study used the same carbon sources to measure
the influence of different glucose and galactose ratios on the production of human
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lipocortin-I under control of the GAL promoter. It was shown that the protein yield was
highest when the Gal: Glu was at a 1:1 ratio, as compared to when the Gal: Glu ratio was
1:9 or 9:1, where the protein production was 1.73 and 1.83 fold less (Chung et al. 1997).
This is likely due to the balance between glucose, which supports yeast growth but which
inhibits protein induction, and galactose, which induces protein production but works as a
less preferred carbon source. The situation may be similar in the present study, where the
1% galactose + 1% glucose condition actually results in the highest UAL expression level
and the AH C-terminal truncation mutant reveals the greatest growth defect. This
explanation is consistent with our hypothesis that the AH C-terminal domain plays a
structural role in UAL. If the domain truncation mutant tends to be less stable and form
insoluble aggregation in the cell, overexpression of UAL will lead to accumulation of
harmful aggregation in the cell. When the overexpression of UAL is highest under 1%
galactose + 1% glucose condition, the amount of aggregation override a threshold and
leads to cell death. This hypothesis might help to explain one phenomenon we observed.
Initially, in vitro studies were attempted on purified ScUAL and CaUAL C-terminal
domain truncated mutants. However, several attempts to purify these enzymes were
unsuccessful, consistent with the protein instability suggested by the growth curves at
37 °C. It appeared that the AH C-terminal domain truncated CaUAL showed much lower
expression and solubility than wild-type CaUAL. This might also imply the critical
functional role of this domain.
For the results observed in the low copy vector, this might be more likely to
reflect the true in vivo situation as this expression system is intended to harbor similar
expression levels by using the native promoter. As no significant differences were
observed between wild-type and mutants in the growth curves, results from the low copy
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vector experiments imply that the C-terminal domain of AH is dispensable to the overall
function of UAL. However, slight differences were observed on the spot test plates that
were not apparent from the growth curves. Compared to the growth curve, the spot test
on plates is more likely to reflect the real condition because it is more sensitive to slight
differences as compared to the homogeneous culturing that occurs liquid media.
Therefore, if the AH C-terminal domain mutant really grows slightly faster than the wildtype strain, this is of great interest because it might imply a negative regulatory role for
this domain on the overall function of UAL. UAL is not essential for yeast growth, and it
is only expressed when urea or other poor quality nitrogen sources are available as the
sole nitrogen source (Genbauffe, Cooper 1986). Therefore, UAL does not need to be very
efficient, or even subject to certain negative regulation mechanisms.
Altogether, these hypotheses have not been or cannot be tested using in vitro
methods and the observations are complex and difficult to explain using simple models.
Therefore, further experiments are required to unveil detailed explanations for these
intriguing observations. Further efforts could be made to purify the UAL C-terminal
domain truncated mutant, and if the mutant was successfully purified, the function of this
domain could be more clearly identified by comparing the overall activity, the activity of
each domain or even the degree of substrate channeling in comparison to the wild-type
enzyme.
6.4.3 Potential Role of C-terminal Domain in UC and AH Interaction
Given that AH activity is typically coupled to the reaction of urea carboxylase and
that they comprise separate domains of urea amidolyase in yeast, it is tempting to
speculate that the C-terminal domain of AH facilitates the interaction and coupling
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between AH and urea carboxylase enzymes or between the individual catalytic domains
in urea amidolyase. Although the results presented in Chapter 5 did not support the idea
of substrate channeling between AH and UC, this possibility cannot be completely
excluded. Because the C-terminal domain of AH is located immediately adjacent to the
N-terminus of UC, it is ideally situated to facilitate communication between these
domains, if such communication takes place. The structure of full-length UAL would be
very helpful to address this question and, at a minimum, would serve to clarify how the
C-terminal domain of AH functionally the UC and AH enzymes, how the two enzymes
are spatially oriented and how it might influence the potential coordination between UC
and AH. Efforts to crystallize full-length UAL are described in the Appendix 1.3.
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CHAPTER 7: DISCUSSION AND SUMMARY
7.1 Characterization of UAL As a Unique Multi-functional Enzyme
A protein “domain” is structurally defined as a distinct, compact and stable
protein structural unit that folds independently of other parts of a protein. Certain
domains may be additionally defined as independent functional units based on sequence
homology. Multi-functional enzymes combine a number of mono-functional catalytic
domains or subunits on a single polypeptide chain. These enzymes have been extensively
studied, in order to understand a central question of enzyme function and evolution: why
and how do multi-functional enzymes evolve from mono-functional enzymes? Previous
studies have established that multi-functional enzymes possess several advantages over
mono-functional enzymes. Multi-functional enzymes increase the catalytic efficiency for
multi-step reactions (Khosla et al. 2014), facilitate intermediate channeling (Raushel et al.
1998), and more readily coordinate and regulate multi-domain interactions (Weinstein,
Scarlata 2011). These advantages support the idea that evolution from mono-functional
enzymes to multi-functional enzymes through gene fusion events is favored by natural
selection and represents a natural evolutionary progression. The current studies with UAL
show that UAL is unique from those of other multi-functional enzymes in several aspects
and, thus, offers important new insights into the underlying basis for the evolution of
multiple enzymatic activities on a single polypeptide chain.
UAL catalyzes two consecutive reactions in the urea degradation pathway: the
carboxylation of urea to allophanate and the hydrolysis of allophanate to ammonia and
CO2, respectively. Prior to this investigation, UAL had never been characterized at the
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molecular level. The work described in this dissertation reveals an unusual multifunctional enzyme that exhibits strict substrate specificity in each domain, but which has
poor direct inter-domain coordination. Thus, studies of UAL offer an opportunity to
expand the existing models of multi-functional enzyme evolution and function.
In this study, the mechanism of UAL has been investigated by addressing four
fundamental questions pertinent to multi-domain enzymes: 1. As a multi-functional
enzyme, UAL shows strict substrate specificity toward the substrates in each domain
(Lin, St Maurice 2013, Kanamori et al. 2004). What are the molecular determinants of
this specificity? Specifically, the AH domain was studied as an example to correlate
molecular structure with the substrate stringency. X-ray crystallography and steady-state
enzyme kinetics were used to determine the molecular basis for substrate specificity in
the AH domain of UAL. Two residues, Tyr299 and Arg307, were identified as playing a
critical role in contributing to the substrate specificity of this domain. 2. What is the
contribution to enzyme catalysis from amino acids that are distant from the active site? A
novel yeast genetic screen was implemented which identified many residues outside of
the enzyme active sites that are likely to be critical for enzyme function. The AH domain
and the B subdomain lid of the BC domain were screened, and mutations were grouped
based on their proximity to the active site. The possible roles of distant residues were
highlighted. 3. Do the individual domains in multi-functional enzymes communicate and
coordinate catalysis? Co-purification, steady-state enzyme kinetics and a substrate
channeling assay were used to probe inter-subunit interactions and intermediate transfer
from one active site to another. The results did not support inter-domain communication
or substrate channeling between UC and AH. Rather, the coupling efficiency among the
three domains of UC is surprisingly low which suggests that, under the conditions
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assayed, UAL is surprisingly poor at coordinating catalysis between the individual
catalytic domains. 4. What is the function of the newly identified C-terminal subdomain of
AH? Both in vitro and in vivo methods were used to investigate the function of the Cterminal subdomain of AH. Truncating this subdomain does not influence AH activity
and specificity, but it does influence the overall UAL function in vivo suggesting that this
domain may play an important, non-catalytic functional role in UAL. Several of these
characteristics set UAL apart from other multi-functional enzymes. The possible
underlying reasons for these unique features of UAL are the subject of this final chapter.
7.2 The Unique Characteristics of UAL Have Implications for the Evolution and
Function of Multi-functional Enzymes
7.2.1 Substrate Specificity is Critical for the Function of UAL As a Multi-functional
Enzyme
Based on substrate stringencies of their catalytic domains, multi-functional
enzymes can be divided into two categories. A widely distributed group of multifunctional enzymes have varying levels of specificity in different domains. An example is
the nonribosomal peptide synthetase multi-enzyme complexes (Mootz HD et al. 2002).
The adenylation domain activates the amino acid substrate and is the primary determinant
of substrate specificity, while much broader substrate specificity is observed in the
peptidyl carrier protein domain and the condensation domains. Despite maintaining
varying levels of specificity in the individual domains, the highly specific step in the
adenylation domain allows the overall enzyme to catalyze highly specific reactions
(Lautru, Challis, 2004). This group of multi-functional enzymes is likely to have resulted
from gene fusion of functionally related promiscuous and specific enzymes, and is
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prevalent in multi-functional enzymes, because it is extraordinarily efficient and enables
the organisms to produce more metabolites with much smaller genomes (Li et al. 2010).
Compared to the first group, the second group of multi-functional enzymes retains strict
substrate specificity in all of the individual domains. The enzymes in this category have
the advantage of very precisely transferring individual intermediates among domains in a
manner analogous to a highly efficient assembly line. However, a cursory survey of
multi-functional enzymes suggests that this group of enzymes is less common.
Based on the high degree of substrate specificity in each of the individual
domains, UAL falls into the second category of multi-functional enzymes. Among the
three catalytic domains, the BC domain is specific in using bicarbonate, ATP and BCCPtethered biotin as substrates. Specifically, the catalytic activity of BC domain reacting
with BCCP-tethered biotin is 8,000 times faster than the activity with free biotin
(Broussard et al. 2013). The CT domain of each biotin-dependent enzyme is highly
specific for the individual substrate (Lietzan, St Maurice 2014, Knowles 1989, Waldrop
et al. 2012). The CT domain of UAL, for example, shows very strict specificity toward
urea. Among all substrate analogs assayed, including acetamide, formamide, L-citrulline,
arginine, succinate, L-ornithine, L-glutamine, L-asparagine, thiourea, and carbamoyl
phosphate, only acetamide and formamide were found to be substrates, but the activities
were very low compared to urea (Kanamori et al. 2004). The AH domain also shows very
strict substrate specificity, as indicated in Chapter 3.
It has been proposed that enzymes evolved to perform multiple reactions in order
to compensate for the relatively small genome size of organisms early in evolution
(Martinez Cuesta et al. 2014). Later, additional functions were acquired by gene
duplication and fusion to generate novel multi-domain enzymes (Long 2000, Suzuki et al.
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1998, Compaan, Ellington 2003). One explanation for the high degree of specificity in
UAL is that UC and AH belong to different enzyme families without a common
evolutionary origin. The mechanisms of UC and AH are significantly different, where AH
belongs to the AS family and utilizes a Ser-cisSer-Lys catalytic triad to nucleophilically
attack the amide carbon, and the CT domain of UAL catalyzes a biotin-dependent
reaction in two steps, including decarboxylation of carboxybiotin and activation of the
substrate for subsequent attack of the released carboxyl group (Figure 1.7). Not
surprisingly, therefore, the substrate specificity determinants in the two domains are
dramatically different. For AH, two residues, Tyr299, Arg307 (see Chapter 3) and an active
site loop (see Chapter 4) directly interact with both the carboxyl moiety and the bridging
amide group, distinguishing allophanate from other closely related molecules. In
particular, arginine is commonly utilized as a specificity determinant in several AS family
enzymes (see Chapter 3). By contrast, the CT domain of UAL is proposed to utilize two
tyrosines and one glycine residue to anchor the urea substrate in place (Fan et al. 2012).
Based on their structure and function, it is clear that AH and UC have evolved from
separate origins, and were subsequently functionally linked. The strict specificity of UC
and AH is also necessary to ensure the maximum overall catalytic efficiency. As AH is
the only enzyme identified so far to specifically catalyze the hydrolysis of allophanate,
the strict production of allophanate from urea allows the enzyme to function in a precise
and efficient manner. Therefore, substrate specificity is an important feature for UAL,
enabling it to function as an efficient a multi-functional enzyme.
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7.2.2 The Yeast Genetic Screen Identifies Possible Contributions to Multi-functional
Catalysis in UAL
As described in Chapter 4, the studies of UAL structure and function yield a
number of interesting results. The yeast genetic screen reveals a complex amino acid
network. In addition to unveiling already known catalytic residues, the yeast genetic
screen highlighted the role of a substrate binding loop in the active site, whose role has
very recently been confirmed by X-ray crystallography. In addition, a hydrogen bonding
network was revealed which provides evidence for the role of second shell residues in
structural stabilization of the active site. Finally, other mutations at the periphery of the
protein, or at the hinge region connecting subdomains were discovered, suggesting
several functional roles for these peripheral amino acids, including their potential
participation in inter-domain interactions.
Traditional descriptions of structure-function relationships are usually focused on
amino acid networks around active sites. My results from the yeast genetic screen are a
reminder that amino acid residues distributed throughout the entire protein can be
critically important to enzyme function, in support of the relatively new theory of longrange amino acid communication networks at the molecular level. Early studies on
amino acid communication networks were performed using computational simulation
methods (Angelova et al. 2011). One might expect that long-range coupling and
interactions is especially critical for the function of multi-functional enzymes, since they
are likely to harbor distant communications of residues from different domains.
Therefore, the allosteric networks observed in UAL are consistent with a more universal
mechanism for enzyme catalysis (Axe, Boehr 2013). Although this study was unable to
find any in vitro evidence for a direct interaction between UC and AH (see Chapter 5),
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mutations at the protein periphery may, nevertheless, may have disrupted important
interactions with other protein components in the cell. Since my yeast genetic screen
probes functional interactions in vivo, results of the screen, combined with results from
the in vivo studies described in Chapter 6, provide an important caveat to the conclusions
in Chapter 5 that there is an absence of inter-domain interactions and substrate
channeling in UAL. The direct attribution of function to the amino acid residues
discovered in the yeast genetic screen would greatly benefit from the purification and
kinetic characterization of, for example, site-directed mutant proteins corresponding to
each of the mutations identified in the AH domain screen. The in vitro characterization of
these residues in the enzyme and substrate channeling assays described in Chapter 5 may
serve to further clarify whether mutations to peripheral residues specifically affect AH
catalysis or UC-AH interactions. In addition, structure of the complete UAL enzyme
would be valuable in further illustrating the relationship between UC and AH and in
offering further insights into the possible influence of surface mutations on domain
coordination.
7.2.3 Possible Reasons for a Lack of Substrate Channeling in UAL
In the in vitro assays described in Chapter 5, substrate channeling was not
observed in UAL. While keeping the obvious caveats concerning in vitro assays in mind,
it is nevertheless intriguing to consider reasons for the absence of substrate channeling in
UAL by comparing the features of UAL with other enzymes that are known to exhibit
substrate channeling. One critical benefit of substrate channeling is the protection of
unstable intermediates. Although it has been reported that allophanate is unstable and
degrades into urea and CO2 under acidic or high buffer conditions (up to 100 mM of
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sodium phosphate buffer), the half-life of allophanate is nevertheless on the order of
hours at conditions approximating the physiological environment (Shapir et al. 2005). By
comparison, carbamoyl phosphate synthase is a classic example of a substrate channeling
enzyme. The two intermediates in this reaction, carbamate and carboxyphosphate, exhibit
half-lives that are in the millisecond range (Thoden et al. 1997). While the actual stability
of allophanate in the cell is unknown, it is clear that lifetime of the allophanate
intermediate might be sufficiently long so as not to require its direct transfer between
active sites by substrate channeling.
What’s more, according to the measured rates of AH and UC, diffusion is not a
rate-limiting step for UAL catalysis. Diffusion limited enzymes are those that catalyze
reaction so efficient that the rate limiting step is diffusion of substrate and product to
access the active site. For those diffusion limited enzymes, their specificity constant
(kcat/Km) is above the order of 108 M-1 S-1 (Berg et al. 2007). Compared to these
kinetically perfect enzymes, the kcat/Km for UC and AH ranges between 102-105 M-1 S-1
(Table 5.1). Therefore, it is likely that the efficiency of catalysis is not high that diffusion
is an appropriate way to transfer intermediate between multiple active sites.
While there was no in vitro evidence to support the existence of substrate
channeling between AH and UC, there is an interesting structural observation regarding
the existence of substrate tunnels in AH. In figure 7.1, the GbAH structure is colored to
represent the surface charge distribution. Two previously identified potential substrate
entry and product release pathways are overlaid on the structure. It is interesting to note
that one pathway is highly surrounded by positive charges and the other is highly
surrounded by negative charges. The pKa for NH4+ is 9.25 (Lundblad, Macdonald 2010),
resulting in the protonated, positively charged NH4+ ion at physiological pH. The grey
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tunnel in Figure 7.1A is almost entirely covered by red, negative charges, which would
appear highly suitable for tunneling of NH4+. For allophanate, there are two ionizable
groups on allophanate, the pKa for amide group of allophanate was predicted to be 14.7
(Lundblad, Macdonald 2010). While the pKa for carboxylic acid in allophanate is
unknown, it should fall into the range of most carboxylic acid, for which pKa values
range from 2-5 (Lundblad, Macdonald 2010). The conjugate base of an amide is
negatively charged. Therefore, acetamide will be neutral up to a pH of 15 and, above that
pH, will lose its proton to become negatively charged. So, below a pH of ~ 5, allophanate
will be neutral, and between a pH of 5 and 15, it will have a single negative charge.
Above a pH of 15, it will have a double negative charge. The predicted tunnel for
allophanate is highly positively charged (Figure 7.1 B). Therefore, one possible
hypothesis raised from this observation is that, under physiological conditions where
allophanate could be negatively charged by itself or by binding to some other molecule in
the cell, it could access the entry tunnel on AH through electrostatic forces. In this way,
even without substrate channeling, the allophanate could enter AH active site
preferentially and specifically.
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Figure 7.1 The structure of GbAH colored in coulombic surface representation,
along with potential allophanate and NH3 tunnels.
Structures of GbAH (PDB ID: 4GYS) are shown as Coulomb surface, where red color
represents negative and blue color positive charge. Tunnels in GbAH are calculated using
CAVER (Petrek et al. 2006). The two tunnels in GbAH are displayed as transparent
surfaces. The predicted tunnel for releasing ammonia (A) is colored grey; the predicted
tunnel for allophanate entrance (B) is colored yellow.
7.2.4 Explanations for the Low Domain Coupling Efficiency in UAL

An earlier study on bacterial UC and AH from Oleomonas sagaranensis indicated
that there is no significant loss of the intermediate between UC and AH (Kanamori et al.
2005). Given the observation of low coupling efficiency between UC and AH outlined in
Chapter 5, the previously reported results are somewhat surprising. However, a detailed
comparison of this earlier study with those described in the present study suggests some
possible flaws in the conclusions reached by previous investigators. Both studies use the
same assay methods and parameters. The ATP breakdown activity for O. sagaranensis
UC is 21.2 U/mg (Kanamori et al. 2004), while the activity for the UC-AH combined
production of ammonia is 10.2 U/mg (Kanamori et al. 2005). So the actual ratio from
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these two procedures is 2:1, and is inconsistent with a tight coupling of 1:1 that would be
required for these authors to conclude that AH and UC activities are strongly coupled.
Furthermore, in the assays for ammonia-generating activity of the combined O.
sagaranesis UC and AH, 24 times more AH was used as compared to UC. This means
that, even when AH activity is 24 times higher than UC, the coupling efficiency is still
less than 2:1. In the assays outlined in Chapter 5, 10 times molar excess of AH was added
to UC, which is sufficient to reflect a condition where UC is the rate-limiting step. In
these assays, the ratio of ATP breakdown to ammonia production was around 4:1 (Figure
5.10), comparable to what was reported in O. sagaranensis. When UC was assayed at the
same concentration as AH, the ratio of ATP breakdown to ammonia production was as
low as 10:1 (Figure 5.10). Under physiological conditions, it is highly unlikely that the
AH to UC expression level will be 24:1. To the contrary, most bacterial UC and AH are
tightly clustered on the genome, including Oleomonas sagaranensis (Kanamori et al.
2004), which strongly suggests that the two genes are on the same operon, and therefore,
should have similar expression levels. In yeast, UC and AH are fused into a single
polypeptide chain, where the ratio of UC to AH must be 1:1. Yeast UAL also reveals a
low coupling efficiency between UC and AH (Figure 5.11). Therefore, based on the
analysis above, the conclusions from Kanamori et al suggesting a tight coupling of UC
and AH does not appear well founded and is based on a simple, one-point analysis. By
contrast, the results presented in this study offer a rigorous and detailed analysis of
coupling efficiency in UAL and indicate a very low coupling efficiency between the two
enzymatic functions.
In fungi, the Saccharomycetes abandoned the use of urease, which catalyzes the
hydrolysis of urea in a one-step process at a high rate, and instead use the energy-
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dependent, biotin-containing UAL (Navarathna et al. 2010). Furthermore, C. albicans is a
biotin auxotroph (Hasim et al. 2013), and it requires 2 to 4 times as much biotin for S.
cerevisiae to grow using urea as a sole nitrogen sources compared with ammonia
(Navarathna et al. 2011). As such, it might be expected that the function of UAL in C.
albicans rely on highly efficient catalysis, in order to rapidly respond to a hostile
environment by the production of germ tubes as a defense against host immune system
(Ghosh et al. 2009). All of the phenomena above are contrary to common rationale that
cells evolve to utilize energy and respond to signals as efficient as possible. Despite these
expectations, the in vitro evidence described in Chapter 5 suggests a very low coupling
efficiency in UAL, resulting in an inefficient enzyme.
There are several possible explanations for the observation of low coupling
efficiency. To begin with, it is possible that an activator is required to facilitate coupling
between the domains. Studies on pyruvate carboxylase showed that, without the allosteric
activator acetyl-CoA, an almost complete loss of coupling is observed between reactions
in the BC and CT domain (Zeczycki et al. 2011). This is similar to what is observed in
UC (Figure 5.9 and Figure 5.10). In pyruvate carboxylase, addition of the allosteric
activator, acetyl-CoA, significantly increased the coupling efficiency to almost 1:1 with
the coupling efficiency increasing at higher pyruvate concentrations. Therefore, based on
pyruvate carboxylase and UC sharing a conserved domain organization and a “swinging
arm” mechanism, it is reasonable to speculate that there are potentially activators of UAL
that will serve to enhance the coupling efficiency. Three routes could be used to search
for an activator. First, a high-throughput screen will be very helpful to find any reagents
that could activate the activity of UAL in vitro. As the activation of UAL activity will
lead to increased production of NH3, it might be possible to utilize the colorimetric
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phenol-hypochlorite assay to broadly evaluate the activation of the enzyme (see Section
2.5.2). A second approach is to directly identify the activator(s) from the cell. For
example, an unbiased method, using serial chromatographic fractionation steps, has been
reported to identify the multi-subunit stem cell coactivator complex (SCC) for gene
activation (Fong et al. 2011). It may be possible to apply this approach to our system, in
order to purify and identify small molecules or proteins responsible for UC activation.
Finally, a third approach is to simply apply a systematic, rational search for potential
activators. In the citric acid cycle, pyruvate is converted to acetyl-CoA, which enters the
cycle and combines with oxaloacetate to form citric acid. Pyruvate carboxylase
replenishes the cycle by producing oxaloacetate directly from pyruvate. Therefore, when
acetyl-CoA levels increase in metabolism, the production of oxaloacetate also increases,
increasing the flux into the citric acid cycle (Adina-Zada et al. 2012). By analogy, it is
worth examining the possible activation of UAL by molecules that are upstream of the
UAL metabolic pathway, based on the rationale that the accumulation of upstream
molecules might accelerate downstream reactions. Five types of compounds have the
potential to be UAL activators. The first types of activator are from the Pseudomonas
syringae DC3000 atrazine degradation pathway. Two molecules can be possible
activators: atrazine and cyanuric acid. The second type of molecules is from the
Pseudomonas syringae DC3000 arginine and proline metabolism pathway and urea
cycle. Arginine, fumarate, ornithine and citrulline are all located near urea in the
metabolic pathway. The third types of molecules are from Pseudomonas syringae
DC3000 purine and allantoin metabolism pathway: (S)-allantoin, (R)-allantoin and
ureidoglycolic acid are possible activators. The fourth type of potential activators are
molecules that arose from previous studies on induction of UAL: arginine, citrulline,
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proline, glutamate and aspartate were all shown to be involved in induction of allantoin
degradative enzymes in Saccharomyces cerevisiae (Cooper, Lawther 1973). Finally, the
last type of compounds are urea and allophanate analogs, such as formamide and
hydantoic acid, though their structural similarity with allophanate makes them less likely
candidates as allosteric regulators.
Another explanation for the low observed coupling efficiency in UAL is that UAL
may be efficient in vivo despite the lack of efficient coupling observed in the in vitro
experiments. The cellular environment is dramatically different from the in vitro enzyme
assay conditions. In the crowded and complex cellular environment, UAL might interact
with as yet unidentified proteins, or the overall conformation of the enzyme might change
to facilitate interdomain coordination. More in vivo studies could be performed to further
investigate this question, such as in vivo mentioned in Section 5.4.
On the other hand, it is entirely possible that UAL is intrinsically catalytically
inefficient. UAL shares a common evolutionary ancestor with methylcrotonyl-CoA
carboxylase, which has not been found to be subject to any regulation by small molecules
or hormones (Stipanuk 2000). Compared with other biotin-dependent carboxylases, the
evolution of UAL is a relatively recent event. It is possible that there has been insufficient
evolutionary time and pressure to naturally select for a UAL enzyme with high coupling
efficiency. What’s more, UAL gene expression is subject to nitrogen catabolite repression
(Jacobs et al. 1985). It only expresses when ammonia and other preferred nitrogen
sources are absent. It is possible that the regulation of UAL at the level of transcription or
translation already provides sufficient control of urea metabolism, such that the
inefficiency and lack of catalytic regulation of UAL does not represent a problem for the
cell. Similar to UAL, the regulation of urease activity is mostly at the transcriptional
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level, based on the relative levels of Ni2+/Co2+ which are specific and required for the
activity of this metalloenzyme (Belzer et al. 2005). All of these possible explanations
serve as interesting topics for future investigations.
7.2.5 Rationales for the Gene Fusion of UC and AH in Fungi
From the studies presented herein, UAL emerges as an unusual example of a
multi-functional enzyme that does not show substrate channeling between its catalytic
domains and which has very poor domain coordination. This raises an interesting
question: if UC and AH are functionally independent, why are their genes fused into a
single polypeptide in fungi?
Indeed, in most model systems for multi-functional enzymes, close coordination
among domains was observed. Many studies have shown tight substrate channeling
among domains in multi-functional enzymes. One of the most impressive model systems
for such flux is found in polyketide biosynthesis, in which the shuttling of intermediates
takes place between a combination of multiple protein assemblies in an extraordinarily
efficient pattern (Khosla et al. 2014). Therefore, the underlying molecular basis for
regulated coordination of catalysis in multi-functional enzymes is of great interest.
There are other examples of multi-functional enzymes that do not channel their
intermediates. One example is the IspD, IspF in the isoprenoid biosynthetic pathway that,
together, catalyze the conversion of 2-C-methyl-D-erythritol 4-phosphate to 2-C-methylD-erythritol 2, 4-cyclodiphosphate (Lherbet et al. 2006). Kinetic evidence for substrate
channeling was sought by measuring the time course of product formation during
incubation of substrate with increasing concentrations of inactive IspE. No evidence for
channeling was observed using this method. Another example is seen in the absence of
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NADH channeling in the coupled reaction of mitochondrial malate dehydrogenase and
NADH: ubiquinone oxidoreductase (complex I) (Kotlyar et al. 2004). In this system, an
in vivo substrate competition assay was performed to indicate the free diffusion of NADH
between the two enzymes. However, in both of these two examples, the two enzymes that
harbor no channeling still associate into a stable complex. It has been reported that gene
fusion tends to facilitate formation of an inter-domain complex by simplifying the protein
complex topologies (Marsh et al. 2013). Therefore, UAL appears contrary to their
rationale and to be unique compared to the examples above, because even though UAL
exists on a single polypeptide chain in fungi, no physical interaction was detected for the
bacterial UC and AH, based on our in vitro evidence.
There are several possible explanations for the fusion of UC and AH in fungal
UAL. In most bacterial species that harbor the UAL activity, the UC and AH genes are
located immediately adjacent to each other (typically separated by only a few
nucleotides), strongly suggesting that they are part of a shared operon along with some
other genes not conserved in fungi (e.g. UAAP1 and UAAP2 as shown in Chapter 5).
Bacterial operons have the advantage of coordinating multi-gene expression in
prokaryotes. This system, however, is not available to eukaryotes. Due to the high
substrate specificity maintained by both UC and AH as well as the fact that there are no
other competing enzymes that hydrolyze allophanate, it is important that when UC
expresses, AH should be regulated and expressed at the same time. Therefore, even
though no coordination was observed at the enzyme activity level, it is possible that
fusing UC and AH in fungi serves simply to express the two genes at similar levels, times
and places in the cell.
As an alternative explanation, several models have been put forward regarding the
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evolutionary basis for gene fusion events (Cheng et al. 2012). Most of them favor the
idea that gene fusion facilitates intermediate transfer, increases catalytic efficiency, and
facilitates regulation at the cellular level (Kaessmann 2010). Another interesting model,
the “selfish operon” model, has raised the hypothesis that gene organization may be
selfish, and does not necessarily favor or benefit the host (Lawrence 1999). In this model,
it has been proposed that the clustering of functionally related genes serves simply to
facilitate the successful inheritance of the gene cluster, both by horizontal gene transfer
and by vertical transmission, because the mechanism of gene transfer is limited by the
size of the mobilized DNA fragments (Lawrence 1999). When the two genes are too far
away, the gene transfer is restricted only to vertical transmission. By comparing gene
fusion in various species, it was reported that gene fusion frequency increases in the
order: archaea < bacteria < eukaryotes (Koonin et al. 2002). Also, genes fuse primarily
via a random process of joining and breaking, such that genes that are functionally related
have a higher tendency to transition from mono-functional enzymes to multi-functional
enzymes (Marsh et al. 2013, Koonin et al. 2002). Therefore, although UC and AH do not
directly link their enzyme activities by domain coordination or substrate channeling, it is
possible that the two genes have fused simply because they are functionally related, and
are closely localized relative to each other. Once fused in fungi, this facilitates
spatiotemporal co-regulation of expression, offering a selective advantage without having
any influence on the direct physical or functional interaction of the protein domains. My
data is consistent with the idea that a physical interaction is not facilitated by the gene
fusion of UC and AH. Artificial fusion of the two enzymes does not influence the activity
of the other (see Chapter 5), and N-terminal fusion of an MBP tag or GST tag to UC does
not influence its activity in vitro (see Appendix 1). Therefore, it is concluded that UC
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exists as an independent entity and fusion of AH and UC do not alter enzyme activity,
either favorably or disfavorably.
In conclusion, the studies described in this dissertation suggest that UAL has
unusual properties, highlighting an example that expands the current description of multifunctional enzyme function. The implications from these studies can be expanded and
further applied to the further investigations of fundamental mechanisms of enzymes as a
whole.
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APPENDIX 1: ATTEMPTS TO CRYSTALLIZE UREA
CARBOXYLASE AND UREA AMIDOLYASE
Appendix 1.1 Crystallization of UC
Appendix 1.1.1 Crystallization of UC from Different Species
First, UC from several different species were cloned and purified, set up for
crystallization trials. Among all bacterial species that express UC, four were chosen,
based on their diversity in Class. Moreover, as UAL in fungi exists as incorporating UC
and AH on one polypeptide chain, the UC genes from two fungi, Saccharomyces
cerevisiae and Candida albicans were chosen and used for crystallization (Appendix
Table 1.1). All of the UC chosen were cloned and over-expressed in E. coli. Several
strategies were used to achieve higher homogeneity of protein, including optimization of
protein over-expression, purification by Ni2+-NTA and Q-sepharose chromatography. An
example of the over-expression test and purification were shown in Appendix Figure 1.1.
To increase the level of biotinylation of enzymes, all UC were co-expressed with BirA,
using the vector pCY216. The level of biotinylation was tested using gel-shift assay as
shown in Appendix Figure 1.2.
Appendix Table 1.1 Species chosen for cloning of UC and UAL
Species
Pseudomonas syringae
Wolinella succinogenes
Verminephrobacter eiseniae
Granulibacter bethesdensis
Saccharomyces cerevisiae
Candida albicans

Kingdom- Phylum- Class- Order
Bacteria-- Proteobacteria--γ-Proteobacteria --- Pseudomonadales
Bacteria-- Proteobacteria--ε-proteobacteria ---Campylobacterales
Bacteria-- Proteobacteria--β-proteobacteria ---Burkholderiales
Bacteria-- Proteobacteria--α-proteobacteria --- Rhodospirillales
Fungi- Ascomycota- Saccharomycetes - Saccharomycetales
Fungi- Ascomycota- Saccharomycetes - Saccharomycetales
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A.
250 kDa
150 kDa
100 kDa
75 kDa
50 kDa
37 kDa

25 kDa

B.

C.

D.

E.

Appendix Figure 1.1 Overexpression and purification of PsUC.
(A) SDS-PAGE gel showing the overexpression of PsUC before and after IPTG
induction. Every three lanes are in a group; each corresponds to total lysate; soluble
fraction and insoluble fraction. Samples before induction and 24 hour, 48 hours post
inductions are shown as indicated on the top of the gel. The PsUC is overexpressed in
BL21 strains using and two types of medium (LB and M9). The bands correspond to the
size of UC are indicated by arrow. (B) SDS-PAGE gel showing the elution profile
through Ni2+- affinity column. Numbers on top indicate the samples collected throughout
the elution. (C) Size exclusion chromatography result for PsUC after Ni2+- affinity
column. One major peak at ~ 15 ml elution volume was observed, corresponds to the size
of 130 kDa of PsUC monomer. One tiny peak at ~ 7-8 ml represents the PsUC
aggregation. (D) SDS-PAGE gel showing the elution profile through Ni2+-affinity
column followed by Q-sepharose column. (E) Size exclusion chromatography result for
PsUC after Ni2+- affinity column and Q-sepharose column. One major peak at ~ 15 ml
elution volume was observed, corresponds to the size of 130 kDa of PsUC monomer. The
aggregation peak observed at ~ 7-8 ml previously in (C) is not observed after a second Qsepharose column.
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Appendix Figure 1.2 Gel shift assay to test biotinylation of the purified PsUC
Biotinylation assay result for PsUC purified samples of fully biotinylated PsUC after
Ni2+-NTA and Q-sepharose column. Lane M is protein molecular marker, lane 1 shows
the PsUC purified after Ni2+-NTA and Q-sepharose column; lane 2 shows the PsUC
concentrated to 10 mg/ml; lane 3 shows the frozen sample diluted to 0.5 mg/ml; lane 4
shows the gel-shift assay result, the avidin and PsUC was pre-incubated at 10:1 molar
ratio before loading onto the gel. Black arrow indicates the size of PsUC at 130 kDa. Red
arrow indicates the shift of protein band upward upon addition of avidin.
Moreover, in case that the N-terminal His-tag might influence the crystallization
of UC, the His-tag was removed from purified enzymes, using TEV protease. The result
of cleaving the His-tag was shown in Appendix Figure 1.3. The progresses of UC
crystallization trials were summarized in Appendix Table 1.2.

Appendix Figure 1.3 Validate the results for cleaving the (His)8-tag
The SDS-PAGE and western blot results showing the PsUC before and after getting rid
of His-tag. The left and right showed the same gel. The left panel shows the SDS-PAGE
result and the right panel shows the western blot result, using anti-His antibody. Lane 1
shows the purified His-tagged PsUC. Lane 2 shows the protein after digested by TEV
protease and before loading to Ni2+-column. Lane 3 and lane 4 represent the samples flow
through or eluted from Ni2+-column.
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Appendix Table 1.2 Summary of progress for attempts to crystallize UC
PsUC
WsUC
GbUC
VeUC
ScUC
CaUC

Cloning
+
+
+
+
-

Purification
+
+
- (Not soluble)

Crystallization
- General screen (no crystal hits)
- General screen (no crystal hits)

+

- General screen (no crystal hits)

Appendix 1.1.2 Crystallization of Individual Domains of UC
As a multi-domain enzyme, UC incorporates three domains, BC, CT and BCCP,
which potentially increases the conformational flexibility and heterogeneity during
crystallization. As crystallization of full-length UC was not successful, efforts were made
to crystallize the individual domains of UC or different domains in combination, by
truncating and re-cloning. Due to the lack of knowledge of protein secondary structure,
one of the greatest obstacles was to define the starting and end point of each domain.
Therefore, several constructs were made to truncate the domains around predicted
domain linker region (Appendix Figure 1.4). The domain constructs were cloned, overexpressed in E. coli. Of the 6 constructs, 5 showed decent over-expression in E. coli
(Appendix Figure 1.5 A), but only the sixth construct (BC-CT6) was soluble and
successfully purified (Appendix Figure 1.5 B). However, initial crystallization trials did
not produce crystal hits.
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Appendix Figure 1.4 Domain structures of UC, and different truncation constructs.
Cartoons show the domain structure of UC and different domain truncation constructs of
UC. The predicted domain linkage region at the start and end of CT domain are shown in
amino acid, sequence zoomed in from cartoon representation. Colored numbers on top of
the sequence represent specific cleavage sites at different positions around the domains
boundary.
A
. 250 kDa
150 kDa
100 kDa
75 kDa
50 kDa

B
.

250 kDa
150 kDa
100 kDa
75 kDa
50 kDa
37 kDa

37 kDa
25 kDa
25 kDa

Appendix Figure 1.5 Overexpression of UC domain truncation constructs.
SDS-PAGE gel showing the overexpression of PsUC different domain constructs. Each
three lanes are one group with each lane corresponds to the total cell lysate; the soluble
fraction and the insoluble fraction. (A) The overexpression of CT1 construct. The
constructs are overexpressed in BL21 or HMS strains using and two types of medium
(LB and M9). Lane 1-3 corresponds to overexpression of CT1 in BL21, LB medium, lane
4-6 corresponds to BL21, M9 medium, lane 7-9 corresponds to HMS, LB medium; lane
10-12 corresponds to HMS, M9 medium. Arrow indicate the size of CT domain, ~ 65
kDa. (B) The overexpression of BC-CT6 construct. Lane 1-3, overexpression of BC-CT6
in HMS, LB medium; lane 4-6, overexpression of BC-CT6 in HMS, M9 medium. Arrow
indicate the size of BC-CT6 construct, ~ 120 kDa.
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Besides working on domain truncation constructs in PsUC, the CT domain from
CaUAL were also cloned and purified. However, initial crystallization trials using our in
house 144 conditions general screen also did not yield any crystal hit. Also, as AH was
amenable to crystallize, the CaUAL_AHBC and ScUAL_AHBC were generated by
introducing two stop codons after BC domain in CaUAL and ScUAL constructs
respectively. Both constructs were not soluble after expression test.
Appendix 1.1.3 Cloning and Purification of Hybrid Enzyme RePC-UC
The BC domains are highly conserved among all biotin-dependent enzymes. As
RePC was amenable to crystallize, it is attempted to use the domains from RePC as
crystallization tag, to help crystallization of UC. Therefore, the gene of R. etli PC BC
domain was fused with the CT-BCCP domain from PsUC or WsUC. For the cloning of
the hybrid enzyme, overlapping PCR was used, as shown in Appendix Figure 1.6 A.
Briefly, for the first step, the RePC BC domain and UC CT-BCCP domain were
individually amplified by traditional PCR, with ~ 20-50 overlap sequences between the
two fragments (Appendix Figure 1.6 B). Second, the two amplified fragments were used
as both template and primer of each other for the second round of PCR. The two
fragments, reaction buffer, dNTP and DNA polymerase were added followed by 5 cycles
of amplification, using an annealing temperature calculated based on the overlapping
sequence. For the third step, a program of 30 cycles was performed, using primers from
the beginning of RePC BC domain and the end of UC BCCP domain (Appendix Figure
1.6 C). The hybrid enzymes harboring BC domain from R. etli PC and CT+BCCP
domain from UC were further used for overexpression and purification. However, the
total protein yield after Ni2+-NTA chromatography was very low and was contaminated
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with abundant non-specific protein. Therefore, it was not used for further crystallization
trials.

A.

B.

C.

Appendix Figure 1.6 Cloning of hybrid enzyme RePC-PsUC.
(A) Cartoon representation showing the procedure of the overlapping PCR. (B-C)
Agarose gel results from (B) PCR products from reaction 1. Lane 1 and 2 shows the PCR
product of RePC BC domain, indicated by red arrow. Lane 3 shows the PCR product of
PsUC CT+BCCP domain, and the lane 4 shows the PCR product of WsUC CT+BCCP
domain, both indicated by black arrow. (C) PCR products after final amplification from
overlapping PCR. Lane 1,2 shows fusion of RePC BC domain with PsUC CT+BCCP
domain, using the ratio of the two fragments from step 1 at 2:1 and 1:2, respectively.
Lane 3 and 4 shows fusion of RePC BC domain with WsUC CT+BCCP domain, using
the ratio of the two fragments from step 1 at 2:1 and 1:2, respectively. The final product
after overlapping PCR is 3.7 kb, which was indicated by arrow.
Appendix 1.1.4 Cloning and Purification of UC with Crystallization Tags
UC exists as a monomer. Since UC cloned from several species showed trouble in
crystallization, it is possible that the lack of protein-protein interaction surface might
have hindered the formation of crystal lattice. The fusion of protein with large-affinity
tags, such as glutathione-S-transferase (GST) or maltose-binding protein (MBP), have
been indicated to improve protein folding, enhance solubility and facilitate crystal
packing (Moon et al. 2010). Therefore, two fusion tags, GST and MBP, were used in this
study, in hope to aid crystal structure determination of UC.
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Appendix 1.1.4.1 UC Fused to GST-tag
To produce GST-UC fusion protein, first, the pET28a-(His)8-TEV-GST vector
was constructed (Appendix Figure 1.7). The gene encoding GST was cloned into
pET28a-(His)8-TEV vector, right after (His)8-tag. The gene of GST was amplified using
pGEX-41T as template and the two primers #501 and #502 (Appendix 3). Both the PCR
and vector were digested by PstI and BamHI and then ligated to form pET28a-(His)8TEV-GST vector.

pET28a-(His)8-TEV vector

Appendix Figure 1.7 Plasmid maps showing the cloning procedure of pET28a(His)8-TEV-GST vector.
Subsequently, the genes of GbUC, VeUC and PsUC were separately cloned into
the pET28a-(HIS)8-TEV-GST vector, with (His)8-tag and GST tag at the N-terminus
(Appendix Table 1.3). The fusion protein was further purified through Ni2+-NTA
chromatography and Q-sepharose ion-exchange chromatography. It was noticed that
fusion of GST tag enhanced the solubility of GbUC. Also, it changed the oligomerization
state. According to size-exclusion chromatography results, the PsUC existed as a
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monomer of ~ 130 kDa. The fusion protein GST-PsUC showed a peak at 400-500 kDa,
corresponding to the size of dimer or trimer (Appendix Figure 1.8). This might imply an
improvement of potential crystal contacts.

Appendix Table 1.3 Summary of cloning strategies of GST tagged UC
Protein
Vector
Primers*
GbUC
pET28a-(HIS)8-TEV-GST #503, #504
VeUC
pET28a-(HIS)8-TEV-GST #505, #506
PsUC
pET28a-(HIS)8-TEV-GST #509, #510
CT8
pET28a-(HIS)8-TEV-GST #507, #508
* Primer sequences are shown in Appendix 3.
A.

Restriction sites
SalI and XhoI
BamHI and XhoI.
BamHI and XhoI.
BamHI and XhoI.

mAU

mAU

B.

Appendix Figure 1.8 Size exclusion chromatography results of PsUC and GSTtagged PsUC fusion protein.
Representative chromatograms for the (A) PsUC and (B) GST-tagged PsUC. (A) The
peak at elution volume of 15 ml corresponds to the PsUC monomer (130 kDa). (B) The
peak at elution volume of 13 ml corresponds to dimer or trimer of GST-PsUC (400-500
kDa). The column was calibrated with molecular weight standards as previously
described (Lietzan et al. 2011).
Appendix 1.1.4.1 MBP-tag Fusion Protein
Protein fusion tags have been reported to enhance crystallization because the tags
themselves are amenable to crystallize, and also they can provide molecular surfaces for
protein-protein interaction. Moreover, it was reported that some specific mutations in
MBP further enhance crystallization because these mutations significantly reduce the
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surface entropy of protein (Moon et al. 2010). Therefore, the gene encoding UC was
cloned downstream of the wild-type and mutant malE gene of E. coli, in hope that the
produced fusion proteins could be amenable for crystallization (Appendix Table 1.4). As
shown in Appendix Figure 1.9, fusion of MBP tag to GbUC greatly enhanced the its
solubility, as compared to His tagged GbUC and GST tagged GbUC.

A.

B.

C.

C

Appendix Figure 1.9 The improvement of protein solubility after fusion of large
affinity tags.
SDS-PAGE results showing the overexpression and solubility of (A) GbUC, (B) GSTtagged GbUC and (C) MBP-tagged GbUC. (A) Overexpression of GbUC in two
expression E. coli strains, BL21 (lane 1-3) and HMS (lane 4-6), in LB medium. (B)
Overexpression of GST tagged GbUC in HMS (lane 1-3) and Rosetta (lane 4-6), in M9
medium. (C) Overexpression of MBP tagged GbUC in HMS in two types of medium, LB
(lane 1-3) and M9 (lane 4-6). In all three gels, lane 1 and 4 shows the total cell lysate
after sonication; lane 2 and 5 shows the soluble fraction of cell lysate; lane 3 and 6 shows
the insoluble fraction by resuspending the insoluble pellet. The bands correspond to the
size of target proteins are indicated by arrows.

Appendix Table 1.4 Summary of cloning strategies of MBP tagged UC
Protein
Vector
Primers *
GbUC
pMALX
#493 and #494
VeUC
pMALX
#495 and #496
PsUC
pMALX
#499 and #500
CT8
pMALX
#497 and #498
*Primer sequences were shown in Appendix 3.

Restriction enzymes
NheI and HindIII
NheI and HindIII
NotI and BamHI
NotI and BamHI

Purification of MBP-GbUC followed two steps. Fusion of a target protein to MBP
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permits its purification using amylose resin (Moon et al. 2010). For the first step of
purification, amylose resin was used according to manual from New England Biolabs
(pMALTM Protein Fusion & Purification System). Briefly, the column buffer containing
20mM Tris-HCl pH 7.4, 200mM NaCl; 1mM EDTA and 0.07% BME was used. 5 mM
maltose was added to the column buffer, making the wash buffer. 40 mM Maltose was
added to the column buffer, making elution buffer. The amount of resin used was decided
upon the amount of fusion protein produced. The typical binding capacity for the resin is
~ 3 mg fusion protein / ml resin.
After purification using amylose resin, the protein is >50% pure, but in the most
concentrated elution fraction, a significant amount of contaminant of ~ 40kDa is
observed (Appendix Figure 1.10).

Appendix Figure 1.10 The purification of MBP-GbUC through amylose resins.
SDS-PAGE gel showing the wash and elution profiles for purification of MBP-GbUC
through amylose resin. Lane 1-11 represents the protein fractions washed using buffer
with 5 mM maltose. Lane 12-20 represents the protein fractions eluted using buffer with
50 mM maltose. The band corresponds to MBP-GbUC was indicated by arrow.
Therefore, a preparative size-exclusion chromatography was used to further purify
the MBP-GbUC. Three peaks are observed after the preparative size-exclusion
chromatography. Besides the aggregation peak at ~ 120 ml and a peak corresponds to
smaller molecules at ~ 230 ml, the peak corresponding to the size of ~ 300 kDa might
represents a dimer of MBP-GbUC (Appendix 1 Figure 11). The fractions from peak were
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collected, dialyzed against storage buffer containing 10 mM HEPES pH 8.0, 50 mM
NaCl and 1 mM DTT. The purified proteins were finally concentrated to 10 mg/ml and

mAU

used for crystallization.

Appendix Figure 1.11 Preparative size exclusion chromatography of MBP-GbUC.
Representative chromatogram for MBP-GbUC through size-exclusion chromatography.
Three peaks are observed after the preparative size exclusion chromatography. The peak
at elution volume of ~ 120 ml corresponds to protein aggregation at the void volume of
the column. The middle peak shown in the red square represents the ~ 300 kDa dimer of
MBP-GbUC. The peak at elution volume of ~ 230 ml corresponds to smaller molecule.
The in-house 144 condition general screen from St. Maurice lab was used for
crystallization. Crystal hits were obtained from two conditions. The general screen
condition #4 (100mM MES/Ac pH 5.5; 10.4% MEPEG5K; 200mM AmSO4) yielded
needle-like crystals spontaneously one week after set up. The general screen condition
#16 (100mM TE pH 8.0; 9.6% MEPEG5K; 240mM (NH4)3PO4 pH 7.0) yielded diamond
shaped crystals after micro seeding from the first drop (Appendix Figure 1.12).

Appendix Figure 1.12 Picture of octahedral-shaped crystal hits obtained from MBPGbUC.
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Appendix 1.2 Crystallization of GbAH-UC
As described in Chapter 5, the genes of AH and UC from G. bethesdensis was
fused, forming an artificial G. bethesdensis urea amidolyase. Because the GbAH was
amenable to crystallize, it was attempted to use it as a crystallization tag to facilitate the
crystallization of GbAH-UC fusion protein.
Two initial hits were obtained from the 144-condition general screen. The
conditions #86 (1 M HEPES pH 7.5; 40% MEPEG 5K; 2 M MgCl2) and #133 (2.0 M
Ammonium Tartrate pH 7.0) yielded needle-like crystallines and were used for further
refinement.
Appendix 1.3 Crystallization of UAL
Obtaining the structure of full-length UAL will help to elucidate several major
questions regarding molecular mechanisms of domain coordination. Both ScUAL and
CaUAL were purified from yeast as shown in Chapter 5. Initial needle-like crystallization
hits were obtained from condition #12 (100 mM MOPS pH 7.0; 17.6% MEPEG 5K; 160
mM potassium glutamate) and condition #44 (100 mM Tris-EDTA pH 7.5; 16.0%
PEG8K; 272 mM NaMalonate). Further refinements did not improve the morphology or
size of crystals.

Appendix 1.4 Cloning of PaUAL
The Pantoea ananatis was reported to be the only bacteria species that harbor
both UC and AH fused as one polypeptide chain. Therefore, it acts as a great target to
express bacterial full-length UAL using bacterial expression system. The UAL gene was
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cloned from Pantoea ananatis genomic DNA into pET28a-(HIS)8-TEV vector, using
primers #750 and #751 (Appendix 3). The cloned UAL gene on the pET28a-(HIS)8-TEV
vector was sequenced. However, the sequencing result obtained was not consistent with
sequence database. In my sequencing results, there is a stop codon (TAA) after AH
domain, while in the genome sequence database provided by NCBI, the adenosine at the
third position of stop codon is a thymine (TAT) instead. Therefore, the conclusion that
Pantoea ananatis is the only bacterial species that have full-length UAL is due to a
mistake in genome sequence.
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APPENDIX 2: SEQUENCE ALIGNMENT RESULTS
GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

1
1
1
1
1
1
1
1
1
1

MTL----------SMTLEGIQAFLAQGGT--IEQVVTEAYD-RITRYGDKAVWIALRPRE
MEST--------LGWSVQDWLSFHSKSTPTKSLELLENLLK-SQKPAPEDPAWISLIPVE
MVQDGS-----------------------------------------GAPQAWIE----MNDTALP-----NNFRLDTVRAA-YQAGHLSPRQLILALREKAAALNPAYHLFIHLLSPA
MTVSSDTTAEISLGWSIQDWIDFHKSSSSQASLRLLESLLD-SQNVAPVDNAWISLISKE
MSY---------LGWSVEDWKKFHYESTPDESFELLSQLLK-SQKAAPEDPAWISLASIE
MIDLDF------RKLTIEECLKLSEEE----REKLPQLSLETIKRLDPHVKAFISVR--MISL---------A----DLQRR----------------IE-TGELSPNAAIAQSHAAIE
MIDLDF------RKLTIEECLKLSEEE----REKLPQLSLETIKRLDPHVKAFISVR--*
....
..
..
. .
.....
.

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

48
52
15
55
60
51
48
31
48
61

EV---LAEA-RALDA-SPATGKPLYGVPFAVKDNIDVAGLPCSAACPAF-TYEPDRDATV
DL---HHQW-NILQSKSNKEELPLYGVPIAVKDNIDYKGLPTTAACPSY-LYQPTRDSYV
------R----FAQPLAGRSTGPLAGLRFAIKDNIDALGWPTTAACPEF-AYRPREHATV
EL---EPYL-AALEGR-DLKDLPLYGVPFAIKDNIDLAGIPTTAACPDY-AYTPERSATI
NL---LHQF-QILKSRENKETLPLYGVPIAVKDNIDVRGLPTTAACPSF-AYEPSKDSKV
NL---EHQW-KFLQSKSNKRDLPLYGVPIAVKDNIDAKTFETTAACPSF-AYSPSKDATT
-------------ENVSVEKKGKFWGIPVAIKDNILTLGMRTTCASRILENYESVFDATV
AREKEVHAFVRHDKSARAQASGPLRGIAVGIKDIIDTANMPTEMGSEIYRGWQPRSDAPV
-------------ENVSVEKKGKFWGIPVAIKDNILTLGMRTTCASRILENYESVFDATV
.
.
.
.
...*.....**.*. ......... . .. . .....

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

102
107
64
109
115
106
95
91
95
121

VARLRAAGAIVLGKTNLDQFATGLVGTRSPFGAPRCVFDQDYISGGSSSGSAVAVAAGLV
VELLRDAGAVVIGKTNLDQFATGLVGTRSPYGKTPCVFNDKYVSGGSSAGSASVVGRGIV
VRKLLDAGASLVGKTNLDQFACGLNGTRSPYGAVPNAFHADYVSGGSSSGSAYVVATGQV
VEQLIALGAVPMGKTNLDQFATGLNGSRSPYGVCPNSILNEYPSGGSSSGSSLAVALGVS
VELLRNAGAIIVGKTNLDQFATGLVGTRSPYGKTPCAFSKEHVSGGSSAGSASVVARGIV
VRLLRDAGAIVIGKTNLDQFATGLVGTRSPYGITPNTFNPKYVSGGSSAGSASVVARGIV
VKKMKEAGFVVVGKANLDEFAMGSSTERSAFFPTRNPWDLERVPGGSSGGSAAAVSAGMV
VMMLKRAGATIIGKTTTTAFAS-----RDPT-ATLNPHNTGHSPGGSSSGSAAAVGAGMI
VKKMKEAGFVVVGKANLDEFAMGSSTERSAFFPTRNPWDLERVPGGSSGGSAAAVSAGMV
* ....*....**.....**... ..*.... ... . ....****.**. .*. *..

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

162
167
124
169
175
166
155
145
155
181

AFSLGTDTAGSGRVPAAFNNLVGVKPTKGLLSTSGVVPACRSLDCVTVFAASVAEGTLIR
PLSLGTDTAGAGRVPAALNNLIGLKPTKGAFSCRGVVPACKSLDCVSVFALNLSDAEIAF
DFALGTDTAGSGRVPAGLNNIVGIKPSRGLLSARGVVPAAQSVDCVSIFARTVAMAARVL
SFSLGTDTAGSGRVPAALNNLVGMKASKGLISTAGVVPACRTQDCVSTFTATAREASQLL
PIALGTDTAGSGRVPAALNNLIGLKPTKGVFSCQGVVPACKSLDCVSIFALNLSDAERCF
PIALGTDTAGSGRVPAALNNLIGLKPTKGVFSCSGVVPACKSLDCVSIFALNLQDAQLTF
VAALGSDTGGSVRQPASLCGVVGYKPTYGLVSRYGLVAFASSLDQIGPITKTVRDAAILM
PLALGTQTGGSVIRPAAYCGTAAIKPSFRMLPTVGVKCYSWALDTVGLFGARAEDLARGL
VAALGSDTGGSVRQPASLCGVVGYKPTYGLVSRYGLVAFASSLDQIGPITKTVRDAAILM
.**..*.*....**........*....... *........*...... .. .. ...

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

222
227
184
229
235
226
215
205
215
241

RIAEGYDA-ADPYSRPSQK---RRLPHV----GLRVGVPRQDQR-EFYG-NTAYAALYQR
KVMNKPDLLEDEYSREFPK---NPISQYP--KDLTIAIPK--EV-PWFG-ETENPKLYTK
QVAQGPDA-QDPYSRTLQ-L--AS-QPFG--HRFRFGLP--DPL-EFFG-DQAAQAAFAQ
GLVARFDP-RDAYSRRNPQW--NDASAFGAPRPLRFGVPRSEDL-AFFG-CSEGPQLFSD
RIMCQPDPDNDEYSRPYVS---NPLKKFS--SNVTIAIPK--NI-PWYG-ETKNPVLFSN
NIMAEEDE-HDEFSRSMPK---NPLLKFG--KKPRVVVPT--NL-LWYG-EKENPKLYQE
EIISGRDE-NDATTVNRKVDFLSEIEEGV--SGMKFAVPE--EI-YEHDIEEGVSERFEE
LAMTGRSE-F---SGIVP----------A--KAPRIGVVR--QEFAGAV-EPAAEQGLQA
EIISGRDE-NDATTVNRKVDFLSEIEEGV--SGMKFAVPE--EI-YEHDIEEGVSERFEE
.. . .
. ...
. .
. .......
. ... . .
..
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GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

272
278
233
284
286
276
269
246
269
301

★
★
ALDEMISLDAELVEIDFAPFRDAAKLLYGGPWVAERLEAVGDHLSRA----P--D----AVASLKNTGAKIVVVDFEPLLELARCLYEGAWVAERYCATRDFLATN----PPES----AVQRLSAIGGVAVALDYRPLAQAAALLYESALVAERYAALRPFFDAH----E--D----AIERLTALGGEAVTLDLSPFLEAAQLLYDGPWVAERYSIAGPLMEEH----P--E----AVENLSRTGANVIEIDFEPLLELARCLYEGTWVAERYQAIQSFLDSK----PPKE----AVAKFEKIGCELVSLDIEPLLELARCLYEGPWVAERYVAVKDFFATN----PPEK----ALKLLERLGAKVERVKIPHIK-YSVATYYVIAPAEASSNLARFDGVKYGLRIKEKGLREM
AIKAAERAGASVQAIDLPEAVHEAWRIHPIIQDFEAHRALAWEFSEH----H--D----ALKLLERLGAKVERVKIPHIK-YSVATYYVIAPAEASSNLARFDGVKYGLRIKEKGLREM
*. . .... .. ... .... . .... ...*.. ... .
.
. .

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

321
329
282
333
337
327
328
295
328
361

-------SF-DPVVRSIVETAKTLSAVD----AFRGQYELAALTQQANAQWARMDILLLP
-------SL-DETVVNIIKGAVKFDAAD----AFKFEYKRQGILQKVNLLLKDIDVLCVP
-------RV-MEPVRSIIARGRGFGAAD----LCAAQTQLQACAQQARALWAGMDVLLVP
-------AV-LPVIRDVLAKAPGVNGVD----TFRAQYRLQALKALCDQALEGLDCVMTP
-------SL-DPTVISIIEGAKKYSAVD----CFSFEYKRQGILQKVRRLLESVDVLCVP
-------DL-DPTVTKIIKGGEHYSAAT----CFQYEYKRQGIVKRVNKLLEGIDAIIVP
YMKTRNVGFGEEVRRRIMIGTFTLSAAYYEAYFNKAMKVRRKISDELNEVLSQYDAILTP
-------EI-APMLRASLDATVGLTPKE----YDEARRIGRRGRRELGEVFEGVDVLLTY
YMKTRNVGFGEEVRRRIMIGTFTLSAAYYEAYFNKAMKVRRKISDELNEVLSQYDAILTP
. ..... .. .. .....
... . ....
.. .. .*.....

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

369
377
330
381
385
375
388
343
388
421

TAPTIHKVEAV--MADPVRLNSQLGHYTNFVNLLDCAAIAVPAGFIETGLPFGVTLVGPA
TCPLNPKLEEV--AQEPVLVNSRQGTWTNFVNLADLAALAVPSGFRSDGLPNGITLIGKK
TAPTHYTIAAM--QADPVALNSHLGQYTNFVNLLDYAAIAVPSSIRPDGLPFGITLIGPC
SIGRPVTSAEL--LAEPVLRNSELGYYTNFVNLLDYAAIAVPSAFMSNGLPWGVTLFGRA
TCPLNPTMQQV--ADEPVLVNSRQGTWTNFVNLADLAALAVPAGFRDDGLPNGITLIGKK
TAPLNPTIEEV--TNEPIKVNSCQGTYTNFVNLADMSALAIPAGFRNDGLPFGVTLLSHK
TSPVTAFKIGE--IKDPLTY-YLMDIFTIPANLAGLPAISVPFGF-SNNLPVGVQVIGRR
SAPGTAPAKALASTGDP--------RYNRLWTLMGNPCVNVPVLK-VGGLPIGVQVIARF
TSPVTAFKIGE--IKDPLTY-YLMDIFTIPANLAGLPAISVPFGF-SNNLPVGVQVIGRR
. ..
. ..
.*. ... .. ......*........* ..
.** *.......

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

427
435
388
439
443
433
444
394
444
481

FSDDSMALIADRLHRRL-EPG--------------YGQ--DR--AS--LPDP-V--LEET
FSDYALLDLAKRFFSVA-FPNNSRT----------YGK--FVDRRI-TVEDELD-GPSKD
GSDWPLAELGQRYHHASGM-LQGALSLPLPAPQALAGMQALADM-PAPAPVAPA--GRAD
FTDQYLLSLADAFQRQTALPLIGGDSP------------SL----PA-----PS---NAA
FTDYALLELANRYFQNI-FPNGSRT----------YGT--FTSSSVKPANDQLV-GPDYD
FNDYALLDLASRYLKLD----NLRT----------CGV--SQKKVS-TIHDELYLLPKST
FADGKVFRIARAIEKN-------------------------------------------GNDAHALATAWFLED--------------------------------------------FADGKVFRIARAIEKN-------------------------------------------..* .. .. .. .
.

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

463
480
444
475
489
476
460
409
460
541

NPEQIALAVVGAHLSGQPLHWQLTERNATLVARTRTAPEYRLYALAETIP-PKPGLVADP
TLNGVKLAVVGAHLKGLPLHWQLQKCNATYLSSPKTSNNYKLYALPKVGPVLKPGLRRVN
DTPHMRLAVVGAHLSGMPLDAQLIERGARLLQATSTAPSYRLYALPGSVP-PKPGLRRVA
RNDMARLVVCGAHLDGLALNWQLIQRGARLLEVTYSSADYQLYALAGGPP-FRPGMVRVA
PSTSIKLAVVGAHLKGLPLHWQLEKVNATYLCTTKTSKAYQLFALPKNGPVLKPGLRRVQ
PEETVKLAVVGAHLKGFELHWQLEKVDARFIESTTTSKNYKLYALPKTGPVAKPGLRRVE
----------------------------------SPYNENGMFPLP----------------------------------------------------------------------------------------------------------SPYNENGMFPLP-------------.......... . . ...
. . . .
. .....
. .... ..
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GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

522
540
503
534
549
536
472
409
472
601

DFTGDGIEIELWSMDAEAFGTFTALVPAPLAIGTLRLADGTSVKGFVCEPAGL--VGAQD
DGTGSQIQLEVYSVPYDRFGDFIAMVPEPLGIGSVELESGEWVKSFICEEFGYTQQGTVD
-TGGAAIALELWDMPQAQMGSFLALIPPPLGLGQVELADGSWATGFICEGYAL--HAAQD
-EHGVAIAVEVWELPSAELGSFLTGIPAPLGLGKVQLADGRWETGFICETSGL--EGARD
DSNGSQIELEVYSVPKELFGAFISMVPEPLGIGSVELESGEWIKSFICEESGYKAKGTVD
-SDGEHIAVETYSIPKEKFGQFIKFVPEPLGIGSVELKSGEWCKSFICEEFGYKQPGTVD
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------. . .... ..
. .. .. ..... . . . .
.... .
. .

GbAH
KlAH
VeAH
PsAH
ScUAL
CaUAL
GatA
MAE2
FAAH
consensus

580
600
560
591
609
595
472
409
472
661

ITRFGGWRAYL------------------------------------------------ITKFGGFKPYIEHIQVT------------------------------------------ITGHGGWRAYLAA----------------------------------------------ISHLGGWRAYLQ-----------------------------------------------ITKYGGFRAYFEMLKKKESQKKKLFDTVLIANRGEIAVRIIKTLKKLGIRSVAVYSDPDK
ITEFGGWKKYQEHLRAS----KKPFNSVLVANRGEIAVRIIKTLKKLGVKSIAVYSDPDK
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------.. .... .

Appendix Figure 2.1 Sequence alignment of AH, UAL and other AS family enzymes
Sequence alignment of AH, UAL and other AS family enzymes shows the AS signature
sequences (Phe71-Leu182 for GbAH, shown in red braces); the conserved Ser-cisSer-Lys triad
(shown with red arrows above); the Tyr299 and Arg307 in GbAH (shown with red star above).
The mutations obtained from yeast genetic screen are also marked. The mutations conserved
in UAL are marked with purple dot on top. The non-conserved mutations as marked with
green reverse triangle on top. GbAH (Granulibacter bethesdensis allophanate hydrolase);
KlAH (Kluyveromyces lactis allophanate hydrolase); VeAH (Verminephrobacter eiseniae
allophanate hydrolase); PsAH (Pseudomonas syringae allophanate hydrolase); ScUAL
(Saccharomyces cerevisiae urea amidolyase); CaUAL (Candida albicans urea amidolyase);
GatA (Thermotoga maritima Glutamyl-tRNA(Gln) amidotransferase subunit A); MAE2
(Bradyrhizobium japonicum malonamidase E2); FAAH (rat fatty acid amide hydrolase).
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RePC
KlUC
CaUC
ScUC
consensus

1
1
1
1
1

--GPISKILVANRSEIAIRVFRAANELGIKTVAIWAEEDKLALHRFKADESYQVGRGPHL
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RePC
KlUC
CaUC
ScUC
consensus

59
55
56
55
61

ARDLGPIESYLSIDEVIRVAKLSGADAIHPGYGLLSESPEFVDACNKAGIIFIGPKADTM
--GRTAAETYLDIDKIINAAKKTGAQAIIPGYGFLSENADFSDRCSQENIVFVGPSGDAI
--GTTAAETYINIEKVIKAAKESGAEAIIPGYGFLSENADFSDRCGKEGIVFVGPSGDAI
--GTTAAQTYLDMNKIIDAAKQTNAQAIIPGYGFLSENADFSDACTSAGITFVGPSGDII
.......*......*..** ..*.**.****.***...*.* *.. .*.*.**..*..

RePC
KlUC
CaUC
ScUC
consensus

119
113
114
113
121

RQLGNKVAARNLAISVGVPVVPATEPLPDDMAEVAKMAAAIGYPVMLKASWGGGGRGMRV
RKLGLKHSAREIAERAKVPLVPGSG-LIKDAKEAKEVAKKLEYPVMVKSTAGGGGIGLQK
RKLGLKHSAREIAEKAGVPLVPGSG-LVKDAKEARAIAAKLEYPIMVKSTAGGGGIGLQK
RGLGLKHSARQIAQKAGVPLVPGSL-LITSVEEAKKVAAELEYPVMVKSTAGGGGIGLQK
*.**.*..**..*....**.**... *.....*....*....**.*.*...****.*...

RePC
KlUC
CaUC
ScUC
consensus

179
172
173
172
181

IRSEADLAKEVTEAKREAMAAFGKDEVYLEKLVERARHVESQILGDTHGNVVHLFERDCS
VDSEDDIERVFETVQHQGKSYFGDAGVFMERFVNNARHVEIQMMGDGFGKAIAIGERDCS
VDSEKDIERVFETVQHQGKSYFGDSGVFLERFVENARHVEIQMLGDGYGNAIAVGERDCS
VDSEEDIEHIFETVKHQGETFFGDAGVFLERFIENARHVEVQLMGDGFGKAIALGERDCS
..**.*........ ......**...*..*.....*****.*..**..* .....*****

RePC
KlUC
CaUC
ScUC
consensus

239
232
233
232
241

VQRRNQKVVERAPAPYLSEAQRQELAAYSLKIAGATNYIGAGTVEYLMDADTGKFYFIEV
LQRRNQKVIEETPAPNLPEATRAKMRAASERLGSLLKYKCAGTVEFIYDEQRDEFYFLEV
LQRRNQKIIEETPAPNLPEETRNKMRKAAESLGSSMKYKCAGTVEYIYDPKRDEFYFLEV
LQRRNQKVIEETPAPNLPEKTRLALRKAAESLGSLLNYKCAGTVEFIYDEKKDEFYFLEV
.******..*..***.*.*..*.... . ....... *..*****...*.....***.**

RePC
KlUC
CaUC
ScUC
consensus

299
292
293
292
301

NPRIQVEHTVTEVVTGIDIVKAQIHILDGAAIGTPQSGVPNQEDIRLNGHALQCRVTTED
NARLQVEHPITEMVTGLDLVEWMLRIAAN---DSPD---FDNTKIEVSGASIEARLYAEN
NARLQVEHPITEMVTGLDLVEWMLLIAAD---TPPD---F-NQKIEVKGASMEARLYAEN
NTRLQVEHPITEMVTGLDLVEWMIRIAAN---DAPD---FDSTKVEVNGVSMEARLYAEN
*.*.****..**.***.*.*.....*...
..*.
.........*.....*...*.

RePC
KlUC
CaUC
ScUC
consensus

359
346
346
346
361

PEHNFIPDYGRITAYRSASGFGIRLDGGTSYSGAIITRYYDPLLVKVTAWAPNPLEAISR
PVKDFRPSPGQLTSVSFPSW--ARVDTWV-KKGTNVSAEYDPTLAKIIVHGKDRNDAIMK
PVKGFMPSPGQLTEVKFPEW--ARIDSWV-EKGTIVSAEYDPTLAKIIVHGKDRDDALKK
PLKNFRPSPGLLVDVKFPDW--ARVDTWV-KKGTNISPEYDPTLAKIIVHGKDRDDAISK
*...*.*..*.......... .*.*... ..*. ....***.*.*..........*...

RePC
KlUC
CaUC
ScUC
consensus

419
403
403
403
421

MDRALREFRIRGVATNLTFLEAIIGHPKFRDNSYTTRFIDTTPELFQQVKRQDRATKLLT
LNQALNETAVYGCITNIDYLRSIASSKMFKEAKVATKVLDSFD-------YKPCAFEVLA
LRQALNETVVYGCITNVDYLRSIANSKMFEEAAVATKVLDSYD-------YKPHAIEILQ
LNQALEETKVYGCITNIDYLKSIITSDFFAKAKVSTNILNSYQ-------YEPTAIEITL
...**.*....*..**...*..* ....*......*.......
....*....
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Appendix Figure 2.2 Sequence alignment of BC domain of UC and PC.
Sequence alignment of BC domain of UC and PC shows the B subdomain (Leu152-Leu225 for
ScUC, shown in red braces). The mutations obtained from yeast genetic screen are marked.
The mutations conserved in UC, PC are marked with purple dot on top. The mutations
conserved in UC are marked with green reverse triangle on top. RePC (Rhizobium etli
pyruvate carboxylase); KlUC (Kluyveromyces lactis urea carboxylase); ScUC (Saccharomyces
cerevisiae urea carboxylase); CaUC (Candida albicans urea carboxylase).
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APPENDIX 3: OLIGONUCLEOTIDES USED IN THIS STUDY
#180 NK_WsUC_for: ACC TCT GCA GTT TCA AAA GGT TTT GAT TGC C
#181 NK_WsUC_rev: GAT CCA TAT GCT ATT ATG CCT TTG AAT TCT CAA C
#184 NK_WsAH_for: CTA GCT GCA GAG AGA GGT GCG GGA G
#185 NK_WsAH_rev: CAA CGC TAG CTT ATC ATC TCA CTC CTT TCA AAA AAT ATT C
#201 NK_PsUC_for: ATT TGC TAG CTT CGA CAA ACT GCT GAT CGC CAA CCG T
#202 NK_PsUC_rev: GAT CGT CGA CTT ATC AGT CTG CTG CCA GCA CTA CGA C
#203 NK_PsAH_for: ATG CCC TGC AGG CGA ACG ACA CAG CTC TGC CGA AC
#204 NK_PsAH_rev: AGT TGC TAG CTT ATC ACA GCT GTT GCA GGT AGG C
#292 YL_PsUC_CT_for: CGA GCT GCA GAG CGG CGG CAC GCA AAC C
#293 YL_PsUC_CT_rev: CGA ATG CGC TCG AGT TCA TCG GCG CTG ACC GGG
#336 YL_PsAH_mutSer165_for: CGA ATA TCC GTC CGG CGG TTC AAG CTC CGG CTC
TTC GC
#337 YL_PsAH_mutSer165_rev: GCG AAG AGC CGG AGC TTG AAC CGC CGG ACG GAT
ATT CG
#338 YL_PsUC_CT_for_3: CAG CCT GCA GTT GCG TCA GGG CAA CCG
#339 YL_PsUC_CT_rev_3: CGC GAG CTC TTC GTC GCT TTG GAA ATC AGC
#344 YL_PsUC_CT_for_4: CCG ATC GTC AGG AGG TGT TAA GCG GCG
#345 YL_PsUC_CT_rev_4: GTT CTC GAG CCT ACT ACG GGT AGA AGC GGA TCT G
#346 YL_PsUC_CT_for_5: GTA TCT GCA GGA TAC GTT CGA GGT GTT AAG CGG
#347 YL_PsUC_CT_rev_5: CAC CTC GAG CCT ACT AGA AAT CAG CCT GGC CG
#348 YL_PsUC_CT_for_6: CTG CTG CAG CGC GCC GAT ACG TTC G
#349 YL_PsUC_CT_rev_6: GTC TCG AGC CTA CTA TTC GTC GCT TTG GAA ATC
#352 YL_VeAH_for: CCC CTG CAG GCG GTG CAA GAC GGA TC
#353 YL_VeAH_rev: CTG CTC GAG TTC AGG CGG GCT TGC AC
#354 YL_GbUC_for: GGG GCT GCA GAT GTT CGA TCA TGT TCT GG
#355 YL_GbUC_rev: CAG CTC GAG GTC AGG CTT CCT CCT CG
#356 YL_GbAH_for: GAA GCT GCA GAT GAC GCT GAG CAT GAC CC
#357 YL_GbAH_rev: CAG ACT CGA GCT TAC TGC GCC AAA TAG GC
#361 YL_PsAH_mutSer155_for: CGT CCG GCG GTG CAA GCT CCG
#362 YL_PsAH_mutSer155_rev: CGG AGC TTG CAC CGC CGG ACG
#363 YL_VeUC_for2: CCC ATA TGA TGC CCA CCC CTC CTG GCT TCG
#364 YL_VeUC_rev2: CCA AGC TTG TCA GCG CGC CGT TGC GCT GTC
#350 YL_VeUC_for: CCT GCA GGC GCC CAC CCC TCC TG
#351 YL_VeUC_rev: CCT CGA GGT CAG CGC GCC GTT GC
#397 YL_PsAH_mutS179A_for: GAC ACC GCA GGC GCG GGG CGA GTG
#398 YL_PsAH_mutS179A_rev: CAC TCG CCC CGC GCC TGC GGT GTC
#405 CaUAL_28a_for: GAG AGT CGA CAA TCA TAC TTA GGT TGG TCA GTA G
#406 CaUAL_28a_rev: GAG ACT CGA GTT ATT CTA AAA CAA CCA CTA AAT CAC C
#407 ScUAL_28a_for: GAG AGT CGA CAA ACA GTT AGT TCC GAT ACA ACT GC
#408 ScUAL_28a_rev: GAG AGC GGC CGC TCA TGC CAA TGT CTC TAT G
#409 CaUAL_pESC_for: GAG AGC GGC CGC ATG GGC AGC AGC CAT CAT C
#410 CaUAL_pESC_rev: GAG AAG ATC TTT ATT CTA AAA CAA CCA CTA AAT CAC CG
#411 ScUAL_pESC_for: GAG AGC GGC CGC ATG GGC AGC AGC CAT CAT C
#412 ScUAL_pESC_rev: GAG AAT CGA TTC ATG CCA ATG TCT CTA TGA CGG
#417 Gal1_for: ATT TTC GGT TTG TAT TAC TTC
#418 Gal1_rev: GTT CTT AAT ACT AAC ATA ACT
#419 Gal10_for: GGT GGT AAT GCC ATG TAA TAT G
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#420 Gal10_rev: GGC AAG GTA GAC AAG CCG ACA AC
#457 YL_RePCUC_for: CAC CTG CAG GGT CCC ATA TCC AAG ATA CTC GTT GC
#458 YL_RePCWsUC_Infor: CTA CAC CAC CCG CTT CTT GAA TGA TTT TGT CGT GG
#459 YL_RePCWsUC_Inrev: GAC AAA ATC ATT CAA GAA GCG GGT GGT GTA GCT G
#460 YL_RePCPsUC_Infor: CTA CAC CAC CCG CTT CCT GGA AGG TCT GGT GTA TCG
#461 YL_RePCPsUC_Inrev: CAC CAG ACC TTC CAG GAA GCG GGT GGT GTA GCT G
#462 YL_ScUC_for: CCC TGC AGA AGA AGT TAT TTG ATA CC
#463 YL_ScUC_rev: GGG TCG ACT CAT GCC AAT GTC TCT ATG
#464 YL_CaUC_for: CCC ATA TGA AAA AAC CAT TCA ATT C
#465 YL_CaUC_rev: GGC TCG AGT TAT TCT AAA ACA ACC AC
#466 YL_WsUCBC_rev: GAC CTC GAG TCA TCA GAA TCT CGT GCT CTG CG
#467 YL_PsUCBC_rev: CAC CTC GAG TCA TCA GCC GTG GAC GCG TTG C
#484 YL_RePCUC_for2: CAG GAT CCC CCA TAT CCA AGA TAC TCG TTG C
#485 YL_PsUCBC_rev2: CAC CTC GAG TCA TCA GCA ACG CGT CCA CGG CTG ACC AC
#493 YL_GbUCMBP1_for: GGG GCT AGC ATG TTC GAT CAT GTT CTG G
#494 YL_GbUCMBP1_rev: GCA AGC TTT CAG GCT TCC TCC TCG ATC AG
#495 YL_VeUCMBP1_for: CCG CTA GCA TGC CCA CCC CTC CTG G
#496 YL_VeUCMBP1_rev: CGA AGC TTT CAG CGC GCC GTT GC
#497 YL_CT8MBP1_for: GTA TGC GGC CGC AGA TAC GTT CGA GGT GTT AAG CGG
#498 YL_CT8MBP1_rev: GTC GGA TCC CTA CTA TTC GTC GCT TTG GAA ATC AGC C
#499 YL_PsUCMBP1_for: GTA TGC GGC CGC ATT CGA CAA ACT GCT G
#500 YL_PsUCMBP1_rev: GTC GGA TCC TCA GTC TGC TGC CAG C
#501 YL_GST_for: CAC TGC AGA TGT CCC CTA TAC TAG G
#502 YL_GST_rev: GGG GAT CCA TCC GAT TTT GGA GG
#503 YL_GbUC_GST_for: GGG TCG ACT GTT CGA TCA TGT TCT GG
#504 YL_GbUC_GST_rev: GCC TCG AGT CAG GCT TCC TCC TCG
#505 YL_VeUC_GST_for: CCG GAT CCA TGC CCA CCC CTC CTG G
#506 YL_VeUC_GST_rev: CGC TCG AGT CAG CGC GCC GTT GC
#507 YL_CT8_GST_for: GGG GGA TCC GAG GTG TTA AGC GGC G
#508 YL_CT8_GST_rev: GCC TCG AGT CAT CAT TCG TCG CTT TGG AAA TC
#509 YL_PsUC_GST_for: GGG GGA TCC TTC GAC AAA CTG CTG ATC GCC
#510 YL_PsUC_GST_rev: CCC TCG AGT CAG TCT GCT GCC AGC
#511 YL_kan_UALKO_S1.1: GAA ATA TCT TTT TTA TAG TCA CAA TAA ATT TCA GTT
TTG ATT AAA AAC GTA CGC TGC AGG TCG AC
#512 YL_kan_UALKO_S2.1: GAC TAA ATG AGT GCT CCT TTG ATT TTA GAT GCC AAC
AAA AGG TAA TAT CGA TGA ATT CGA GCT CG
#513 YL_kan_UALKO_S1.2: CAG TGG AGC AGC TGA TAT ACA CCA AAT TTC AAT TTA
CAT TAA TAT AAA AGA TAA AAA ATA GAA AT
#514 YL_kan_UALKO_S2.2: CTA TGT ACA TAT ATA TTC GTC ATT AAA AAT AGC TAG
AAA AAG GCA TGC TAT AAA GAC TAA ATG AGT GCT C
#515 YL_kan_UALKO_A1: GGC TCA AGT TTT TAT AAG C
#516 YL_kan_UALKO_A2: CTT TTC ATA CAT TTT ACA G
#536 YL_GbUCMBP2_rev: CCC CAA GCT TTC AGG CTT CCT CCT CGA TCA G
#537 YL_VeUCMBP2_rev: CCC CAA GCT TTC AGC GCG CCG TTG C
#538 YL_CT8MBP2_for: AAG GAA AAA AGC GGC CGC AGA TAC GTT CGA GGT GTT
AAG CGG
#539 YL_PsUCMBP2_for: AAG GAA AAA AGC GGC CGC ATT CGA CAA ACT GCT G
#540 YL_CaUAL_AHBC_for: GAG GAA GCA GCT GTA GCC TAG TAA GTT TTG GAC
TCT TAT GAC TAC AAG CC
#541 YL_CaUAL_AHBC_rev: GGC TTG TAG TCA TAA GAG TCC AAA ACT TAC TAG
GCT ACA GCT GCT TCC TC
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#542 YL_ScUAL_AHBC_for: GTG ATT TCT TTG CTA AAG CAA AAG TTT CTA CAT AGT
AAT TGA ACT CTT ATC AAT ATG AGC CTA CCG CC
#543 YL_ScUAL_AHBC_ rev: GGC GGT AGG CTC ATA TTG ATA AGA GTT CAA TTA CTA
TGT AGA AAC TTT TGC TTT AGC AAA GAA ATC AC
#544 YL_GbAH_del_for: GCT GGA GGA GAC TAA TTA GTG ACA GAT CGC GCT GGC
TGT GGT CGG
#545 YL_GbAH_del_rev: CCG ACC ACA GCC AGC GCG ATC TGT CAC TAA TTA GTC
TCC TCC AGC
#550 YL_UAL_Lys1798mut_for: CTA ATT ATT GAA GCC ATG CAA GCG GAA ATG ATT
ATA TCC
#551 YL_UAL_Lys1798mut_rev: GGA TAT AAT CAT TTC CGC TTG CAT GGC TTC AAT
AAT TAG
#552 YL_UAL_pESCURA_for: ACG CGT CGA CAT GAC AGT TAG TTC CG
#553 YL_UAL_pESCURA_rev: CCG GCT AGC TCA TCA TGC CAA TGT CTC TAT G
#554 YL_GbAH_Y299F_for: GCC AAA CTG CTG TTC GGT GGC CCA TGG G
#555 YL_GbAH_Y299F_rev: CCC ATG GGC CAC CGA ACA GCA GTT TGG C
#556 YL_GbAH_R307A_for: CCC ATG GGT TGC GGA AGC GTT GGA GGC TGT CG
#557 YL_GbAH_ R307A_ rev: CGA CAG CCT CCA ACG CTT CCG CAA CCC ATG GG
#583 YL_GbAH_S172A_for: GAC ACG GCT GGG GCC GGT CGG GTA C
#584 YL_GbAH_S172A_ rev: GTA CCC GAC CGG CCC CAG CCG TGT C
#621 YL_CaUAL_AHBC_for: GAC TCT TAT GAC TAC TAG TGA CAT GCC ATT GAA ATT
TTA C
#622 YL_CaUAL_AHBC_rev: GTA AAA TTT CAA TGG CAT GTC ACT AGT AGT CAT AAG
AGT C
#623 YL_GbAH_Y299A_for: GCT GCC AAA CTG CTG GCC GGT GGC CCA TG
#624 YL_GbAH_Y299A_ rev: CAT GGG CCA CCG GCC AGC AGT TTG GCA GC
#625 YL_GbAH_R307M_for: CAT GGG TTG CGG AAA TGT TGG AGG CTG TC
#626 YL_GbAH_R307M_ rev: GAC AGC CTC CAA CAT TTC CGC AAC CCA TG
#627 YL_CaUAL_CT_for: CTA CCT GCA GCA TGC CAT TGA AAT TTT AC
#628 YL_CaUAL_CT_rev: GTT TCT CGA GTT CAC TGT TTG AG
#631 YL_ScUAL_AHrdmmutPCR_for: GCG AAG CGA TGA TTT TTG ATC
#632 YL_ScUAL_AHrdmmutPCR_rev: GTG CAA TCT GTC TAG CAG
#633 YL_GbAH_UC_rev: GTT TTT TGG AGG CAC GCA AAT GTT CCT GAT AGG CAC
GCC ATC C
#634 YL_GbAH_UC_rev: CAT TTG CGT GCC TCC AAA AAA CCA ATG TTC GAT CAT GTT
C
#635 YL_GbAH_HindIII_for: CGC AGG AAG CTT GAG CAC CAC CAC CAC
#636 YL_GbAH_HindIII_rev: GTG GTG GTG GTG CTC AAG CTT CCT GCG
#637 YL_CaAH_for: GTT GGA AAA AGT ATC AAG AAT AGT AGC GTG CCT CCA AAA
AAC
#638 YL_CaAH_rev: GTT TTT TGG AGG CAC GCT ACT ATT CTT GAT ACT TTT TCC
AAC
#639 YL_ScAH_for: GGT GGA TTT AGA GCA TAT TAG TAA ATG TTG AAG AAA AAA
GAG TCC C
#640 YL_ScAH_rev: GGG ACT CTT TTT TCT TCA ACA TTT ACT AAT ATG CTC TAA ATC
CAC C
#641 YL_CaUAL_pESCURA_FLAG_for: GCA GAT CTC CAT GTC ATA CTT AGG
#642 YL_CaUAL_pESCURA_FLAG_rev: GGT TAA TTA ATC ATT ATT CTA AAA CAA CCA
C
#643 YL_ScUAL_pESCURA_FLAG_for: GAC GGA TCC CCA TGA CAG TTA GTT CCG
#645 YL_ScUAL_pESCURA_FLAG_rev: GCG AGC TCT CAT CAT GCC AAT GTC TCT ATG
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#646 YL_GbUC_HindIII_linker_for: GGG GAA GCT TTA CGT GCT TCT AAA AAA CCT
ATG TTC GAT CAT GTT C
#647 YL_GbUC_HindIII_linker_rev: GGG ATC GAG ATC TCG ATC C
#652 YL_ScAH2_for: CCC TGC AGA TGA CAG TTA GTT CCG
#653 YL_ScAH2_rev: CCC TCG AGC TAC TAA TAT GCT CTA AAT CC
#662 YL_ScUAL_Cdel_for: GTG GGA CCA GAC TAT GAA ATG TTG AAG AAA AAA GAG
TCC
#663 YL_ScUAL_Cdel_rev: GGA CTC TTT TTT CTT CAA CAT TTC ATA GTC TGG TCC
CAC
#666 YL_ScUAL_Cdel_HindIII_for: CCC AAG CTT GAA ATG TTG AAG AAA AAA GAG
TCC C
#667 YL_ScUAL_Cdel_HindIII_rev: CCC AAG CTT ATA GTC TGG TCC CAC
#702 YL_GbUC_Psil_rev: GGC CGA AAT CGG CAA AAT CCC
#707 YL_pET28_NcoI_for: CCA TGA TTA CGA TAT CCC AAC CAT GGA AAA CCT GTA
TTT TCA AG
#708 YL_pET28_NcoI_rev: CTT GAA AAT ACA GGT TTT CCA TGG TTG GGA TAT CGT
AAT CAT GG
#709 YL_myc-His-ScUAL_for: GAA ATA ATT TTG TTT AAC TTT ACC CGG GGA GAT ATA
CCA TGG GCA GC
#710 YL_myc-His-ScUAL_rev: GCT GCC CAT GGT ATA TCT CCC CGG GTA AAG TTA
AAC AAA ATT ATT TC
#720 YL_PsAHR319A_for: CCC GTG GGT GGC CGA GGC CTA CAG CAT CGC CGG GC
#721 YL_PsAHR319A_rev: GCC CGG CGA TGC TGT AGG CCT CGG CCA CCC ACG GG
#727 YL_CaUALBspEI1_for: GGA ATT GTG TTT GTT GGT CCA TCC GGA GAT GCC ATT
AGA AAA TTG GG
#728 YL_CaUALBspEI1_rev: CCC AAT TTT CTA ATG GCA TCT CCG GAT GGA CCA ACA
AAC ACA ATT CC
#729 YL_CaUALBspEI2_for: GGA AAA TCC TAT TTC GGA GAC TCC GGA GTA TTT TTG
GAA AGA TTT GTT G
#730 YL_CaUALBspEI1_rev: CAA CAA ATC TTT CCA AAA ATA CTC CGG AGT CTC CGA
AAT AGG ATT TTC C
#731 YL_CaUALTCCGAA3_for: GAA AGG AGG AAC TAT ATC AGG CTT GGC GAA TGG
GAC GCG
#732 YL_CaUALTCCGAA3_rev: CGC GTC CCA TTC GCC AAG CCT GAT ATA GTT CCT
CCT TTC
#733 YL_CaUALTCCGAA4_for: CAT CCT GCG ATG CAG ATC AGG CAC ATA ATG GTG
CAG GG
#734 YL_CaUALTCCGAA3_rev: CCC TGC ACC ATT ATG TGC CTG ATC TGC ATC GCA
GGA TG
#736 YL_CaUALBCsub_rdmmut_for: CAA AGC AGC CAA GGA GTC TGG
#737 YL_CaUALBCsub_rdmmut_rev: GGG TGC AGG TGT CTC TTC
#738 YL_CaUALAHBC_for: CAA GCC ACA TGC CAT TGA ATG ATT ACA ACC AGG TGC
TTA CAC TAC AG
#739 YL_CaUALAHBC_rev: CTG TAG TGT AAG CAC CTG GTT GTA ATC ATT CAA TGG
CAT GTG GCT TG
#740 YL_GbAHBC_for: CCT ATC AGC CCT CGA CCT GAG ATG TGC TGG CCC CCG GCG
#741 YL_GbAHBC_rev: CGC CGG GGG CCA GCA CAT CTC AGG TGC AGG GCT GAT
AGG
#742 YL_ScAHBC_for: GAG CCT ACC GCC ATC GAA TGA ACT TTG CCC GGT GCA CAC
AC

191
#743 YL_ScAHBC_rev: GTG TGT GCA CCG GGC AAA GTT CAT TCG ATG GCG GTA GGC
TC
#744 YL_PSPTO_4241_for: CCC CAT GGG CAT GAC TGA CTC GAC C
#745 YL_PSPTO_4242_for: CCC CAT GGG CAT GAA CTC ACA TAA TC
#746 YL_PSPTO_4241_His_for: CCC TGC AGA TGA CTG ACT CGA CC
#747 YL_PSPTO_4241_rev: GGC TCG AGT CAT CAA GCG AAC AGG CGG
#748 YL_PSPTO_4242_His_for: CCC TGC AGA TGA ACT CAC ATA ATC
#749 YL_PSPTO_4242_rev: GGC TCG AGT CAT CAG TCG CGA ATC AGC
#750 YL_PaUAL_for: CCC CAT ATG ATG GCT TCG ACA TTC GG
#751 YL_PaUAL_rev: GGG AAG CTT CTA TTA TTC CAG CCA CAG CAG
#772 YL_CaUALBlidrdmmut_for2: GGG GGT AAA ATC TAT TG
#773 YL_CaUALSfol_for: CAA AGC AGC CAA GGA GTC AGG CGC CGA AGC TAT CAT
CCC AGG
#774 YL_CaUALSfol_rev: CCT GGG ATG ATA GCT TCG GCG CCT GAC TCC TTG GCT
GCT TTG
#775 YL_mycScUALchromefor: GAA ATA TCT TTT TTA TAG TCA CAA TAA ATT TCA GTT
TTG ATT AAA AAG AAC AGA AGT TGA TTT CCG
#776 YL_mycScUALchromerev: GCT ATA AAG ACT AAA TGA GTG CTC CTT TGA TTT
TAG ATG CCA ACA AAA GGT AAT TCA TGC CAA TGT
CTC TAT G
#777 YL_CaUALCdel_SalIfor: CCC GTC GAC TTC AAT TCA GTT TTG GTT GC
#778 YL_CaUALCdel_SalIrev: CCC GTC GAC GGT AGA TTT TGG TAA TAA GTA CAA
TTC
#779 YL_CaUALHis_for: CCC TCA CTA AAG GGC GGC
#780 YL_CaUALHis_rev: CCA AAC CTC TGG CGA AGA ATT G
#781 YL_PaUAL*toY_for: GGC TCG CTT CTC TGG AGA GTT ATT CAA TCA TGT TCA
GCA CCG
#782 YL_PaUAL*toY_rev: CGG TGC TGA ACA TGA TTG AAT AAC TCT CCA GAG AAG
CGA GCC
#792 YL_ScUALchromint500_for: CCC CGT CGA CCC AGG CTT TTT CCC C
#793 YL_ScUALchromint500_rev: CCC GGA TCC GAT GGA GGT TGG ATG
#794 YL_ScUALchromint1000_for: CCC CGT CGA CGG TCC CCG CTG AAA C
#795 YL_ScUALchromint1000_rev: CCC GGA TCC GGG GAA GTT AAG AGA GAA G
#808 YL_CaUAL_S176A_for: GGT ACC GAT ACT GCT GGA GCA GGA AGA GTC CCC
GCA G
#809 YL_CaUAL_S176A_rev: CTG CGG GGA CTC TTC CTG CTC CAG CAG TAT CGG
TAC C
#810 YL_CaUAL_K1819E_for: GAT TGT TGT TGA AGC AAT GGA AAC AGA AAT GGT
TGT TAA TGC ACC
#811 YL_CaUAL_K1819E_rev: GGT GCA TTA ACA ACC ATT TCT GTT TCC ATT GCT TCA
ACA ACA ATC
#828 YL_UAL_BdomainSacI_for: GGC TAA GAA AGT CGC CGC GGA ATT GGA ATA CCC
#829 YL_UAL_BdomainSacI_rev: GGG TAT TCC AAT TCC GCG GCG ACT TTC TTA GCC
#830 YL_UAL_BdomainNgoMIV_for: GGA GAT GGT TTT GGT ACG GCC GTT GCT TTG
GGC GAA C
#831 YL_UAL_BdomainNgoMIV_rev: GTT CGC CCA AAG CAA CGG CGG TAC CAA AAC
CAT CTC C
#832 YL_YCplacBrdmmut_for: GTT GGT CCT TCG GGA G
#833 YL_YCplacBrdmmut_rev: CCC AAA CTT TCA GCT GCC
#834 YL_ScUALD1326A_for: CCT TCA AAC ACT CAC GCT TAC GTT TAT TCT CTG GG
#835 YL_ScUALD1326A_rev: CCC AGA GAA TAA ACG TAA GCG TGA GTG TTT GAA GG
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#836 YL_ScUALY1329F_for: CAA ACA CTC ACG ATT ACG TTT TTT CTC TGG GTG CAA
TTA ATT TC
#837 YL_ScUALY1329F_rev: GAA ATT AAT TGC ACC CAG AGA AAA AAC GTA ATC GTG
AGT GTT TG
#838 YL_ScUALE1795A_for: GGT CAA GGG CTA CTA ATT ATT GCA GCC ATG AAA GCG
G
#839 YL_ScUALE1795A_rev: CCG CTT TCA TGG CTG CAA TAA TTA GTA GCC CTT GAC
C
#842 YL_CaUALK1819Q_for: GCA TTA ACA ACC ATT TCT GTT TGC ATT GCT TCA ACA
ACA ATC
#843 YL_CaUALK1819Q_rev: GAT TGT TGT TGA AGC AAT GCA AAC AGA AAT GGT
TGT TAA TGC
#844 YL_CaUALK1630A_for: GTT CTT GAT GGA TTA TAT GCG GTA CCC AAT AAT CTA
TGT CTT GGG
#845 YL_CaUALK1630A_rev: CCC AAG ACA TAG ATT ATT GGG TAC CGC ATA TAA TCC
ATC AAG AAC
#846 YL_CaUALE949Q_for: GAC CAT TTC TGT AAT TGG ATG TTG AAC TTG TAA TCT
GGC
#847 YL_CaUALE949Q_rev: GCC AGA TTA CAA GTT CAA CAT CCA ATT ACA GAA ATG
GTC
#848 YL_YCplac33_NgoMIV2_for: GTA TTT ATA TAC TAA GCT GCC GGT GGT TGT TTG
CAA GAC CG
#849 YL_YCplac33_NgoMIV2_rev: CGG TCT TGC AAA CAA CCA CCG GCA GCT TAG
TAT ATA AAT AC
#850 CB_UAAP_for: AGC TGG TAC CTC GAT GAC TGA CTC GAC CAC CC
#851 CB_UAAP_rev: ATC CCT GCA GGT CAA GCG AAC AGG CGG TC
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